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ABSTRACT 
 
Oligomerization of the LysR-Type Transcriptional Regulators  
in Escherichia coli. (May 2008) 
Gwendowlyn Sue Knapp, B.S., Purdue University 
Chair of Advisory Committee: Dr. James C. Hu 
 
Protein-protein interactions regulate and drive biological processes and 
understanding the assembly of these interactions is important. The LysR-Type 
Transcriptional Regulators (LTTRs) are a large family of transcriptional regulators 
found in prokaryotes. I have used the LTTRs as a model for protein specificity. In order 
to understand a residue’s contribution to oligomerization, alanine-scanning mutagenesis 
was used to probe the contribution of residues identified from in silico analysis of two 
proteins: OxyR and CynR. The contribution of the residues to oligomerization was 
characterized using lcI repressor fusions.  In OxyR, seven residues were identified as 
hot spots. Moreover, these hot spots are not especially conserved. The interaction surface 
of OxyR was mapped onto a multiple sequence alignment of the LTTR family.  This 
mapping identified putative contacts in the CynR regulatory domain dimer interface. 
Combined with the in vivo testing, three residues were identified as hot spots. The 
residues identified in OxyR and CynR do not overlap. To investigate the assembly of the 
LTTRs I used a negative-dominance assay with lcI repressor fusions. Taken together, I 
show that the LTTRs in E. coli K-12 are mostly specific in their interactions.  
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CHAPTER I 
 
INTRODUCTION 
 
 
OVERVIEW 
 
For my graduate studies, I have been working with a family of transcriptional 
regulators called the LysR-Type Transcriptional Regulators (LTTRs) as a model to study 
protein-protein interactions.  In this dissertation, I describe the work that I have done to 
understand the oligomeric properties of the LTTRs. In this first chapter, I will first 
introduce the basic concepts of protein oligomerization.  Second, I will examine general 
characteristics of protein-protein interfaces.  Third, I will review the LTTRs from E. coli 
K-12 that have been studied. Finally, a review of the LTTRs with available high-
resolution crystal structures is provided. 
 
PROTEIN-PROTEIN INTERACTIONS 
 
 Protein-protein interactions regulate and drive biological processes in highly 
specific manners and they consist of polypeptide chains associating to form a particular 
quaternary structure. These polypeptide chains can be encoded by one or more genes.  If 
the polypeptides are identical, the complex is said to be homotypic, while two or more 
different polypeptide chains interacting is said to be heterotypic. Larger complexes can 
contain both homo- and heterotypic interacting polypeptides, but by definition, the 
minimum number of interacting polypeptides is two.  However, the cap on the number  
____________ 
This dissertation follows the style of Protein Science. 
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of interactions is essentially unlimited.  
 Protein-protein complexes are abundant in many biological processes.  A review 
of the enzymes involved in glycolysis show that all enzymes except phosphoglycerate 
kinase are comprised of multiple subunits (Klotz et al. 1975).  Furthermore, all enzymes 
in the TCA cycle have a quaternary structure that is higher than a monomer. What 
advantage, though, does a cell gain by using protein complexes instead of one large 
polypeptide?  Several advantages have been proposed. First, utilizing smaller subunits to 
assemble into larger complexes can require less DNA, allowing for the size of the 
genome to be smaller than what would be needed for processing many single, large 
macromolecules. Secondly, a smaller polypeptide restricts the number of errors 
introduced during the processing of the polypeptide than a larger polypeptide.  Finally, 
genes encoding an oligomer with either an advantageous or deleterious mutation are 
more rapidly selected for or against than a monomeric protein, most likely due to the 
higher copy number of the subunits in the complex than that of a monomeric protein 
(Klotz et al. 1975).  
Recent studies of protein-protein interactions have focused on cataloguing those 
proteins that form complexes and characterizing the physical and chemical nature of the 
interior interface of an oligomer; it is the latter on which I will focus.  
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CHARACTERISTICS OF THE PROTEIN-PROTEIN INTERACTION 
INTERFACE 
The physical and chemical properties of a protein-protein interaction are 
important as they contribute to the specificity and stability of the oligomer. Studies 
analyzing a set of protein-protein interactions are comprised of protein complexes 
crystallized and deposited in the Protein Database (PDB) (Berman et al. 2000).  The 
dataset are non-redundant within themselves and do not contain structures that fall into 
domain-swapping categories (Liu and Eisenberg 2002).  Domain-swapping proteins will 
not be discussed further. Factors such as the size of the interface, the type and number of 
bond interactions, the types of residues involved in the interface and the contribution of 
these residues to oligomerization have been examined (Argos 1988; Janin et al. 1988; 
Jones and Thornton 1995; 1996; Chakrabarti and Janin 2002; Wodak and Janin 2002; 
Bahadur et al. 2003). These factors and their influence on protein-protein interactions are 
discussed below.  
 
Types 
 
Jones and Thornton (1996) categorized protein-protein complexes into 
permanent and non-obligate complexes.  By definition, the subunits that make the 
permanent complexes exist only in the complex, meaning that these proteins are not 
found as monomeric subunits without denaturation in vitro. Though homooligomers 
contribute largely to this class, hetero complexes are also found. Non-obligate 
complexes can exist independently as individual subunits and assemble into the 
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appropriate protein-protein complexes.  Primary examples include enzyme-inhibitor and 
antibody-antigen complexes. Specifically, Jones and Thornton (2000) give cytochrome c 
peroxidase (CCP) and cytochrome c in yeast as examples of non-obligate association. 
Both exist separately, but interact with one another for respiration in yeast. 
 
Size 
 
The size of the interface can be measured by calculating the change in solvent 
accessible surface area (ASA) when going from a monomeric to the oligomeric state 
(Chothia 1974).  Upon complex formation, part of a monomer of a protein-protein 
complex is buried in the interface, protecting a portion of the subunit from the aqueous 
environment. Those residues that are buried are said to be part of the oligomer interface.  
The size of the interface in homooligomeric proteins (permanent complexes) is 
correlated to the size of the protomer (Jones and Thornton 1996).  Burial of 5% of the 
monomer was suggested as a minimum for this stabilization (Argos 1988).  In other 
complexes, such as an inhibitor-enzyme complex, the size of the interface is limited by 
the size of the smallest participant. 
 
Amino Acid Composition 
The types of residues found at the protein-protein interface have been 
investigated.  Jones and Thornton (1995) calculated that the interface was composed of 
residues that were 47% hydrophobic, 37% polar and 22% charged. The exterior of the 
protein was comprised of residues that were 41% hydrophobic, 29% polar and 30% 
charged. The amino acid composition of the interior of the protein was calculated and 
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determined to be 71% hydrophobic, 23% polar and 6% charged. Comparing the 
numbers, the interface of the protein-protein interaction is more similar to the exterior of 
the protein than that of the interior. This observation was also noted by Argos (19888).  
Jones and Thornton (2000) compared the residue composition of permanent 
dimer complexes and non-obligate dimer complexes.  They concluded that non-obligate 
complexes tend to be more hydrophilic as the individual subunits exist in the cell 
independently, while the permanent complexes are more hydrophobic. Wodak and Janin 
(2002) also recognize this general conclusion.  
The residue frequency of each residue type in the interface has been calculated.  
In Janin et al. (1988),  leucine was the most common residue in the interface, followed 
by arginine..  Jones and Thornton (1995) agreed with this observation.  In their 
comparison of permanent and non-obligate interfaces, they also observed that histidine, 
tyrosine and tryptophan had a higher propensity of being in the non-obligate interface  
(Jones and Thornton 2000). 
 
Bonds 
The variety of bonds in a protein-protein interface contribute to the overall 
stability of the complex and also places restrictions on the structures, forcing the binding 
faces of an oligomer to be somewhat complementary (Chothia and Janin 1975). 
 Hydrogen bonds have been suggested to provide specificity of the protein-
protein complex. In their study of 75 complexes, Lo Conte et al. (1999) determined that 
there are average of 10.1 hydrogen bonds per interface. Further, the different types of 
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hydrogen bonds were calculated: 0.24 were main-chain-main-chain, 0.4 were main-
chain-side-chain and 0.36 were side-chain-side-chain.  
The number of salt bridge interactions was found to vary among complexes, with 
a range of zero to five.  There is not a clear correlation between the number of salt 
bridges at an interface and the size of an interface (Jones and Thornton 1996).  
 
Cores and Rims 
 Because of the differences observed between the obligate and non-obligate 
residue compositions, Chakrabarti and Janin (2002) observed that it was difficult to 
identify protein interaction sites based on chemical composition. Thus, they took a 
different approach in studying protein-protein interfaces. 
 Using 70 non-obligate complexes, they demonstrated that the interfaces can be 
subdivided into different patches.  In the larger interfaces (>2000Å2), there were several 
different patches.  In interfaces < 2000Å2, there was one patch identified. Within each 
patch, a core and rim is identified. A core residue is defined as having at least one atom 
of a residue buried in the interface.  A residue is in the rim if they contain only 
accessible atoms.  In a study of 122 homodimers, Bahadur et al. (2003) determined that 
the core had an amino acid composition similar to that of the protein interior. The core of 
the patch was more hydrophobic.  In approaching the rim, the hydrophobicity decreased.    
 
CONTRIBUTIONS OF INDIVIDUAL RESIDUES 
 
 While general characteristics of protein-protein interactions can be described, 
these properties give little insight into the energetic contributions of individual residues.  
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Determining which residue in the interface contributes to the binding of a complex 
yields important information concerning complex formation.  Replacing a residue with 
an alanine generates a hole in place of atoms distal to Cß in the wild-type residue.  
Studying protein-protein interactions using alanine scanning is useful because it allows 
for the selective removal of individual side chains to probe the contribution of that 
specific side chain to protein binding.  The hole created by the alanine can do one of 
several things to the complex.  The bond between the subunits may be weakened, 
decreasing the affinity of the monomers.  Conversely, the bond may have been a de-
stabilizing contributor to the complex.  The removal of the wild-type residue thus may 
stabilize the complex.  Finally, replacing the residue may do nothing to the complex.   
These ideas were most clearly demonstrated in examining the human growth 
hormone (hGH) receptor binding with the extracellular domain of hGHbp (Clackson and 
Wells 1995). In this study, thirty-three alanine mutations were made at the interface of 
the hGHbp. Only two residues had a large change in binding energy (>4.5kcal/mol), 
while significant effects were seen for four residues (1.5-3.0 kcal/mol). Further, these 
residues were in contact with other residues that did not contribute greatly to the binding 
free energy.  
Residues that contribute significantly to the overall binding energy of a protein-
protein complex are termed hot spots.  ASEdb, the first database to have assembled 
alanine-scanning data, was assembled to anaylse the available data as a whole, 
identifying several trends  (Bogan and Thorn 1998). First, despite the large size of 
binding interfaces, single residues contribute a large fraction of the free-binding energy 
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in an interface.  Second, these hotspots are generally surrounded by energetically 
unimportant contacts referred to as an O-ring around the hotspots.  Third, hot spots are 
generally near the center of the interface and in contact with other hot spots of the 
opposite subunit. In addition to the Bogan and Thorn dataset, Hu et al. (2000) found that 
hot spots are enriched for tryptophan, tyrosine and arginine.    
Alanine-scanning continues to be an important technique in studying the 
contribution of a residue to the oligomerization of a protein and new databases continue 
to attempt to mine the literature.  Contributions to AESdb are still accepted. However, 
while submissions of data are still accepted, active curation of the current literature does 
not appear to be a priority.  Ninety-one protein-protein interaction complexes are noted, 
representing 118 different proteins. Fischer and colleagues have organized a new 
database, termed BID (Binding Interface Database) that has mined and curated the 
primary literature (Fischer et al. 2003). A wiki format has been implemented to allow for 
community annotation of the interactions. Currently, 467 interaction pairs with 7000 hot 
spots are in the database (Tsai 2008).  
 
 
THE LysR-Type TRANSCRIPTIONAL REGULATORS  
 
The LysR-Type Transcriptional Regulators (LTTRs) are a diverse family of 
oligomeric transcription factors that are found in prokaryotes.  The family was initially 
identified by Henikoff in 1988 with roughly 50 members (Henikoff et al. 1988).  With 
the continuous sequencing of new genomes, that number has grown to over 18,000 
potential members (IPR000847 HTH_LysR (Quevillon et al. 2005)), making it perhaps 
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the largest family of transcriptional regulators among prokaryotes.   
In E.coli K-12 the target genes of the LTTRs include those that are involved in 
general functions of nitrogen source utilization, amino acid biosynthesis and catabolism, 
oxidative stress response and detoxification of the cell (Christman et al. 1989; Schell et 
al. 1990).  In other organisms, however, LTTRs serve a more glamorous role. RovA of 
Yersinia pestis is a global transcription factor that plays a role in virulence (Cathelyn et 
al. 2006).  Work from the Rahme lab has shown MvfR from Pseudomonas aeruginosa 
PA14 serves a critical role in pathogenicity by regulating quorum-sensing regulated 
virulence factors (Xiao et al. 2006a; Xiao et al. 2006b).  In Vibrio cholerae, AphB, in 
cooperation with AphA, is needed for activation of the ToxR virulence cascade, by 
activating the tcpPH operon (Kovacikova and Skorupski 1999).    
In general, LTTRs act as transcriptional regulators, typically activating their 
target gene or operon and negatively regulating their own gene.  Most are homotetramers 
and respond to the presence of a small-molecule inducer. The regulators are able to bind 
to DNA in the absence of the small-molecule.  In the ir presence, however, there is a 
conformational change that alters the binding and/or bending of the DNA. They have a 
general binding site of T2-N11-A2.  Table 1.1 shows a summary of the 46 E. coli K-12 
LTTRs as identified by version 1of the COGs database.  Below, I will discuss the 20 E. 
coli K-12 LTTRs described in the literature.  I have grouped them into three categories: 
well-characterized, characterized and annotated. 
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Well-characterized LTTRs 
1. AaeR 
AaeR is the transcriptional regulator for the aae operon and lies upstream of the 
aae promote. The operon was identified using DNA microarrays by exposing E. coli 
cells to p-hydroxybenzoic acid (pHBA) (Van Dyk et al. 2004).  The three genes in the 
aae operon had at least a ten-fold increase in transcript level in the presence of pHBA.  
AaeA and AaeB comprise an efflux pump and membrane protein, while AaeX is a small 
protein of unknown function.  
AaeR was demonstrated to be necessary for the expression of the operon by 
introducing a plasmid containing the aaeXAP-luxCDABE gene fusion into a strain 
containing a null mutation in aaeR, as well as the isogenic parental strain. When both 
strains were exposed to various levels of pHBA, there was up to a 90-fold increase of 
luciferase activity in the wild-type as compared to the null mutant.  pHBA, which is an 
intermediate in ubiquinone biosynthesis, plays the role of a signal sensor for metabolic 
imbalance in the cell and is thought to be the inducer of AaeR, though specific binding 
of pHBA to AaeR has not been demonstrated. The concentration of pHBA is normally  
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Table 1.1. Summary of the E. coli K-12 LysR-Type Transcriptional Regulators 
  Member Other Name Target Gene, Operon or Regulon Associated Small-molecule*  
1. AaeR yhcS yhcSRQP/ aaeARXAB pHBA, salicylate, benzoate,  
2. Alls ybbs, glxA1 allD allantoin or glyoxylate 
3. ArgP iciA argK, argO, dnaA L-arginine 
4. Cbl   cysteine regulon 5’-phosphosulphate 
5. CynR   cyn operon  Cyanate 
6. CysB   cysteine regulon O-accetyle serine; N-accetyle serine 
7. DsdC   dsdA D-serine 
8. GcvA   gcv operon Purines and glycine 
9. HcaR phdR, yfhT hca operon 3-phenylpropionic acid 
10. IlvY   positive regulator of ilvC Acetoacetate, acetohydroxyburate 
11. MetR   metA, metE, metH, glyA Homocysteine, methionine 
12. NhaR antO nhaA, pgaABCD Na+ or Li+ 
13. OxyR momR activator of oxyS Oxidative stress response 
14. TdcA   Tdc operon None known 
15. XapR   xapA Xanthosine 
16. AbgR ydaK Possibly abg operon p-aminobenzoyl-glutamate  
17. LeuO   Leu operon None known 
18. LrhA genR flagellar, motility and chemotaxis genes  None known 
19. LysR   positive regulator of lys Diaminopimelate 
20. Nac   nitrogen assimilation control proteins None known 
21. YafC   putative LysR-type transcriptional regulator Not known 
22. YagP  putative LysR-type transcriptional regulator Not known 
23. YahB   putative LysR-type transcriptional regulator Not known 
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Table 1.1. Continued 
  Member Other Name Target Gene, Operon or Regulon Associated Small-molecule*  
24. YbdO   putative LysR-type transcriptional regulator Not known 
25. YbeF   putative LysR-type transcriptional regulator Not known 
26. YbhD   putative LysR-type transcriptional regulator Not known 
27. YcaN   putative LysR-type transcriptional regulator Not known 
28. YcjZ   putative LysR-type transcriptional regulator Not known 
29. YdaK   putative LysR-type transcriptional regulator Not known 
30. YdcI   putative LysR-type transcriptional regulator Not known 
31. YdhB   putative LysR-type transcriptional regulator Not known 
32. YeaT   putative LysR-type transcriptional regulator Not known 
33. YeeY   putative LysR-type transcriptional regulator Not known 
34. YeiE   putative LysR-type transcriptional regulator Not known 
35. YfeR   putative LysR-type transcriptional regulator Not known 
36. YfiE   putative LysR-type transcriptional regulator Not known 
37. YgfI   putative LysR-type transcriptional regulator Not known 
38 YgiP   putative LysR-type transcriptional regulator Not known 
39. YhaJ   putative LysR-type transcriptional regulator Not known 
40. YhjC   putative LysR-type transcriptional regulator Not known 
41. YiaU   putative LysR-type transcriptional regulator Not known 
42. YidZ   putative LysR-type transcriptional regulator Not known 
43. YifD+A   putative LysR-type transcriptional regulator Not known 
44. YjiE   putative LysR-type transcriptional regulator Not known 
45. YneJ   putative LysR-type transcriptional regulator Not known 
46. YnfL   putative LysR-type transcriptional regulator Not known 
*This does not mean binding of the molecule to the protein.  The small-molecule merely influences the activity of the 
LTTR. 
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low. When metabolic processes are unbalanced, the level of pHBA increases, allowing 
for the activation of the aae operon. 
 
2. AllS 
The allantoin regulon consists of genes that are transcribed from three promoters: 
allA, glc and allD (Cusa et al. 1999).  Under anaerobic conditions, the genes in the 
regulon allow for the utilization of allantoin as a sole source of nitrogen, breaking down 
the allantoin into ureidoglycolate.  The ureidoglycolate has two fates: NH4+, CO2 and 
ATP or 3-phosphoglycerate.  Allantoin and glyoxylate induce all three promoters; 
however, different gene products are required depending on the condition. allA and glc 
are expressed under both aerobic and anaerobic conditions, while allD is only expressed 
under the anaerobic conditions.  AllR represses allA, glc and allS in the absence of 
glyoxylate.  
allS, also known as ybbS, encodes a transcriptional regulator that targets allD 
(Rintoul et al. 2002).  Binding of AllS to the allD promoter was shown to be 
independent of any intermediates.  Further, the binding site of AllS had the LTTR 
binding motif of T5-N5-A2-C-A2.  
 
3. ArgP 
Mutations in argP were identified in cells that were able to grow in the presence 
of canavanine, which is a natural analog for arginine.  It was observed that there was a 
40% reduction in the transport of L-arginine, L- lysine and L-ornithine.  Additionally, the 
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ATP binding protein ArgK had a 20% reduction in activity.  The mutations in these 
canavanine resistant strains mapped to argP.  Thus, the author concluded ArgP, the 
product of argP, is a regulator of the process of transporting arginine (Celis 1999).  In 
vitro transcription assays showed that ArgP was able to increase transcription of argK 
seven-fold.  The addition of 10mM L-arginine inhibited binding of ArgP to the DNA.   
 In the same study, Celis observed that the previously published sequence called 
iciA was identical to that of argP (Thony et al. 1991).  IciA was previously identified as 
an inhibitor of chromosomal initiation replication in vitro (Hwang et al. 1992) as well as 
an activator of transcription of dnaA (Lee et al. 1996; Lee et al. 1997). The author 
proposes that ArgP and IciA are the same protein (Celis 1999). 
 
4. Cbl 
Cbl, standing for CysB-like, is responsible for the regulation of the tau and ssu 
gene clusters.  These genes allow for the utilization of taurine or alpiphatic sulphonates 
for the liberation of sulphite, which enters the cysteine biosynthesis system.  These genes 
are repressed under conditions with cysteine or sulphate present.   Cbl and CysB were 
shown to bind directly to the tau and ssu promoters (van Der Ploeg et al. 1999).  Cbl and 
not CysB is only able to activate transcription, with CysB having a negative effect on the 
ssu promoter (Bykowski et al. 2002).   Expression from ssu promoter by Cbl was 
inhibited by 5’-phosphosulphate (APS) (van Der Ploeg et al. 1999). cbl is activated by 
CysB, the master regulator of sulphur assimilation (see below).   
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5. CynR 
CynR is the transcriptional regulator of the cyn operon, which encodes genes that 
allow cyanate to be used as a sole source of nitrogen. The operon consists of cynT, cynS, 
cynX, which encode a carbonic anhydrase, a cyanase and a protein of unkown function, 
respectively (Sung and Fuchs 1988).  Plasmids encoding for cynR were able to restore 
the function of CynR in strains deleted for cynR (Sung and Fuchs 1992).   In DNA 
binding experiments in vitro, CynR was able to bind to DNA in the presence or absence 
of cyanate.  However, CynR binding induced bending of the DNA. The amount of DNA 
bending was decreased in the presence of cyanate (Lamblin and Fuchs 1994).  
 
6. CysB 
CysB is the positive regulator of the cys genes, which are needed for the uptake 
and reduction of oxidized forms of inorganic sulfur to sulfide.  Full expression of the 
genes requires the small molecule inducer N-acetylserine and low sulphur conditions. 
CysB, like other LTTRs, repress its own transcription (Jagura-Burdzy and Hulanicka 
1981). In solution, CysB is a tetramer of four individual subunits.  Through the use of 
circular DNA fragments to study the amount of bending, Hryniewicz and Kredich 
(Hryniewicz and Kredich 1994) calculated bend angles of 102° and 96° with the cysK 
and cysP promoters. Upon the addition of N-acetylserine, the bending relaxed to 
approximately 50° for both promoters. At cysB, acetylserine reduces CysB binding to 
DNA and thus relieves the self- repression.   
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7. DsdC 
DsdC was shown to be a specific activator of dsdX and dsdA, requiring D-serine 
for activation. D-serine deaminase, the product of dsdA, enables E. coli to use D-serine 
both a sole source of carbon and nitrogen in minimal media, by breaking it down to 
pyruvate and ammonia; the function of dsdX is not known. Otherwise, D-serine is toxic 
to the cell, as it inhibits L-serine and panthothenate synthesis.   
 
8. GcvA 
GcvA is one of five regulators of the gcv operon (Heil et al. 2002). This operon 
contributes enzymes that are part of the glycine cleavage pathway.  In the presence of 
glycine, GcvA activates the gcv operon.  In the presence of purines a five-fold repression 
of the operon is observed (Jourdan and Stauffer 1998).  Glycine, however, does not bind 
to GcvA, interacting instead with GcvR. With DNaseI footprinting assays Wilson et al. 
(Wilson et al. 1995) demonstrated the presence of three GcvA binding sites in the region 
between gcv and gcvA.  All three sites were needed for repression of gcv in the presence 
of purines, while only two were necessary for activation by glycine. 
In their model, Heil et al. proposed that in the absence of glycine, Lrp and GcvA 
helped to bend the DNA, such that GcvA and GcvR could interact to form a GcvA-
GcvR-GcvA complex, with each protein binding at individual sites. In the presence of 
glycine, the GcvR is displaced, allowing for interactions between the two units of GcvA 
and the a subunit of the RNA polymerase (Jourdan and Stauffer 1999; Ghrist et al. 2001; 
Heil et al. 2002). 
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9. HcaR 
HcaR controls the expression of hcaE, hcaF, hcaC, hcaB and hcaD, which are 
genes that code for dioxygen detoxification processes, as well as catabolism of 3-
phenylpropionic acid.  In a 2D gel electrophoresis study comparing wild-type E. coli to 
an E.coli hcaR::cat strain, 51 proteins were found whose regulation is influenced by the 
absence of hcaR (Turlin et al. 2005).  Expression of several glycolysis and TCA cycle 
enzymes decreased, while some of the gene products involved in gluconeogenesis 
increased.  Additionally, genes involved in the oxidative stress response where 
identified: thioredoxin reductase, DNaK and MnSOD.  Further investigation 
demonstrated these observations to be related to the regulatory effect that HcaR has on 
hcaA. 
 
10. IlvY 
IlvY is the transcriptional regulator for ilvC, whose product is acetohydroxy acid 
isomeroreductase (EC 1.1.1.86), an enzyme involved in the synthesis of branched chain 
amino acids.  The induction of ilvC requires IlvY, as well as either of its two substrates:  
a-acetolactate or a-acetohydroxybutyrate.  Binding of IlvY to the ilvC promoter was 
shown to be required, but not sufficient, for the transcription of ilvC (Rhee et al. 1998).  
The presence of an inducer molecule prompted a conformational change in the IlvY-
DNA complex, enhancing the RNA polymerase recruitment to the ilvC promoter region.  
This mechanism of the presence of a small-molecule causing a conformational change in 
the protein-DNA complex is the most common mode of activation in the LTTR family. 
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The mechanism by which IlvY forms protein-DNA complexes was intensely studied and 
was the first of the LTTRs to have its mechanism elucidated.   
 
11. MetR 
MetR plays a role in the regulation of met gene expression. Currently, MetJ and 
MetR are known regulators of these genes. While MetJ, which is not a LTTR, appears to 
be the global regulator, MetR is specifically necessary for the expression of metE, with 
homocysteine required for full metE expression. Further, the full-expression of metH 
requires MetR, though basal levels of metH are higher than that of metE in the absence 
of MetR protein, with homocysteine having a negative effect on metH expression. 
Expression of metA was shown to require MetR, though the presence of homocysteine 
decreased the activation of metA by MetR (Mares et al. 1992).  Additionally, MetR has 
shown to play a role in the expression of glyA.  Plamann and Stauffer demonstrated that 
MetR and homocysteine were required for activation of glyA (Plamann and Stauffer 
1989), while Lorenz and Stauffer investigated the binding region of MetR in the 
upstream region of glyA (Lorenz and Stauffer 1995).  
 
12. NhaR 
nhaA encodes a sodium antiporter and is responsible for growth in alkaline pH in 
the presence of Na+ (Padan et al. 1989).  It was demonstrated that a multi-copy plasmid 
containing nhaR could enhance the activation of a nhaA’-‘lacZ fusion  in a Na+ 
dependent manner. The effect of NhaR was not seen without Na+ (Rahav-Manor et al. 
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1992).   Additional studies by Goller et al. showed that NhaR could activate the 
pgaABCD operon. This operon is needed for the production of poly-ß-1,6-N-acetyl-D-
glucosamine (PGA), which is a necessary molecule in biofilm formation. Strains deleted 
for nhaR had a decrease in the formation of biofilm and PGA was undectable (Goller et 
al. 2006).  
 
13. OxyR 
The transcription factor OxyR senses H2O2.  OxyR targets genes that are 
involved in the cells response to oxidative stress, including oxyS, ahpCF, katG, dps, 
sufA, grxA, gorA and itself, oxyR. Two positions, Cys199 and Cys208 were shown to be 
important for the activation of OxyR.  Changing these positions to serine caused OxyR 
to be unable to activate its target genes.  Upon exposure to H2O2, there is a large subunit 
rotation (as shown in the crystal structures (Choi et al. 2001), see below for more details) 
to facilitate bringing these two cysteines closer together and allowing for disulfide bond 
formation.  The redox potential of OxyR was determined to be -185mV, well below the 
cells internal redox potential of -260mV (Zheng et al. 1998).  Therefore, OxyR is 
reduced under normal growth conditions.   
 
14. TdcA 
TdcA is an unusual LTTR, as it is transcribed with the genes that it targets: the 
tdc operon.  The tdc operon is involved in the transport and metabolism of threonine and 
serine during anaerobic growth.  It is interesting to note that there is an upstream, 
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divergently transcribed gene, tdcR, which is necessary for the expression of tdc.  There 
are two mechanisms of tdc expression: one that is influenced by metabolic intermediates 
and one that is under anaerobic control.  The latter is described elsewhere 
(Chattopadhyay et al. 1997; Sawers 2001).  The former is influenced by CAP and IHF, 
with TdcR and TdcA required for full expression.  tdcA was identified as being a 
member of the LTTRs, as well as demonstrating that the tdcA gene product could act in 
trans as a positive regulator of tdc (Ganduri et al. 1993). Further, work from the Datta 
lab went on to show that all named factors above act together for the regulation of tdc, 
suggesting bending and looping of DNA were involved (Hagewood et al. 1994).   
 
15. XapR 
In E. coli, xanthosine is cleaved into the nucleoside base and pentose-1-
phosphate in a reaction catalyzed by xanthosine phosphorylase, which is encoded by 
xapA (Seeger et al. 1995).  xapA lies in an operon with xapB, which encodes a 
membrane protein similar to NupC, which is a nucleoside transport protein.   xapA and 
xapB expression is dependent on the transcriptional regulator, XapR (encoded by the 
gene xapR), as well as xanthosine.  
XapR, unlike the majority of LTTRs, is constitutively expressed and not 
autoregulated.  Mutant studies of XapR have identified regions important for xanthosine 
binding.  Additionally, these studies have identified mutants that can be induced by other 
nucleosides; in particular, deoxyinosine (Jorgensen and Dandanell 1999). 
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Characterized 
16. AbgR 
AbgR is implicated as the regulator of the regulator of abgA, abgB and abgT 
genes whose products are involved in the uptake and catabolism of p-aminobenzoate. 
AbgR is transcribed in the opposite direct of abg.  AbgR has 27% identity to TdcA (see 
below) (Hussein et al. 1998).  They also found in the abgR-abgA intergenic region two 
half sites of 5’ –GATAA-3’, which is one-half of the T-N11-A typical LTTR binding site 
(Carter et al. 2007).  Taken together, this is strong evidence that AbgR is the regulator of 
abg; however, further investigation is needed. 
 
17. LeuO 
LeuO is a complicated LTTR.  It has been shown to have several jobs in E. coli.  
First, it has been shown to activate the leuLABCD operon.  Second, it has been shown to 
affect the expression of DsrA-RNA, which is a small regulatory RNA (Klauck et al. 
1997). Through this regulation, LeuO indirectly reduces rpoS levels at low temperatures.  
Additionally, LeuO has been shown to relieve H-NS dependent bgl silencing.  The 
expression of LeuO is sensitive to levels of ppGpp (Fang et al. 2000).  H-NS severely 
represses the expression of leuO.  
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18. LrhA 
 LrhA was identified as a global regulator for chemotaxis, flagella and motility. 
Comparing the expression of MG1655 and a MG1655 lrhA- identified a large number of 
genes whose expression was upregulated when compared to the wild-type MG1655.  In 
the same study, it was further shown that, unlike the majority of LTTRs, LrhA 
positively regulates its own expression.  There is no known inducer of LrhA.  
 
19. LysR 
LysR is the namesake of the LTTR family. It regulates lysA, which encodes a 
diaminiopimelate decarboxylase and is responsible for the conversion of 
diaminopimelate to lysine (Stragier et al. 1983).  It was originally known that mutations 
in lysA led to a Lys- phenotype. Attempts to more precisely map the lysA gene led to the 
discovery of a second class of mutants that led to the Lys- phenotype: mutations that 
were found in lysR.  Stragier and colleagues went on to further characterize LysR to 
identify the characteristic divergently transcribed promoters of the LTTR to its target 
gene (Stragier and Patte 1983).  
 
20. Nac 
The nitrogen assimilation control protein, or Nac, appears to serve a role of 
transcriptional regulator in nitrogen metabolism of E. coli.  Among the genes it targets, it 
represses gdh and asnC, while activating codAB, nupC and gabDTPC (Muse and Bender 
1998; Zimmer et al. 2000; Poggio et al. 2002; Muse et al. 2003).  There is no clear 
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inducer of nac. It should be noted that Rosario and Bender (Rosario and Bender 2005) 
observed Nac from Klebsiella pneumoniae to be a tetramer while Nac from E. coli 
appears to be a dimer.   
 
Annotated 
The following gene products have been annotated based on the clusters of 
orthogolous groups (Tatusov et al. 1997) : YafC, YagP, YahB, YbdO, YbeF, YbhD, 
YcaN, YcjZ, YdaK, YdcI, YdhB, YeaT, YeeY, YeiE, YfeR, YfiE, YgfI, YgiP, YhaJ, 
YhjC, YiaU, YidZ, YifD+A, YjiE, YneJ, YnfL.  At the time of this writing, no further 
information could be found on these gene products.  
 
ORGANIZATION OF THE LTTR POLYPEPTIDE 
The LTTRs are relatively the same size of roughly 300 residues.  Numerous 
mutational experiments were done to probe the mechanism of transcriptional activation 
by LTTRs, identifying several regions with different functions.  The N-terminus, 
consisting roughly of the first 60 residues, is responsible for the binding of the DNA 
molecule. Several studies have identified residues in this region that are necessary for 
the activation of the target gene. Residues 92- 271 comprise the inducer 
binding/oligomerization domain.  Finally, residues 272-298 contribute to the activation 
of the target gene and, in some cases, to the DNA binding.  This organization is shown 
in Table 1.2. 
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Table 1.2. Organization of the Polypeptide of the LTTR 
DNA Binding Domain Helical linker Oligomerization/ Inducer 
Binding Domain 
Activation 
1-60 59-88 92-271 272-298 
 
 
 
The N-terminal DNA binding domain was shown to consist of a helix- turn-helix 
motif. Though previously published similarity scores only included about 50 LTTRs, 
there was a >20% identity in this region amongst the LTTRs (Schell 1993).  Mutational 
analyses of several LTTRs have probed the role of residues in the DNA-binding domain 
to identify two main classes of mutations.  The first class consists of mutations that 
contribute to the DNA-binding of the protein.  GcvA from E. coli requires positions V32 
and S38 for binding DNA (Jourdan and Stauffer 1998).  Mutagenesis studies in OxyR 
found that the following mutations: R4C, Y8C, A22V, P30L, T31M, L32F, S33N and 
R50W significantly lowered or even abolished the ability of OxyR to activate 
transcription at PoxyS  (Kullik et al. 1995a; Wang et al. 2006).  In CysB several mutations 
were found to affect DNA binding:  I33N (Colyer and Kredich 1994), S34R (Kredich 
1992), T21, E41K, L44R and I48T REF.  Further, in NahR from Pseudomonas several 
positions including T26, A27, P35, R43, R45 and T56 had importance for DNA binding.  
It was thought that, in general, residues 23-45 held significance for protein-DNA 
interactions (Schell 1993).   However, with additional LTTRs being identified, that 
window could be expanded.   The second class of mutations in this region affected 
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activation.  In the same study of GcvA, positions L30 and F31 were identified as causing 
a defect in activation of gcvT-lacZ fusion (Jourdan and Stauffer 1998).  
Using the CbnR numbering (because it is the only LTTR with an available high-
resolution crystal structure for the full protein), residues 59-88 consist of a region that is 
comprised of a coil-coil domain. This region serves as a linker, connecting the regulatory 
domain to the DNA binding domain. A systematic and detailed analysis of this region is 
not found in the literature.   
The C-terminal domain, comprised of residues 88- to the end of the protein is 
known both as the regulatory domain and the effector binding domain; the majority of 
oligomerization occurs here. The details of the available structures are discussed 
elsewhere (see below). However, extensive mutational analysis looking for an inducer 
binding site have mapped the area to the C-terminal domain, thus the name.  The overall 
structure of this domain looks like a periplasmic sugar binding protein.   
CbnR: The Full-length Structure  
 
Although there are many members in the LTTR family, there are only a few 
high-resolution atomic structures available.  The first structure of a full- length LTTR 
was CbnR from Ralstonia eutropha NH9. Ogawa et al. demonstrated that cbnABCD was 
the target of CbnR by utilizing transcriptional fusions in the presence of 3-
chloroobenzoate or benzoate, two inducers of CbnR.  In the absence of inducers, a 60 bp 
region  from -20 to -80 upstream of cbnA was protected by CbnR (DNase I footrpinting).  
Further, they showed a bending of DNA occurred (70°) without the inducer. In the 
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presence of cis-cis muconate, this was relaxed to 54°.  It was noted that the footprint did 
not change in the presence of 1mM inducer.   
The structure of CbnR was solved to a resolution of 2.5Å (Muraoka et al. 2003) 
and was comprised of a homotetramer, consisting of a dimer of dimers.  Examination of 
the monomers shows two distinct conformations: extended and compact. It is 
hypothesized that these conformations facilitate the promoter binding and DNA bending, 
as described above (Muraoka et al. 2003). 
The regulatory domain of CbnR can be divided into two subdomains, regulator 
domains I and II. RDI, consisting of residues 88-161 and 265-294, contains a core of 
five ß-strands, three a-helices and a 310-helix. RDII is similar to that of RDI. RD1 and 
RDII are connected by a ß-strand and a loop. Both features combined is called hinge 
region 3. It is thought that this hinge region undergoes a conformational change upon 
inducer binding.  Although the inducer was present in the crystallization reaction, it was 
not found in the structure. However, mutational analysis of CysB, OxyR and NahR 
strongly suggest that the binding site is located in the hinge region 3. (Schell et al. 1990; 
Kullik et al. 1995a; Lochowska et al. 2001)f 
 
Structures of Regulatory Domains : BenM, CatR, Cbl, CynR, CysB, DntR and 
OxyR 
Crystallization of full- length LTTRs has been described as being difficult, due to 
solubility issues.  Further, the inducer’s ability to bind to the protein may be hampered 
by the high-salt conditions of crystallization. (Ezezika et al. 2007).  Nonetheless, high-
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resolution structures of regulatory domains were available before the publication of the 
CbnR structure, and continue to be described thereafter. The important structural 
features of the available regulatory domain crystal structures are depicted below. 
 
1. BenM 
BenM, from Acinetobacter baylyi ADP1, works with CatM for aromatic 
compound degradation. In the presence of benzoate, BenM works with CatM to activate 
genes for the utilization of benzoate as a sole-source of carbon and represses genes that 
consume other aromatic compounds.  The combined presence of both cis,cis-muconate 
and benzoate (both effectors of BenM) was shown to have a synergisitic effect on 
transcriptional activation on benA (Bundy et al. 2002).   
The structures of BenM and CatM are the only structures available that have 
physiologically relevant effectors co-crystallized. The effector binding domain was 
crystallized and found to be an a/ß domain much like that of CbnR (Ezezika et al. 2007).  
As in other C-terminal domains, there are two regions separated by a hinge region.  
Domain I consists of residues 87 to 161 and residues 268 to the end of the C-terminus. 
Domain II is comprised of residues 162-267. 
cis,cis-muconate was present in one subunit of BenM between domain I and 
domain II.  This site has been designated the primary binding site and is highly 
conserved in CatM (see below). A molecule of benzoate was discovered in a secondary 
effector-binding site. The authors speculate that this site must be a high-affinity site, as 
exogenous benzoate was not present in crystal conditions.    
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In crystals that were soaked in benzoate, benzoate was bound to both the primary 
and secondary effector-binding sites.  The benzoate interacts in a mainly hydrophobic 
fashion, with residues L100, L105, I108, F144, L159, I269 and I289 interacting with the 
ring of benzoate.  Comparison of structures with bound and unbound benzoate in the 
secondary site led the authors to predict that a charge-relay system enhances the signal 
from the bound muconate in the primary site.  At the heart of their argument is Glu162.  
When benzoate is not present in the site, Glu162 forms a salt-bridge with Arg160. They 
speculate that when benzoate binds at the secondary site, Arg160 forms a salt-bridge 
with the carboxyl of benzoate.  This causes Glu162 to form a salt-bridge with Arg146, 
which is located in the primary site, where cis,cis-muconate is bound. Formation of the 
salt-bridge leads to an increased electrostatic potential on the cis,cis-muconate, which 
allows for the helixes to tighten up on the cis,cis-muconate.  The authors suspect that this 
conformational change will then affect transcription (Ezezika et al. 2007).   
 
2. CatM 
CatM from Acinetobacter baylyi ADP1 works with BenM for the utilization of 
benzoate as a sole source of carbon.  Unlike BenM, CatM only responds to cis,cis-
muconate as an inducer.  BenM and CatM have 59% sequence identity with an overall 
similarity of 85%.  The structure of CatM’s effector binding domain was solved by 
Momany and colleagues (Ezezika et al. 2007).  
The overall structure of CatM is similar to that of BenM.  The a/ß fold is the 
same as seen in other C-terminal domains of LTTRs.  Both the structures with bound 
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and unbound cis,cis- muconate were solved.  The muconate molecule was found in the 
equivalent primary binding site of BenM and the protein-molecule interactions are 
similar. Extensive hydrogen bonding between the carboxylates of the cis, cis- muconate 
occurs with residues comprising the effector binding pocket, including Ser99, Thr128, 
Lys129, Pro201, F203 and Val227.  Various water molecules are also involved. A 
difference between the binding of the cis,cis- muconate of BenM and CatM is seen at 
position 98.  In CatM, there is a serine, which does not interact with the molecule. In 
BenM, position 98 is glycine. In BenM, a water molecule is able to fill the space at the 
position. 
 
3. Cbl 
The regulatory domain of Cbl was published in 2006 by Bujacz and colleagues 
(Stec et al. 2006).  The structure was reported to 2.8 Å resolution and the effector 5’-
phosphosulphate was modeled.  Residues 88-307 were included in all four chains solved. 
Two subdomains exist and the crossover region is residues 163-166 and 266-269.  RDI 
has residues 88-162 and 270-307, while RDII has residues 166-265.   
 
4. CynR 
 The structure of the regulatory domain of CynR with no inducer was deposited 
into the PDB (2HXR). The authors were kind enough to share the structure of the 
regulatory domain with the inducer (Personal Communication, Alexi Savchenko).  These 
structures are addressed further in Chapter III.  
  
30 
 
5. CysB 
Tyrell et al. (Tyrrell et al. 1997) described the 1.8Å crystal structure of residues 
88-324 of CysB from Klebsiella aerogenes (PDB 1AL3). The fragment consists of two 
a/ß domains, which the authors call I and II.  The two regions are connected by cross-
over regions encompassing 163-166 and 266-269.  Region I contains residues 88-162 
and 270-292, while II is comprised of residues 166-165. The first domain having five ß 
strands, which form a ß-sheet, and four a helices. The second domain is similar to the 
first, having five ß sheets and only three helices.  
A cleft of 10 Å wide with a diameter of 6 Å was found and included residues 
100, 101-103, 149, 164, 166, 202 and 270. This was thought to be an inducer binding 
pocket.  The dimerization interface is formed by a1, a2 and ßB, (residues 101-106, 109-
118 and 121-128, respectively) which pack against a VI and ßG (227-235 and 219-224, 
respectively) of the opposite monomer.  
 
6. DntR 
 DntR was isolated from Burkholderia sp. Strain DNT.  This strain (in addition to 
several others) can utilize the synthetic compound 2,4-dinotrotoluene (2,4-DNT) as a 
sole source of carbon.  2,4-DNT is of interest, as it is used in the manufacturing of 
pesticides, explosives and munitions, and is highly toxic to animals.  DntR was studied 
with a desire to design a mechanism for the detection and removal of such compounds. 
The gene for DntR was found upstream of those genes involved in the degredation of 
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2,4-DNT to usable metabolic intermediates.  Though DntR responded poorly to 2, 4-
DNT as an inducer, it was extremely sensitive to salicyclic acid.  The desire to rationally 
redesign DntR to better bind 2, 4-DNT led the authors to solve the crystal structure of 
DntR from Burkholderia sp. DNT. 
 The structure was solvedin 2004 (Smirnova et al. 2004).  The full- length protein 
was present, however only the C-terminal domain was able to be refined to a high-
resolution. 1,539Å2 were buried at the interface.  The overall structure is similar to other 
LTTR C-terminal domains, with a head-to-tail orientation.  Residues 90-166 and 274-
301 make the RDI, while residues 171-269 make up RDII.  The hinge region is 
comprised of residues 167-170 and 270-273.  Salt bridge interactions between the 
monomers were found at H228 and D105 and R248 and E300.  Acetate and thiocyanate 
were found in the inducer binding cavity and this allowed the authors to model in the 
saliclate and 2,4-dinitrotoluene. 
 The crystals of another crystallization condition than that from above showed the 
homotetramer. Though only at 3Å, these crystals had cleaner helix-turn-helix domain 
electron densities, allowing the authors to generate a full- length model of DntR.  The 
overall structure looks similar to that of CbnR, with monomeric units having either an 
extended or compact conformation.  Superposition of the CbnR and DntR molecules 
show the helical linkers positioned differently.  This positions the HTH differently then 
in CbnR, putting the HTH farther apart in DntR then in CbnR.  The authors believe that 
because CbnR had no molecule in the binding pocket, while DntR did, the CbnR 
molecule should be considered an inactive conformation, while the modeled DntR 
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structure should represent the active conformation (Smirnova et al. 2004).   
  
7. OxyR 
OxyR is a transcription factor that senses H2O2. The two structures (PDB 1I69 
and 1I6A) for OxyR contain the regulatory domain in both a reduced and oxidized form.  
When exposed to H2O2, there is disulfide bond formation between Cys199 and Cys208. 
The oxidized OxyR can then induce the cooperative binding of RNA polymerase to 
activate transcription. Similar to the other structures, OxyR consists of two a/b  domains 
that are connected via two interdomain strands.  Domain I has four b-strands and two a 
helices with domain II having b-strands 5-10 and helices C and D.  There is another b-
strand and helix that is at the end of domain II that reaches up to interact with domain I.  
Cys199 is located between the two domains, while Cys208 is at the lower end of domain 
II. In the reduced form, these two residues are substantially separated.  
The transition from reduced to oxidized form results in a major structural 
conformational change. There is a large rotation between the two subunits of 
approximately 30°.   In the oxidized form, the two loops for the active cysteines move to 
allow disulfide bond formation, bringing the Cys199 and Cys208 closer together.  The 
authors of the paper believe that there is a rearrangement of the hydrophobic core 
between the reduced and oxidized forms. In the reduced form, A233 interacts with I110 
and L124 of the opposite monomer, while in the oxidized form, the core is reformed 
between F219 and the I10 and L124.  Many proline residues stack to form a flat helix 
surface that helps the conformational change between the reduced and oxidized forms. 
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These include prolines 99, 103, 107 and 111.   
 
SUMMARY 
In summary, the global features of the regulatory domains of the LTTRs with 
available high-resolution atomic structures are the same, as shown in Figure 1.1. 
However, major differences between the structures are seen in the external faces of the 
structures. Closer examination of the structural features of the interfaces highlights that 
the structural motifs are the same. Differences of the interface features, as shown in 
Figure 1.2, are observed. Though the same motifs can be found at the interface, the 
positioning of the helix and strand to the opposite monomer show differences. How the 
residues that comprise these interface structures interact with one another is the global 
question I seek to address.  
 
OVERVIEW OF DISSERTATION 
This dissertation is an effort to dissect the residues that contribute to the 
oligomerization of the LysR-Type Transcriptional Regulators.  In Chapter II, I describe 
the work that was done to identify residues important for the oligomerization of OxyR.  
In Chapter III, I describe our efforts to determine the regions of CynR necessary for 
oligomerization.  Further, we predicted the residues identified from OxyR which may 
identify important residues for the oligomerization of CynR. In Chapter IV,  I describe 
the work that was begun to identify LysR-Type Transcriptional Regulators that could 
form potential heterotypic interactions. Chapter V describes the work done to show that 
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the  AcrAB multidrug resistant efflux pump is responsible for conferring resistance to 
methotrexate upon E. coli laboratory strains. This study was the result of my rotation 
project.  Chapter VI is a global discussion about the oligomerization of the LTTRs.  
  
35
 
Figure 1.1. Crystal Structures of LTTR Regulatory Domains.  One monomer is colored blue, the other in orange. 
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Figure 1.2. The Interface Motifs of the Regulatory Domains.  One side of the interface is colored purple, while the other face 
is colored red.
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CHAPTER II 
THE OLIGOMERIZATION PROPERTIES OF OxyR IN VIVO 
 
OVERVIEW 
We examine the contribution of residues at the dimer interface of the 
transcriptional regulator OxyR to oligomerization.  Residues in contact across the dimer 
interface of OxyR were identified using the program Quaternary Contacts (QContacts).  
Alanine-scanning mutagenesis was performed on the non-alanine or glycine residues 
identified in the resultant contact profile and the oligomerization ability of the mutant 
proteins was tested us ing the lcI repressor system to identify residues that are hot spots 
in OxyR.   Interestingly, these important residues for oligomerization are not especially 
conserved amongst a set of OxyR orthologs.  We compare the properties of these hot 
spots to those described in the literature from other systems.  
 
INTRODUCTION 
Protein-protein interactions regulate and drive many biological reactions. 
Understanding the contributions of individual residues to the oligomerization of a 
protein is necessary for appreciating the highly-specific nature of the interaction.  The 
LysR-Type Transcriptional protein OxyR is a global response regulator to oxidative 
stress.  In E. coli, OxyR controls a regulon including katG, dps, ahpCF, sufA, grxA, gorA 
and oxyS. OxyR has been extensively studied to understand the molecular basis of the 
oxidative stress response in E. coli.  In its monomeric form, OxyR is a 34kDa protein, 
  
38 
with the active form of OxyR being homoteterameric, consisting of a dimer of dimer. 
Mutational studies identified Cys199 and Cys208 necessary for the response to oxidative 
stress (Kullik et al. 1995b).  
The crystal structures of the reduced and oxidized forms of the regulatory 
domain (residues 80-305), solved by Choi et al. (2001) demonstrated a large 
rearrangement of the subunits, creating two distinct structural forms of the protein 
characterized by a 30° rotation between the subunits.  This rearrangement was brought 
about by the formation of an intramolecular disulfide bond between Cys199 and Cys208, 
which are 17Å apart in the reduced form.   
Alanine scanning has been used to investigate individual residues’ contributions 
to the oligomerization of many oligomers (Clackson and Wells 1995; Bogan and Thorn 
1998).  In this report we examine the roles of residues in the subunit interfaces of OxyR 
in stabilizing the oligomeric forms. We identified residues with potential for contributing 
to the oligomerization of OxyR utilizing QContacts (Fischer et al. 2006).  The generated 
list of residues in contact, or contact profile, was used as a guide for alanine scanning 
mutagenesis, and the ability to form oligomers was assessed using the lambda repressor 
fusion assay.  We find a small subset of the candidate residues have strong 
oligomerization phenotypes in the tetramer, consistent with these residues being hot 
spots in one or both oligomeric forms of OxyR.  Other residues in the interface have 
weaker but significant energetic contributions to oligomerization, as determined from 
repressor fusion assays using the regulatory domain instead of the full length OxyR. 
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METHODS 
Generation of the Contact Profile 
The crystal structures used in these studies were PDB files 1I69 (reduced) and 
1I6A (oxidized) (Choi et al. 2001).  The dimeric form of 1I6A was constructed using the 
PQS Server (Henrick and Thornton 1998). QContacts (Fischer et al. 2006) was used to 
calculate the residues in contact across each chain. The output of QContacts was filtered 
for redundant pair-wise interactions and the subsequent culled residue contact profiles 
are shown in Tables 2.1 and 2.2. 
 
Alanine Scanning Mutagenesis 
Using the contact profiles as a guide, the identified non-alanine and glycine 
residues of OxyR in the lcI OxyR repressor fusion were mutated to alanine. PrimerX 
(http://www.bioinformatics.org/primerx) was used to generate the primer sequence and 
primers were ordered from IDT (Iowa). Pfu Turbo (Stratagene) or Pfx Platinum 
(Invitrogen) was used for the polymerase.  pGK702 was the DNA template. Reactions 
were treated with 2U of DpnI for 2 hours and transformed into Mach1-T1R, Top1-T1R 
(Invitrogen) or XL-1Blue Supercompetent (Stratagene) cells. Transformants were 
recovered and sequenced (LPGT, TAMU).   
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Table 2.1.   Identified Residues in Contact in the Oxidized Form of OxyR 
Chain Residue # Name  Contacts Chain Residue # Name 
A 97 LEU to B 222 THR 
A 102 GLY to B 226 THR 
A 103 PRO to B 226 THR 
A 103 PRO to B 229 ASN 
A 103 PRO to B 225 GLU 
A 103 PRO to B 223 SER 
A 104 TYR to B 229 ASN 
A 104 TYR to B 225 GLU 
A 106 LEU to B 226 THR 
A 106 LEU to B 230 MET 
A 106 LEU to B 222 THR 
A 106 LEU to B 219 PHE 
A 107 PRO to B 229 ASN 
A 107 PRO to B 230 MET 
A 107 PRO to B 233 ALA 
A 107 PRO to B 226 THR 
A 110 ILE to B 230 MET 
A 110 ILE to B 219 PHE 
A 110 ILE to B 235 SER 
A 111 PRO to B 233 ALA 
A 111 PRO to B 230 MET 
A 111 PRO to B 235 SER 
A 114 HIS to B 235 SER 
A 114 HIS to B 219 PHE 
A 121 GLU to B 218 HIS 
A 122 MET to B 218 HIS 
A 123 TYR to B 218 HIS 
A 123 TYR to B 217 THR 
A 123 TYR to B 220 ARG 
A 124 LEU to B 219 PHE 
A 124 LEU to B 222 THR 
A 124 LEU to B 218 HIS 
A 124 LEU to B 221 ALA 
A 124 LEU to B 220 ARG 
A 125 HIS to B 221 ALA 
A 125 HIS to B 222 THR 
A 126 GLU to B 222 THR 
A 126 GLU to B 221 ALA 
A 126 GLU to B 223 SER 
A 126 GLU to B 226 THR 
A 126 GLU to B 128 GLN 
A 131 GLN to B 131 GLN 
A 225 GLU to B 225 GLU 
A 247 PRO to B 252 ASP 
A 248 GLU to B 252 ASP 
A 251 ARG to B 251 ARG 
A 251 ARG to B 252 ASP 
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Table 2.2.  Identified Residues in Contact in the Reduced Form of OxyR 
Chain Residue # Name Contacts Chain Residue # Name 
A 94 HIS to B 219 PHE 
A 103 PRO to B 225 GLU 
A 103 PRO to B 229 ASN 
A 106 LEU to B 229 ASN 
A 106 LEU to B 226 THR 
A 106 LEU to B 225 GLU 
A 107 PRO to B 252 ASP 
A 107 PRO to B 229 ASN 
A 107 PRO to B 228 ARG 
A 107 PRO to B 232 ALA 
A 110 ILE to B 233 ALA 
A 110 ILE to B 232 ALA 
A 110 ILE to B 229 ASN 
A 111 PRO to B 252 ASP 
A 111 PRO to B 253 GLY 
A 111 PRO to B 232 ALA 
A 114 HIS to B 233 ALA 
A 114 HIS to B 234 GLY 
A 114 HIS to B 232 ALA 
A 114 HIS to B 172 ASP 
A 114 HIS to B 170 TYR 
A 120 LEU to B 233 ALA 
A 121 GLU to B 235 SER 
A 122 MET to B 233 ALA 
A 122 MET to B 235 SER 
A 122 MET to B 230 MET 
A 123 TYR to B 219 PHE 
A 123 TYR to B 230 MET 
A 123 TYR to B 235 SER 
A 123 TYR to B 218 HIS 
A 124 LEU to B 226 THR 
A 124 LEU to B 230 MET 
A 124 LEU to B 229 ASN 
A 124 LEU to B 219 PHE 
A 124 LEU to B 233 ALA 
A 124 LEU to B 221 ALA 
A 125 HIS to B 219 PHE 
A 125 HIS to B 226 THR 
A 126 GLU to B 223 SER 
A 126 GLU to B 222 THR 
A 126 GLU to B 226 THR 
A 126 GLU to B 225 GLU 
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Identification of Candidates 
Gateway Cloning Technology (Invitrogen) was used to facilitate moving the 
mutated gene to other vectors. pGK702 contains the lcI OxyR repressor fusion. oxyR is 
flanked by the att sites for the Gateway system, effectively making this vector a 
Gateway expression vector. The mutated oxyR gene was moved into pDONR201 via the 
back reaction to generate a Gateway Entry Clone (Walhout et al. 2000). The entry clones 
were used to move the gene into several destination vectors: pLM1000 (Marino-Ramirez 
et al. 2004), pAZ299 and pGK751 (this study) via the LR reaction (see Table 2.3. for 
descriptions).  The reactions were transformed into Mach1-T1R cells. Candidate DNA 
was transformed into JH787 (Marino-Ramirez and Hu 2002) or AG1688 (Hu et al. 
1993), streak purified and freezer stocks made.  
 
Immunity Assay 
To test for the repressor fusion’s ability to oligomerize, cross-streak assays were 
done. Strains were struck out for single colonies and incubated for 16 hours at 37°C.  
Three individual colonies were challenged against lines of phage lKH4, lvir and control 
phage li21c (Hu et al. 1990) on tryptone agar plates and incubated for 7 hours at 37°C.  
Those that were able to grow across the lKH54 line were called immune and those that 
were not able to grow were sensitive.  All colonies died at the control li21c phage.  
Strains immune to lKH4 were given a score of one, while sensitive phenotypes received 
a score of zero. Each strain was tested three times with three individual colonies and the 
average calculated. 
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Table 2.3. Strains, Plasmids and Primers  
AG1688 araD139 D(ara, leu)7697, DlacX74, galU, galK, hsdR, strA F'128 lacIq lacZ::Tn5 
JH787 AG1688 F80 su3  supF 
Mach1-T1R F-  DlacX74 hsdR(rk- mk+) Drec1398 endA1 tonA 
pAZ299 P7107-cI-Gateway cassette 
pDONR201 Gateway entry clone vector; contains ccdB, CmR, KmR  
pGK702 P7107-cI-attB1-OxyR(2-305)-attB2,  AmpR 
pGK751 PlacUV5-cI-amber-Gateway cassette CmR, AmpR 
pLM1000 P7107-cI-amber-Gateway cassette CmR, AmpR 
OxyR RD GW f 5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTATGAGATGGCAAGCCAGCAGGGCGAG-3’ 
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Generation of lcI Regulatory Domain Repressor Fusions  
Entry clones were generated of the 233 amino acids that comprise the regulatory 
domain of OxyR.  Residues 80-305 of the regulatory domain of the full- length oxyR 
mutants were amplified with the primers OxyR RD GW-f and attB2 to attach in-frame 
attB sites.  Using the PCR product, entry clones were generated in pDONR201 and the 
mutated genes subsequently moved to pLM1000, pAZ299 and pGK751 to generate lcI-
regulatory domain repressor fusions. 
 
Conservation Calculations  
Ninety-seven OxyR orthologs were identified by using performing a BLAST 
search. We required the sequences have a cysteine at the equivalent E. coli positions of 
199 and 208. A multiple sequence alignment was generated using the default settings on 
CLUSTAL-W. The different residues present at each position identified in QContacts 
were counted using the program QConAAtally.pl (see Appendix A) and the identity and 
conservation at the identified positions compared. Identical residues were scored for an 
exact match to the E. coli K-12 OxyR sequence.  Conservation of residues were based on 
the following categories:  Hydrophobic residues were VPWAILFM. Polar non-charged, 
GSTYCNQ.  Positively charged positions were KRH and negatively charged residues 
were ED. A complete list of the orthologs is shown in Appendix B. 
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RESULTS 
Identification of Interface Contact Residues 
Residues in contact in both the reduced and oxidized forms of the OxyR were 
identified from the crystal structures as targets for alanine mutagenesis. Choi et al. 
described several residues that comprise the interfaces of the two forms of OxyR, 
including I110, H114, E121, L124, D172, H218, F219 and A233, but they do not present 
a comprehensive analysis of the interfaces.  To provide such an analysis, we used the 
program QContacts to identify residues in Voronoi contact across the interfaces of the 
reduced and oxidized forms. The non-redundant contact profiles generated by QContacts 
are shown in Tables 2.2 and 2.3.  The contact profile yields two types of information: the 
residues involved at the interface and the residues with which they interact on the 
opposite chain. When comparing these residues with the predicted residues from 
QContacts, we identify the specific residues described in the paper, as well as additional 
residues.  We mapped these contacts on the reduced form of OxyR, as shown in Figure 
2.1. 
In the crystal structures solved by Choi et al. (Choi et al. 2001), the transition 
from the reduced to the oxidized form is mediated by a large rotation between the two 
subunits.  To examine whether this involves formation of contacts between different sets 
of residues or changes in the contacts made by a common set of residues, we compared 
the contact profiles of the reduced and oxidized forms.  Twenty-four residues were 
found in the contact profiles for both forms, while 18 are specific to only one of the two 
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Figure 2.1. Comparison of Identified Structure Residues to QContacts.  Residues 
detected by QContacts are green. Residues only described by Choi et al. (2000) are 
colored yellow.  Residues colored purple are found in both studies. 
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forms (Figure2.2A).  However, when we examined the pair-wise contacts between the 
two profiles, only four are shared between the two forms (Figure2.2B). Additionally, 
though some atom-atom interactions are conserved, many are different.   For example, in 
the reduced form, P103 Ca is making contacts with E225 Cß and Oe1, while in the 
oxidized form, Ca is not making any contacts (not shown).  
 
Individual Residues’ Contributions to Oligomerization 
To systematically determine each residue’s contribution to oligomerization, non-
alanine or glycine residues were mutated to alanine.   The mutant oxyR genes were 
subcloned into the l repressor fusion vectors pLM1000, pAZ299 and pGK751. These 
vectors allow for increasing amounts of fusion protein to be expressed. Cross-streaks 
were performed to assay the fusions ability to oligomerize as described in the Materials 
and Methods. In all three vectors, full- length wild-type OxyR is immune.  We sorted the 
immunity results of the full- length OxyR mutations into three classes: 1) Those that were 
not able to achieve immunity in any of the vectors, 2) those that were unable to 
oligomerize in pLM1000, but able to oligomerize in pAZ299 or pGK751 and 3) those 
that behaved as wild-type, being immune in all three vectors.  These results are listed in 
Table 2.4.There are seven residues in class I, seventeen in class II and three in class III.  
Though the crystal structure of OxyR is dimeric, the full length protein is 
tetrameric (Kullik et al. 1995a).  Crystal structures of other LTTRs such as CbnR from 
Ralstonia eutropha NH9 (Muraoka et al. 2003) and DntR from Burkholderia sp. strain 
DNT (Smirnova et al. 2004) show the tetramer as a dimer of dimers.  To determine if the  
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A. Shared Residues 
 
B. Shared Contacts 
 
 
Figure 2.2. Comparison of the Contact Profiles of Reduced and Oxidized OxyR. Part 
A shows the residues found in both contact profiles. Part B shows the shared contacts 
found in both contact profiles of OxyR. 
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tetramer interactions were masking the dimeric interactions, we constructed lcI fusions 
to mutant and wild-type regulatory domains in all three vectors and assayed for 
immunity; the results are shown in Table 2.4. There are 20 class I, 8 class II and four 
class III residues.   Comparing the full- length results to the regulatory results allowed for 
subcategorization. These are also listed in Table 2.4.  The residues are illustrated in 
Figure 2.3. 
Table 2.4. Immunity Result Classes 
Position Full-length Regulatory Domain Sub-class 
E126 I I 1A 
R228 I I 1A 
E248 I I 1A 
H125 I II 1B 
H218 I II 1B 
M230 I II 1B 
S235 I III 1C 
Y104 II I 2A 
L106 II I 2A 
I110 II I 2A 
P111 II I 2A 
H114 II I 2A 
L120 II I 2A 
Q131 II I 2A 
T217 II I 2A 
S223 II I 2A 
E225 II I 2A 
D252 II I 2A 
Q128 II II 2B 
D172 II II 2B 
R220 II II 2B 
E121 II III 2C 
T226 II III 2C 
P107 III I 3A 
P103 III I 3A 
M122 III I 3A 
F219 III I 3A 
N229 III I 3A 
Y170 III II 3B 
T222 III III 3C 
H94 ND II   
L97 ND I   
L124 ND I   
  
 
 
 
 
Figure 2.3. Mapped Classes of the Full- length Immunity Results. Red, Class I, purple Class II, blue Class III. 
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Conservation of Residues 
To determine if there was a correlation between conservation of a residue 
amongst other OxyR orthologs and oligomerization, ninety-seven orthologs were 
identified (see Methods) and the number of different residues at each position calculated.  
Examination of the identity of the regulatory domain positions shows a broad range of 
numbers for both the residues that are important and not important.  Figure 2.4A shows 
this range of identity from 20-100% (red bars).  The same range of numbers is seen for 
residues that do not significantly contribute to oligomerization of OxyR (blue bars).  
Note that for simplicity, class II and class III residues were combined.  The conservation 
of a residue was calculated and based on four categories of conservation: hydrophobic, 
polar uncharged, positively charged and negatively charged (see Methods).   Considering 
conservation, the range, the range of percent conservation of the residues that contribute 
to the oligomerization largely overlaps with the residues that had no affect in 
oligomerization.   
The same analysis was applied to the full- length residues.  Considering identity 
only, the same range of percent identity found in the regulatory-domain results is found 
in both residues important and not important for oligomerization in the full- length 
(Figure 2.4B).  Our conservation calculations are different than other’s have used. Using 
the amino residues used by Keskin et al. and Guharoy and Chakrabarti, (Guharoy and 
Chakrabarti 2005; Keskin et al. 2005), we calculated conservation scores. The scores did 
not significantly alter our observed results (data not shown). Taken together, the residues 
important for oligomerization of OxyR are not more conserved than other interface  
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A.  Regulatory-Domain: Identity and Conservation 
 
 
B.  Full- length: Identity and Conservation  
 
Figure 2.4. Comparison of Identity and Conservation of Residues Based on 
Oligomerization Results. Each line represents a position that was designated important 
for oligomerization (red) or not important for oligomerization (blue). 
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residues. 
 
 DISCUSSION 
In this study, we have combined in silico analysis and in vivo testing to address 
the oligomeric properties of OxyR. The residues targeted for alanine-scanning were 
generated from analysis using QContacts. There are residues unique to each contact 
profile, as well as shared residues.   The shared residues, however, are involved in 
different contacts across the subunit, indicative of the large rotation between the subunits 
in the reduced versus oxidized form. One example is seen with described interactions by 
Choi et al. In the reduced form, A233 is interacting with I110 and L124.  In the oxidized 
form, I110 and L124 are interacting with F219 (Choi et al. 2001).  These interactions are 
detected by QContacts.   
Utilization of repressor fusions enabled a systematic study of an individual 
residue’s contribution to oligomerization. Testing the contribution of each residue in 
both a full- length and regulatory domain repressor fusion allowed us to identify residues 
that behave differently in each state. The regulatory domain removes the tetrameric 
interactions from the system, identifying residues that contribute to oligomerization, 
though not as much as residues identified by the full- length experiments (see classes 2A, 
3A, 2B and 3B) and essentially validate the residues generated from QContacts. 
 Seven residues were identified as being important for the oligomerization of 
OxyR. We calculated the conservation at these positions in OxyR orthologs and did not 
find a correlation between conservation and oligomerization.  This is uncharacteristic of 
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other hot spots found in literature.  If we consider the characteristics described in 
Chapter I, the hot spots identified in this study are not typical hot spots.  While they 
appear to largely contribute to the oligomerization, they are not interacting with hot 
spots on the opposite subunit. Further, while they are polar in nature by Hu et al. 
standards, none are tryptophan, tyrosine and only one is arginine; residues for which hot 
spots are especially enriched (Bogan and Thorn 1998; Hu et al. 2000).  
 Keskin et al.(2005), as did Bogan and Thorn (1998), found that the hot spots 
tended to be clustered together. Keskin et al. termed these hot regions.  Further, these 
regions tended to be protected from bulk solvent and located toward the center of the 
interface. We find that this is quite the opposite of our relevant OxyR positions.  As seen 
in Figure 2.3, the hot spots are distributed over the surface of the interface. Finally, the 
hot spots in OxyR are not especially conserved. This, by far, was the most surprising 
result of this study, as several studies have emphasized the observation that the hot spots 
are conserved (Tsai et al. 1996; Hu et al. 2000).   
The large rotation between the subunits observed in the transition from the 
reduced to oxidized form may provide an explanation for the uncharacteristic properties 
of the hot spots observed in this study. With such a large rotation, having all hot spots 
toward the center of the molecule may inhibit the molecule’s ability to undergo this 
conformationl change. Closer examination of the hot spots’ contacts in each crystal form 
illustrate this point. As shown in Table 2.5, in the reduced form, M230 makes 
interactions with M122, Y123 and L124. In the reduced form, these interactions are 
  
 
55 
replaced with interacting residues L106, P107, I110 and P111. Additional examples are 
found in other hot spots’ contacts. 
 
 
 
 
 
 
 
 
 
Five of the seven hot spots are involved in contacts that are shared between the 
two forms, while E248 is found only in the oxidized contact profile and R228 is found 
only in the reduced contact profile. While we have a working assumption the cell is 
under a reduced state, the assay is in vivo and the cells are being exposed to phage. This 
exposure may influence the conformation of the protein, allowing for residues in the 
oxidized profile to be detected.  
Subclasses 1B and 1C are interesting in so much that they are sensitive as full-
lengths and immune in the regulatory domain.  While we do not understand what is 
happening, one possibility may lie in the oxidation state of the protein, as this has not 
been addressed. We attempted to do the repressor assays under a constitutively oxidized 
state; however, control assays did not behave as expected and thus, the results were not 
Table 2.5. Interactions of M230 in the Reduced and Oxidized Forms 
REDUCED  OXIDIZED 
M230 M122  M230 L106 
 Y123   P107 
 L124   I110 
    P111 
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interpretable (data not shown). While we have a working assumption that the cell is in a 
reductive state, we can not be sure.  By extension, we do not know the conformation of 
OxyR. Thus, subclasses 1B and 1C may be explained by a change in oxidation. 
Subclass 3C is unique ly interesting. It is immune in both the full- length and 
regulatory domain.  We examined the location of the position, T222, and found that it 
was located toward the middle of the interface. Examination of the interacting atoms 
shows all atoms in T222 interacting with residues in V97, L106, L124, H125 and E126 
in the oxidized form and E126 in the reduced form.  H125 and E126 are both hot spot 
residues.   
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CHAPTER III 
THE OLIGOMERIZATION PROPERTIES OF CynR 
 
OVERVIEW 
 Deletion analysis and alanine-scanning based on a homology-based interaction 
model were used to identify determinants of oligomerization in the transcriptional 
regulator CynR, a member of the LysR-Type Transcriptional Regulator (LTTR) family.  
Deletion analysis confirmed that the putative regulatory domain of CynR was essential 
for driving the oligomerization of l cI repressor-CynR fusion proteins.  The interaction 
surface of a different LTTR, OxyR, was mapped onto a multiple sequence alignment of 
the LTTR family.  This mapping identified putative contacts in the CynR regulatory 
domain dimer interface, which were targeted for alanine scanning mutagenesis.   
 
INTRODUCTION 
Most LTTRS are dimers of dimers, and oligomerization is essential for their 
function as transcriptional activators. In the full- length structure of CbnR, the first LTTR 
for which a full- length structure was determined,  a coiled-coil links the DNA-binding 
domain to the regulatory domain within one monomer (Muraoka et al. 2003). There are 
two possible interactions among the monomeric subunits in dimer formation: one at the 
regulator domain of subunits B and P; the other at the a-helical linker of B and A.    
Many organisms encode multiple LTTRs in the ir genomes.  There are 47 in E. 
coli and 123 in P. aeruginosa.  Because the oligomerization of the LTTRs shows high 
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specificity (Chapter IV), the oligomerization interfaces must have diverged within a 
common structural framework to achieve specificity while maintaining stability.  To 
understand the evolution of specificity in protein interactions, we are analyzing the basis 
of regulatory domain dimerization in LTTRs.  Previously (Chapter II), we used the 
program QContacts and alanine-scanning mutagenesis to identify residues that 
contribute to the oligomerization of OxyR, identifying seven hot spot residues. 
CynR is the transcriptional regulator of the cyn operon, which encodes genes that 
allow cyanate to be used as a sole-source of nitrogen. The operon cons ists of cynT, cynS, 
cynX, which encode a carbonic anhydrase, a cyanase and a protein of unknown function, 
respectively (Sung and Fuchs 1988). CynR binds to DNA in vitro in the presence or 
absence of cyanate. CynR binding induced bending of the DNA under both conditions, 
but the amount of DNA bending was decreased in the presence of cyanate (Lamblin and 
Fuchs 1994).  Unlike OxyR, a structure for the CynR regulatory domain was not 
available when this study was begun. 
Here, we describe studies on the oligomerization determinants of CynR, using 
the domain structure of CbnR and analysis of the interaction surface of the OxyR 
regulatory domain dimer to guide deletions and alanine scanning mutagenesis. The 
results reveal interesting similarities and differences between OxyR and CynR.  During 
the course of this study, the structure of the regulatory domain of CynR without the 
inducer was deposited in the PDB (2HXR), allowing us to evaluate the performance of 
the homology-driven targeting of sites for mutations. 
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METHODS 
 
Construction of Deletion Mutations  
 
 Relevant strains, primers and plasmids are described in Table 3.1. To determine 
the equivalent positions of CbnR in CynR, a multiple sequence alignment of COG0583 
(Tatusov et al. 2000) and CbnR from R. eutrophea (Muraoka et al. 2003) was generated 
using CLUSTAL W (1.82).  The regions used to determine the constructs are based on 
those described in the crystal structure paper of CbnR.  Oligos were designed to attach 
in-frame SalI and BamHI sites and ordered from IDT (Iowa). These oligos were used to 
amplify the appropriate fragments out of full- length CynR (pGK304) and checked for 
the appropriate size on a 1.8% agarose gel, and digested with SalI and BamHI. The 
inserts were cleaned using a Qiagen PCR Clean-up Kit and ligated into digested pJH391 
digested with SalI and BamHI, generating lcI repressor fusions.  Ligations were 
transformed into AG1688 and transformants were recovered and sequenced (LPGT, 
TAMU).   
 
Immunity Assay 
Cross-streak assays were used to test the ability of the lcI fusions to oligomerize. 
In general, cells were streaked out for single colonies and incubated for 16 hours at 
37°C.  Individual colonies were challenged against lines of phage lKH4, lvir and 
control phage li21c (Hu et al. 1990) on tryptone agar plates and incubated for 7 hours at 
37°C.  Those that were able to grow across the lKH54 line were called immune and 
those that were not able to grow were sensitive.  All colonies died at the control l21c 
  
 
60 
phage.  For the deletion mutation cross-streaks, stains were simply called immune or 
sensitive, based on their phenotype to lKH54.  For other described cross-streaks, strains 
immune to lKH4 were given a score of one, while sensitive phenotypes received a score 
of zero. Each strain was tested three times with three individual colonies.  Immune 
colonies were given a score of 1, with sensitive colonies given a score of 0.  The average 
of all experiments was calculated to give an immunity score.  
 
Dimerization and Tetramerization Test 
 To distinguish between cI repressor fusions of dimer and tetramers, the clones 
were moved into JH607 and XZ980 via M-13 transduction. JH607 and XZ980 are 
strains that are used to distinguish cooperative oligomerization and have been previous ly 
described (Zeng and Hu 1997).  Briefly, JH607 contains the construct l112OsPs, which 
contains a synthetic promoter that drives expression of cat and lacZ. A weak lambda 
operator overlaps the promoter and a strong operator is upstream of the weaker 
promoter.  Strong repression is only detected in higher order oligomerization states. 
XZ980 contains the same weak promoter. The strong upstream operator was replaced 
with a l434 operator.   ß-galactosidase assays were done according to Miller (Miller 
1972).    
 
Generation of Contact Profiles 
In chapter II, the use of QContacts to generate a contact profile of the two forms 
of OxyR utilizing the available crystal structures of the regulatory domain was 
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described.  The combined contact profiles generated from the OxyR study were used as a 
template to generate predicted CynR contact profiles. The multiple sequence alignment 
described above was used.  A PERL script called QConalign.pl (Appendix A) was 
written to parse the residues at equivalent positions in OxyR out of CynR using the 
multiple sequence alignment, generating a predicted contact profile for CynR.  
 
Alanine Scanning Mutagenesis 
Using the contact profiles as a guide, the identified non-alanine and glycine 
residues were mutated to alanine. PrimerX (http://www.bioinformatics.org/primerx) was 
used to generate the primer pairs and primers were ordered from IDT (Iowa). Pfu Turbo 
(Stratagene) or Pfx Platinum (Invitrogen) was used for the polymerase.  pGK343 was the 
DNA template. Reactions were treated with 2U of DpnI for 2-6 hours and transformed 
into Mach1-T1R, Top1-T1R (Invitrogen) or XL-1Blue Supercompetent (Stratagene) cells. 
Transformants were picked and streak purified, cultured and plasmid recovered and 
sequenced (LPGT, TAMU).   
 
Generation of lcI Repressor Fusions with Different Expression Levels  
For each mutant, we generated a Gateway Entry Clone (Walhout et al. 2000). 
pGK343 is a lcI repressor fusion of full- length CynR with Gateway attachment sites 
flanking the full- length CynR.  The mutated cynR gene was moved into pDONR201 via 
the back reaction to generate the entry clone, transformed into Mach1-T1R cells and 
selected on LB plates containing kanamycin. Candidates were screened for the loss of 
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ampicillin resistance by streak purification on LB kanamycin and LB ampicllin plates. 
The entry clones were used to move the gene into several destination vectors: pLM1000 
(Marino-Ramirez et al. 2004), pAZ299 and pGK751 via the  LR reaction.  The reactions 
were transformed into Mach1-T1R cells. Candidates were screened for loss of grown on 
LB kanamycin, LB chlorepnenicol and ability to grow on LB ampicillin.  All constructs 
were subjected to restriction mapping to ensure the appropriate clone was generated.  
Depending on  the fusion, the plasmid was transformed into either JH787 (Marino-
Ramirez and Hu 2002) or AG1688 (Hu et al. 1993).   
 
Generation of lcI Regulatory Domain Fusions  
Entry clones were generated of the mutated regulatory domains.  Residues 89-
299 of the regulatory domain of the full- length CynR mutants were amplified with the 
CynR RD GW-f and CynR RD GW-r or attB2 in-frame attB sites.  Using the PCR 
product, entry clones were generated in pDONR201.  To generate lcI regulatory domain 
fusions, most of the mutated genes were subsequently moved to pLM1000, pAZ299 and 
pGK751. 
 
Growth Curves 
 
 2mL overnights of strains deleted for cynR, cynT or cynS and the parental 
BW25113 were grown in LB with aeration at 37°C. Cultures were typically diluted 
1:200 into 25mL of pre-warmed Minimal A + 0.2% glucose  + AAA-Arg. Cells were 
grown in a 37°C shaking water bath until an OD600 of 0.2 was reached.  Freshly made 
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KCON was added to 1mM or 5mM concentrations and growth monitored by removing 
.5mL samples and measuring the OD600.  
 
 
Table 3.1. Relevant Strains, Primers and Plasmids 
pGK304 P7107-cI-amber-CynR 
pGK343 P7107-cI-amber-att-CynR-att 
pJH391 PlacUV5-cI vector 
pLM1000 P7107-cI-amber-Gateway® cassette 
pGK751 PlacUV5-cI-amber-Gateway® cassette 
pAZ299 P7107-cI-Gateway® cassette 
AG1688 araD139 D(ara, leu)7697, DlacX74, galU, galK, hsdR, strA 
F'128 lacIq lacZ::Tn5 
JH787 AG1688 F80 su3 supF  
JH607 AG1688 l112OsPs 
XZ980 AG1688 lXZ970 
Mach1-T1 F-  DlacX74 hsdR(rk- mk+) Drec1398 endA1 tonA 
CynR RD-GW-f 5’GGGGACAAGTTTGTACAAAAAAGCAGGCTATCTGA
CGCGAGGATCGCTG 
CynR RD GW-r 5’GGGGACCACTTTGTACAAGAAAGCTGGGTCCTACC
GTGATTCATTTCCGCCAA-3’ 
BW25113 D(araD-araB)567, DlacZ4787(::rrnB-3), lambda-, rph-1, 
D(rhaD-rhaB)568, hsdR514  
JW0311 BW25113 cynS781(del)::kan 
JW0330 BW25113 DcynT780::kan 
JW5894 BW25113 DcynR::kan 
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RESULTS 
 
Regions Sufficient for Oligomerization 
 
The crystal structure of CbnR showed interactions between all four subunits.  If 
named A, B, P and Q, interactions between B and P at the C-terminal region were 
observed, with interactions between subunits A and B at the helical linker.  To determine 
which portions of the CynR protein were necessary and sufficient for oligomerization, 
deletion mutations of CynR were fused to the DNA binding domain of lcI to construct l 
repressor fusions.  The deletion mutations constructed are shown in Figure 3.1.  The 
repressor fusions were challenged against phage lKH54 and immunity assayed.   
 
Determination of Oligomerization State 
 
In the CbnR structure, the tetramer consists of a dimer of dimers.  To determine 
whether or not the immune fusions were forming dimers or higher order oligomers, the 
clones were moved into lacZ reporter strains that can distinguish between monomers and 
higher order oligomers (Zeng and Hu 1997) and the ability to repress the reporter was 
assayed using ß-galactosidase assays ; results are shown in Table 3.2. pZ150 is the empty 
vector. pKH101 is the N-terminal DNA binding domain of lcI repressor. The constructs 
containing only the full regulatory domain of CynR (Table 3.2, constructs F and G) 
showed repression levels similar to those of the dimeric control (pJH370).  Only the full-
length (Table 3.2, construct E) showed repression levels similar to that of the tetrameric 
control (pJH157).  Taken together with the cross-streak assays, these results indicate that 
the full regulatory domain is sufficient for dimerization while the whole protein is 
necessary for tetramerization. 
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Figure 3.1.  Constructed Deletion Mutations.  The amino acid regions in CbnR are 
described in the top row.  In the second row, the regions in CynR that were constructed 
are described. The regions included in each construct (A-J) are shaded under the 
described included amino acid region.  
 
 
   
CbnR 1-57 58-87 88-165 166-259 260-294  
CynR 1-57 58-88 89-165 166-257 258-299  
 DNA Binding 
Domain 
Helical 
Linker 
Regulatory Domain Immunity 
A   S 
B    S 
C    
 
S 
D      I 
E      I 
F     I 
G     I 
H 
 
   S 
I    S 
J    
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Table 3.2.  Assay for Higher Order Oligomers 
Construct JH607 XZ980 
pZ150 100% ± 0 100% ± 0 
pKH101 34 ± 7 116 ± 44 
pJH157 (tetramer) 4 ± 2 78 ± 24 
pJH370 (dimer) 45 ± 21 45 ± 16 
D 80 ± 44 115 ± 48 
E 7 ± 5 69 ± 4 
F 38 ± 17 85 ± 5 
G 34 ± 10 81 ± 24 
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Prediction of the CynR Interface 
 Because of the overall similarity in the structures of the regulatory domains of 
LTTRs, we hypothesized that positions important for oligomerization in one LTTR may 
be important in the oligomerization of another LTTR.  In a previous study of OxyR 
oligomerization, a set of residues that contribute to oligomerization through the use of 
alanine-scanning was identified.  Using the multiple sequence alignment described in the 
Methods and the program QConAlign.pl (Appendix A), the equivalent positions in the 
contact profiles ident ified in the OxyR study in CynR were determined, generating 
predicted contact profiles for CynR, as shown in Tables 3.3 and 3.4.  
The residues at the positions of the contact profiles were compared between 
OxyR and CynR.  Of the 42 residues in the OxyR contact profile, six positions were 
identical in both proteins: Y104, L124, E126, A221, S223 and S235. Three positions, 
251, 252 and 253, were not present in the CynR contact profile. 
 
Determination of Real CynR Interface 
 During the course of this study, the structure of the regulatory domain of CynR 
without the inducer was deposited in the PDB (2HXR).  The unreleased structure of the 
regulatory domain of CynR with sodium azide bound was graciously provided to us by 
Savchenko and colleagues, allowing for the actual contacts of the CynR structure to be 
calculated using QContacts, generating a real contact profile for each form of the CynR 
structures.   These contacts are shown in Tables 3.5 and 3.6.  
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Table 3.3 Predicted Contacts in CynR Based on Reduced OxyR 
Chain Residue # Name Contacts Chain Residue # Name 
A 103 S to B 225 S 
A 103 S to B 229 E 
A 106 I to B 229 E 
A 106 I to B 225 S 
A 106 I to B 226 A 
A 107 G to B 252 - 
A 107 G to B 229 E 
A 107 G to B 228 L 
A 107 G to B 232 R 
A 110 M to B 233 R 
A 110 M to B 232 R 
A 110 M to B 229 E 
A 111 A to B 252 - 
A 111 A to B 253 - 
A 111 A to B 232 R 
A 114 Y to B 233 R 
A 114 Y to B 234 T 
A 114 Y to B 232 R 
A 114 Y to B 172 H 
A 114 Y to B 170 A 
A 120 I to B 233 R 
A 122 L to B 233 R 
A 122 L to B 235 S 
A 122 L to B 230 L 
A 122 L to B 218 V 
A 123 Q to B 219 I 
A 123 Q to B 230 L 
A 123 Q to B 235 S 
A 123 Q to B 218 V 
A 124 L to B 226 A 
A 124 L to B 230 L 
A 124 L to B 229 E 
A 124 L to B 219 I 
A 124 L to B 233 R 
A 124 L to B 221 A 
A 125 Q to B 219 I 
A 125 Q to B 226 A 
A 126 E to B 223 S 
A 126 E to B 222 N 
A 126 E to B 226 A 
A 126 E to B 225 S 
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Table 3.4.   Predicted Contacts in CynR Based on Oxidized OxyR 
Chain Residue # Name Contacts Chain Residue # Name 
A 97 V to B 222 N 
A 102 T to B 226 A 
A 103 S to B 226 A 
A 103 S to B 223 S 
A 103 S to B 229 E 
A 103 S to B 226 A 
A 104 Y to B 229 E 
A 104 Y to B 225 S 
A 106 I to B 230 L 
A 106 I to B 222 N 
A 106 I to B 219 I 
A 106 I to B 226 A 
A 107 G to B 229 E 
A 107 G to B 230 L 
A 107 G to B 233 R 
A 107 G to B 226 A 
A 110 M to B 235 S 
A 110 M to B 230 L 
A 110 M to B 219 I 
A 111 A to B 233 R 
A 111 A to B 230 L 
A 111 A to B 235 S 
A 114 Y to B 235 S 
A 114 Y to B 219 I 
A 121 T to B 235 S 
A 121 T to B 218 V 
A 122 L to B 218 V 
A 123 Q to B 218 V 
A 123 Q to B 217 V 
A 123 Q to B 220 E 
A 124 L to B 221 A 
A 124 L to B 222 N 
A 124 L to B 218 V 
A 124 L to B 220 E 
A 125 Q to B 221 A 
A 125 Q to B 222 N 
A 126 E to B 223 S 
A 126 E to B 226 A 
A 126 E to B 128 S 
A 131 K to B 131 K 
A 225 S to B 225 S 
A 247 Q to B 252 - 
A 248 H to B 252 - 
A 251 - to B 251 - 
       
69 
 
 
 
Table 3.5.  Contact Profile of Uninduced CynR 
Res. Num Residue Chain Contacts Res. Num Residue Chain 
102 THR A to 225 SER B 
102 THR A to 229 GLU B 
102 THR A to 226 ALA  B 
102 THR A to 223 SER B 
103 SER A to 225 SER B 
106 ILE  A to 230 LEU B 
106 ILE  A to 229 GLU B 
106 ILE  A to 226 ALA  B 
107 GLY A to 229 GLU B 
107 GLY A to 230 LEU B 
107 GLY A to 226 ALA  B 
107 GLY A to 233 ARG  B 
108 PRO A to 233 ARG  B 
108 PRO A to 229 GLU B 
111 ALA  A to 230 LEU B 
111 ALA  A to 234 THR B 
111 ALA  A to 219 ILE  B 
111 ALA  A to 233 ARG  B 
114 TYR A to 236 LEU B 
114 TYR A to 234 THR B 
114 TYR A to 219 ILE  B 
114 TYR A to 218 VAL  B 
114 TYR A to 190 LYS B 
115 ALA  A to 234 THR B 
118 PRO A to 218 VAL  B 
118 PRO A to 190 LYS B 
120 ILE  A to 218 VAL  B 
120 ILE  A to 219 ILE  B 
121 THR A to 218 VAL  B 
121 THR A to 217 VAL  B 
121 THR A to 220 GLU B 
121 THR A to 219 ILE  B 
122 LEU A to 219 ILE  B 
122 LEU A to 218 VAL  B 
122 LEU A to 220 GLU B 
122 LEU A to 230 LEU B 
123 GLN A to 220 GLU B 
123 GLN A to 219 ILE  B 
123 GLN A to 197 GLU B 
123 GLN A to 195 SER B 
124 LEU A to 221 ALA  B 
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Table 3.5. Continued 
Res. Num Residue Chain Contacts Res. Num Residue Chain 
124 LEU A to 220 GLU B 
124 LEU A to 219 ILE  B 
124 LEU A to 222 ASN  B 
124 LEU A to 230 LEU B 
124 LEU A to 226 ALA  B 
125 GLN A to 222 ASN  B 
125 GLN A to 195 SER B 
125 GLN A to 197 GLU B 
126 GLU A to 222 ASN  B 
126 GLU A to 223 SER B 
223 SER A to 124 LEU B 
225 SER A to 225 SER B 
229 GLU A to 247 GLN B 
229 GLU A to 104 TYR B 
229 GLU A to 103 SER B 
232 ARG  A to 248 HIS B 
233 ARG  A to 247 GLN B 
248 HIS A to 229 GLU B 
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Table 3.6. Contact Profile of Induced CynR 
Res. Num Residue Chain Contacts Res. Num Residue Chain 
102 THR A to 223 SER C 
102 THR A to 225 SER C 
102 THR A to 226 ALA C 
102 THR A to 229 GLU C 
103 SER A to 225 SER C 
103 SER A to 229 GLU C 
104 TYR A to 229 GLU C 
106 ILE A to 226 ALA C 
106 ILE A to 230 LEU C 
107 GLY A to 230 LEU C 
107 GLY A to 229 GLU C 
107 GLY A to 226 ALA C 
107 GLY A to 233 ARG C 
108 PRO A to 229 GLU C 
108 PRO A to 233 ARG C 
111 ALA A to 230 LEU C 
111 ALA A to 234 THR C 
111 ALA A to 233 ARG C 
114 TYR A to 230 LEU C 
114 TYR A to 219 ILE C 
114 TYR A to 234 THR C 
114 TYR A to 236 LEU C 
114 TYR A to 218 VAL C 
114 TYR A to 190 LYS C 
115 ALA A to 234 THR C 
115 ALA A to 233 ARG C 
118 PRO A to 190 LYS C 
118 PRO A to 218 VAL C 
120 ILE A to 218 VAL C 
120 ILE A to 219 ILE C 
121 THR A to 218 VAL C 
121 THR A to 217 VAL C 
121 THR A to 216 GLN C 
122 LEU A to 219 ILE C 
122 LEU A to 218 VAL C 
122 LEU A to 230 LEU C 
122 LEU A to 220 GLU C 
123 GLN A to 220 GLU C 
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Table 3.6. Continued 
Res. Num Residue Chain Contacts Res. Num Residue Chain 
123 GLN A to 221 ALA C 
123 GLN A to 195 SER C 
124 LEU A to 220 GLU C 
124 LEU A to 221 ALA C 
124 LEU A to 230 LEU C 
124 LEU A to 219 ILE C 
124 LEU A to 226 ALA C 
124 LEU A to 223 SER C 
124 LEU A to 222 ASN C 
125 GLN A to 222 ASN C 
125 GLN A to 197 GLU C 
125 GLN A to 221 ALA C 
125 GLN A to 195 SER C 
126 GLU A to 222 ASN C 
126 GLU A to 223 SER C 
190 LYS A to 119 SER C 
190 LYS A to 118 PRO C 
197 GLU A to 123 GLN C 
225 SER A to 225 SER C 
229 GLU A to 247 GLN C 
232 ARG A to 248 HIS C 
233 ARG A to 247 GLN C 
248 HIS A to 248 HIS C 
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The two contact profiles based on the CynR structures were compared for 
similarities and differences.  We first looked at residue similarities and found that all the 
residues contributing to the interface of the uninduced contribute to the interface of the 
induced.  Only two residues were found in the induced structure that were not in the 
uninduced structure: 119 and 216.  
Next, the individual contacts contributing to the interface were compared. 
Overall, the uninduced structure had 59 contacts, while the induced structure had 60 
contacts.  Compared together, they shared 53 contacts.  The uninduced had six unique 
while induced had seven (Figure 3.2, Top).  However, examination of the actual atomic 
level interactions reveals differences between the atoms in the contacts.  For example, in 
both crystal forms, L106 interacts with A226.  In the uninduced structure, Cß of the 
alanine interacts with Cd1 of the ILE.  In the induced structure, Cß is now interacting 
with Cg2.  An additional contact of the Ca of the alanine is also interacting with Cg2 
(Figure 3.2, Bottom). 
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Figure 3.2.  Comparison of the Contact Profiles of CynR. The top portion shows the 
residues found in both contact profiles of CynR based on the crystal structures.  The 
bottom shows the contacts that are shared between the contact profiles. The atomic 
contacts, however, are different.  
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Comparisons of All Contact Profiles 
The list of residues from the predicted contact profiles were combined and 
compared to the real contact profiles of the uninduced and induced forms of CynR. 
Residues shared by the real and predicted contact profiles are shown in Table 3.7. Of the 
48 residues amongst all four contact profiles, 21 residues were found in all contact 
profiles.  Residues unique to the contact profiles based on OxyR were: R94, V97, M110, 
S128, K131, A170, H172 and L228. Residues unique to the contact profiles based on the 
CynR crystal structures were: P108, A115, P118, S119, K190, S195, E197, Q216 and 
L236  
 To illustrate why some residues predicted from the OxyR based contact profile 
were not detected in the contract profiles based on the CynR structures, the residues 
found in all contact profiles were mapped onto the surface of the structures of CynR 
(Figure 3.3).  Further, the residues found in only the contact profiles detected form the 
CynR contact profiles and the predicted contact profiles are also noted on the structure 
of CynR. The shared residues map to the interface of CynR (purple color).  
 
Individual Residues’ Contributions to Oligomerization 
 To determine a residue’s contribution to oligomerization, non-alanine or glycine 
residues were mutated to alanine.  The mutant cynR genes were moved to pLM1000 and 
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Table 3.7.  Residues from the Four Contact Profiles of CynR 
Predicted from OxyR 
Reduced 
Predicted from OxyR 
Oxidized CynR Uninduced 
CynR 
Induced 
R94 V97   
 T102 T102 T102 
S103 S103 S103 S103 
 Y104 Y104 Y104 
I106 I106 I106 I106 
G107 G107 G107 G017 
M110 M110 P108 P108 
A111 A111 A111 A111 
Y114 Y114 Y114 Y114 
  A115 A115 
  P118 P118 
   S119 
I120  I120 I120 
 T121 T121 T121 
L122 L122 L122 L122 
Q123 Q123 Q123 Q123 
L124 L124 L124 L124 
Q125 Q125 Q125 Q125 
E126 E126 E126 E126 
A170 S128 K190 K190 
H172 K131 S195 S195 
  E197 E197 
   Q216 
 V217 V217 V217 
V218 V218 V218 V218 
I219 I219 I219 I219 
 E220 E220 E220 
A221 A221 A221 A221 
N222 N222 N222 N222 
S223 S223 S223 S223 
S225 S225 S225 S225 
A226 A226 A226 A226 
L228    
E229 E229 E229 E229 
L230 L230 L230 L230 
R232 R232 R232 R232 
R233 R233 R233 R233 
T234  T234 T234 
S235 S235   
  L236 L236 
 Q247 Q247 Q247 
 H248 H248 H248 
    
  
 
 
Figure 3.3.  Mapped Comparison of the Predicted and Real Contact Profiles of CynR  The left-hand side shows one 
monomer, turned about the y-axis 180°.  On the right-hand side are the dimer complexes.  Top: Uninduced. Bottom: Induced. 
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pAZ299 and, in some cases, pGK751. These three vectors contain the lcI with the 
oligomerization domain replaced by a Gateway cloning cassette. pAZ299 and pLM100 
are under the control of a weak, constitutive promoter, P7107. pGK751 is under the 
control of Placuv5. Both pGK751 and pLM1000 contain an amber mutation at codon 103 
that is suppressed in JH787.  These three vectors were chosen to give an increasing 
amount of fusion protein. Cross-streaks were performed to assay the fusion’s ability to 
oligomerize. In all three vectors, full- length wild-type CynR is immune. We sorted the 
immunity results of the full- length CynR mutations into three classes:  1) those that were 
not able to achieve immunity in any of the vectors, 2) those that were unable to 
oligomerize in pLM1000, but able to oligomerize in pAZ299 or pGK751 and 3) those 
that behaved as wild-type, being immune in all three vectors.  These results are listed in 
Table 3.8.  There are four residues in Class I, sixteen in Class II and nine residues 
belonging to Class III.  
Because residues 89-299 are sufficient to drive oligomerization, and because the 
tetrameric contacts of the full- length could be masking the destabilization effects of the 
alanine mutation at the dimeric interface, entry clones of residues 89-299 containing the 
mutations were constructed.   These entry clones were used to construct various lcI 
fusions with the regulatory domain of CynR.  These constructs were assayed for 
immunity.  These results were sorted based on the ability to oligomerize. The results are 
shown in Table 3.8. 
Four residues were found to be required for the oligomerization of full- length 
CynR as assayed by lcI repressor fusions.  We mapped these residues onto the surface 
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of the structure and examined the residues that were exposed to the surface (Figure 3.4). 
By simple examination of the atom’s exposure to the surface, exposure to the surface, 
L228 was almost completely buried in both forms of CynR. Because it is not at the 
surface, we conclude that L228 is not directly involved in oligomerization.  However, it 
could be influencing another residue at the interface. Thus, we conclude that three 
residues in the dimeric interface of CynR are required for oligomerization: L122, E220 
and E229. 
 
Attempts to Detect Oligomerization in the Presence of Cyanate 
The small-molecule associated with CynR is cyanate.  A general characteristic of 
LTTRs is that in the absence of inducer molecule, the protein can form its tertiary 
complex and bind DNA.  Upon binding of the inducer, there is a conformational change 
among the regulatory domains.  This conformation change is most readily seen in the 
OxyR crystal structures, with the reduced and oxidized forms having a 30° rotational 
change between the subunits upon exposure to oxidative stress (Choi et al. 2001).  We 
wanted to know if immunity of CynR would change in the presence of KCON, the 
small-molecule associated with CynR.  Class I and Class III’s ability to oligomerize was 
assayed on freshly made tryptone plates containing 1 or 10mM KCON.  No change in 
immunity was detected (data not shown). 
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Table 3.8. Oligomerization Results of CynR 
  Full-length Regulatory Domain Sub-Class 
L122A I I 1A 
L228A I* I 1A 
E229A I I 1A 
L124A II I/II 2A 
Q247A II I/II 2A 
Y104A II II 2B 
I120A I/II II 2B 
I121A II II 2B 
L230A II II 2B 
R233A II II 2B 
S235A II II 2B 
Y114A II III 2C 
E126A II III 2C 
Q123A III II 3A 
Q125A III II/III 3A 
H172A III III 3C 
S223A III III 3C 
E220A I ND   
R94A II ND   
L106A II ND   
M110A II ND   
K131A II ND   
V218A II ND   
R232A II ND   
H248A II ND   
S103A III ND   
S128A III ND   
I219A III ND   
S225A III ND   
T234A III ND   
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Figure 3.4. Determination of Buried Atoms. On the left-hand side, the surface of one 
monomer is shown and the hot spots are shown as stick representations. The atoms distal 
to Ca are colored orange and red.  On the right-hand side, the complete surface is shown. 
Top: Uninduced. Bottom: Induced. 
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The Search for a Phenotype of a cynR Strain  
One of the goals of this project was to determine whether or not the lcI-full-
length CynR fusions were in fact behaving as CynR.  A mutation that did not affect 
oligomerization could be affecting other functions of the protein.  To address this, I 
attempted to find a growth phenotype for a strain deleted for cynR.  Strains deleted for 
either cynR, cynS or cynT were obtained from the ASKA collection, as well as the 
parental strain BW2511 (Baba et al. 2006).  Growth curves were done to determine if 
there was a different growth phenotype in response to the addition of KCON.   Figure 
3.5 shows a representative curve for all four strains at 0, 1 and 5mM KCON. At 1mM 
KCON, all strains grew at approximately the same rate as the cultures with no KCON.  
At 5mM KCON, though growth was significantly slower then 0 and 1mM KCON, the 
OD600 did begin to increase around the 150 minute point.  
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Figure 3.5.  Growth Curves of cyn Strains
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DISCUSSION 
 
Numerous studies of LTTRs, including CysB, NahR and GcvA identify the C-
terminal region of the LTTRs participating in oligomerization of the protein (Schell et al. 
1990; Jourdan and Stauffer 1998; Lochowska et al. 2001).  However, the crystal 
structure of the full- length protein CbnR suggests that several other regions of the 
protein could contribute to the oligomerization of the LTTR, including the coiled-coil 
linker between the DNA binding domain and the regulatory domain, and a subdomain 
near the C-terminus (Muraoka et al. 2003).  Further, mutations in the Leu41-Ile48 region 
of CysB DNA binding domain of CysB lacked a dominant-negative effect on the 
chromosomally produced CysB, suggesting that, among other possibilities, this region 
contributes to oligomerization REF.   
By expressing different pieces of CynR as lcI fusion proteins in E. coli, we 
could detect oligomerization domains.  We were able to identify domains sufficient for 
oligomerization, as well as domains that contributed to the stability of the multimer. 
Truncations containing portions of the regulatory domain were immune to phage 
infection, indicating oligomerization. In an assay based on cooperative binding to 
multiple l operators, these behaved as dimers, while the full- length protein behaved as a 
higher ordered oligomer, consistent with the observation that most LTTRs are tetramers 
and clarifies the oligomerization state of CynR. Previous reports by the Fuchs group 
have said that CynR is a dimer of dimers or it is dimeric as indicated by gel- filtration 
studies (Anderson et al. 1990; Lamblin and Fuchs 1994).  
85 
 
 
Constructs D, F and G are sufficient for oligomerization, indicating that residues 
88-257 are sufficient for oligomerization. None of these constructs are indicative of 
higher oligomer states. The region including residues 258-299, which is the only 
difference between construct D and E, is most likely involved in the stability of the 
multimer.  
The region containing the coiled-coil observed in CbnR in CynR was neither 
sufficient for driving oligomerization, nor were regions containing the coiled-coil able to 
form higher-ordered oligomers.  Muraoka et al. observed a hydrophobic patch between 
residues I71, L74 and A75, as well as two hydrogen bonds between residues R81 and 
D67 and S82 and A60 (Muraoka et al. 2003).  Analysis with QContacts detected 
additional interactions within this region. (data not shown).  Assembly of the coiled-coil 
in the tetrameric protein is most likely driven by the local environment.  
We identified three residues important that contribute to the oligomerization of 
CynR: L122, E220 and E229.  Comparisons of these hot spots with the general trends 
discussed in Chapter I show that the hot spots in CynR share several of the typical 
characteristics of hot spots.  For example, as shown in Figure 3.6, the hot spots make 
contact with another hot spot.  Additionally, the hot spots are surrounded by residues 
that are not especially important for oligomerization. However, one major difference 
observed between the hot spots and the characterized hot spots is composition. Studies 
by Bogan and Thorn and Hu et al emphasize that the hot spots are enriched for 
tryptophan, tyrosine and arginine (Bogan and Thorn 1998; Hu et al. 2000).  Two hot 
spots are glutamic acid and the other is leucine.   
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Figure 3.6. Hot Spot Contacts.  Above is the uninduced CynR interface. The 
surface of one monomer is shown. Hot spots are red.  Blue residues are Class III 
residues that are in contact with the hot spot.  Yellow are Class II residues. The 
opposite monomer is shown with the stick representation.  
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We identified the hot spots through the use of alanine-scanning mutagenesis and 
these residues were identified as targets through the use of predicted interactions. We 
used the contact profiles identified in OxyR (Chapter II) as a template to generate a 
predicted profile of the residues involved in oligomerization in CynR.  There was an 
overlap in the residues in the predicted contact profiles and the contact profiles generated 
from the crystal structures of CynR.  The differences can be attributed to the uniqueness 
of the OxyR and CynR structures, as shown in Figure 3.3. 
Due to the structural similarities between the regulatory domains of the LTTRs, 
we originally hypothesized that there would be some overlap between the residues 
identified as hot spots in OxyR and CynR.  However, as shown in Figure 3.7, this is not 
the case.  Of the seven residues from the OxyR study, three were not found in either of 
the contact profiles generated from CynR (Table 3.7).  During this study, additional 
regulatory domain crystal structures were released of various LTTRs (Chapter I).  We 
were able to utilize QContacts on these structures to determine the contact profiles. The 
contact profiles are mapped in blue in Figure 3.7. While there are some residues that are 
in the contact profile of all the RD structures, very few overlap with the hot spots of 
CynR and OxyR, supporting the idea that the protein-protein interactions in the cell are 
highly specific.  
If the hot spots are not shared amongst proteins in the same family, then one 
could hypothesize that contact residues that are unique to a structure might hold clues to 
the residues responsible for oligomerization.  For example, positions 190, 195 and 197 
were identified as being contact residues in the CynR contact profiles, while 170 and 172 
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were unique contact residues in OxyR.  Neither set of residues were found in the other 
protein. Though 190, 195 and 197 were not tested as mutations, 170 and 172 were and 
neither contributed to the oligomerization of OxyR nor to the oligomerization of CynR. 
 
  
 
 
Figure 3.7. Contact Residues and Hot Spots Mapped onto the Multiple Sequence Alignment of the LTTRs with a 
Crystal Structure.  89
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CHAPTER IV 
 
HETEROTYPIC INTERACTIONS OF THE LysR-TYPE TRANSCRIPTIONAL 
REGULATORS 
 
 
 
OVERVIEW 
 
How the protein knows which protein to form a partner with is a fundamental 
question of biology. The LysR-Type Transcriptional Regulators form perhaps the largest 
family of transcriptional regulators.  Because genomes often encode many LTTR family 
members, it is assumed that many distinct oligomers are formed simultaneously in the 
same cell without interfering with each other’s activities, suggesting specificity in the 
interactions. However, this assumption has not been tested. Through the use of a 
negative-dominant assay with lcI repressor fusions, I show that the LTTRs in E. coli K-
12 are mostly specific in their interactions.  
 
INTRODUCTION 
The LysR-Type Transcriptional Regulators (LTTRs) are a diverse family of 
oligomeric transcription factors that are found in prokaryotes.  The family was initially 
identified by Henikoff in 1988 with roughly 50 members (Henikoff et al. 1988).  With 
the continuous sequencing of new genomes, that number has grown to over 18,000 
potential members (IPR000847 HTH_LysR (Quevillon et al. 2005)), making it perhaps 
the largest family of transcriptional regulators among prokaryotes.  Numerous LTTRs 
are found in a single species. For example, E coli K-12 has 47 members, while 
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Pseudomonas aeruginosa has 112 members (Tatusov et al. 2001). 
Studies investigating the oligomerization of the LTTRs have demonstrated that 
they are homooligomeric proteins, consisting mostly of tetramers and in some cases, 
dimers.  As reviewed in Chapter I, examination of the available crystal structures shows 
an overall structural similarity (see Figures 1.2 and 1.3). These interactions are essential 
for function of the protein.  With the abundance of proteins in the cell, it could be 
potentially detrimental to the cell if the LTTRs could form heteromultimers, suggesting 
that complex formation should be highly specific. However, the specificity of the LTTRs 
has not been explicitly tested. In this study, we utilize the available lcI repressor LTTR 
fusions in a negative-dominance assay to test for the LTTR’s ability to form heterotyp ic 
interactions.   
   
METHODS 
Construction of Fusions  
Immune lcI LTTR fusions were identified in a screen for homotypic interactions 
in E. coli K-12 (Marino-Ramirez et al. 2003).  Thirteen lcI LTTR fusions were 
identified. To take advantage of the Gateway recombination system, the clones were 
amplified from the plasmid DNA using primers attB1 and attB2 (PAGE purified, IDT, 
Iowa) which attach Gateway cloning sites. Reactions were done in 50µl total volume, 
using Pfx Platinum (Invitrogen).   The size of the amplified product was checked on a 
1% TBE Agarose gel and a Qiagen PCR Clean-up Kit used.  
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Entry clones were generated using 2µl of the eluted PCR product, 2µL of the 5x 
BP Clonase Buffer (Invitrogen), 2µl TE, 2µl of 100 ng/µL pDONOR201 and 2µL BP 
Clonase (Invitrogen).  The reactions were incubated together overnight at room 
temperature and transformed into either MC1061 or Mach T1 (Invitrogen).  In addition 
to the constructs described above, we obtained the rest of the LTTRs cloned as lcI 
repressor fusions.  Entry clones were generated via the back reaction by Adrienne 
Zweifel.   Relevant clones are described in Table 4.1. 
 
Negative-Dominant Assay 
 Zeng et. al (Zeng et al. 1997) developed a negative-dominance assay based on 
the lcI repressor system in which two constructs are used and is illustrated in Figure 4.1. 
The first, termed termed cI+, is a lcI fusion with a wild-type DNA binding domain with 
a protein fused to it that is stable enough to oligomerize and confer immunity to l 
infection.  This fusion is expressed from a weak, constitutively expressed promoter, The 
second construct has a mutated cI DNA binding domain that is unable to bind DNA and 
is expressed in an excess amount in the cell.   
 To test for heterotypic interactions using this dominant-negative assay, strains 
carrying the co-expressed plasmids are exposed to phage l.  Fusions that can form 
heterotypic interactions will be sensitive to l if the cI+ homooligomer levels fall below 
the critical level required for immunity to l. Immunity to l is scored when the cI+/ cI+ 
complex is more stable than a cI+/cI- complex. For the negative-dominant fusion, we 
utilized a thioredoxin-fusion protein. The thioredoxin plasmid, pJM198, is a modified
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Table 4.1.  Relevant Strains and Plasmids  
          pLM1000  pJM197  
Gene 
Name IST ID* Location 
GK 
Name IST in pDONR201  MC1061 JH787 MC1061 JH787 
yhjC EB099.012  EB09901H12 GK300 GK313 GK326 GK339 GK352 GK365 
yafC EH099.013 EH09901F01 GK303 GK316 GK329 GK342 GK355 GK368 
cynR EH100.049 EH10002E11 GK304 GK317 GK330 GK343 GK356 GK369 
pssR EH100.093 EH10001H02 GK305 GK318 GK331 GK344 GK357 GK370 
yiaU EH100.118 EH10004A06 GK306 GK319 GK332 GK345 GK358 GK371 
gcvA EH100.160 EH10004H12 GK307 GK320 GK333 GK346 GK359 GK372 
ilvY EH101.053 EH10102F02 GK308 GK321 GK334 GK347 GK360 GK373 
ynfL EH101.073 EH10103H12 GK310 GK323 GK336 GK349 GK362 GK375 
iciA EH101.093 EH10103C12 GK312 GK325 GK338 GK351 GK364 GK377 
NhaR             RS322 RS345 
YneJ pMD33           RS321 RS344 
YgiP pMD28     AZ488     RS320 RS343 
YdhB pMD22     AZ482     RS318 RS341 
YbeF pMD16     AZ478     RS316 RS339 
YbbS pMD14     AZ477     RS315 RS338 
YagP pMD12     AZ475     RS314 RS337 
TdcA pMD10     AZ473     RS313 RS336 
LysR pMD5     AZ468     RS312   
YfiE pMD26     AZ486     RS311 RS334 
YidZ pMD29     AZ490     RS310 GK385 
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Table 4.1. Continued 
         pLM1000  pJM197  
Gene Name IST ID* Location GK Name 
IST in 
pDONR201  MC1061 JH787 MC1061 JH787 
YgfI pMD27     AZ487     RS309 RS332 
YdaK pMD20     AZ481     RS308 RS331 
YbhD pMD17           RS307 RS330 
YahB pMD13     AZ476     RS306 RS329 
PerR pMD9     AZ472     RS305 RS328 
OxyR pMD8     AZ471     RS304 RS327 
MetR pMD6     AZ469     RS303 RS326 
LrhA pMD4           RS302 RS325 
Cbl pMD1     AZ465     RS300 RS323 
CysB pMD2     AZ466     RS301 RS324 
GCN4    GK210  LM239 JM185 GK221 
*Strains starting with an E are from the IST Screen and are located in microtiter plates (Marino-Ramirez et al. 2004). I made 
freezer stocks and gave the clones GK names. The plasmids listed as pMD*** were obtained from Hirotada Mori as lcI 
repressor fusions cloned into SfiIsites. They were obtained by Adrienne Zweifel and are in her collection. Note, however, that 
entry clones with AZ numbering do not have a stop codon and most, if not all, were sensitive as lcI fusions without the stop 
codon. 
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Figure 4.1.  Negative-dominance Assay. The oligomerizing cI fusion is shown on the 
left-hand side. The proteins tested for heterotypic interactions are represented by the 
colored spheres. (Top, right) Proteins that can form heterotypic interactions with the 
immune cI fusion generate a sensitive phenotype. Those that can not form an interaction 
remain immune.(Bottom, right) 
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version of pBAD49 and made by Jon Minor and Gregory Munoz. The backbone was 
swapped out to have pACYC184 origin, as well as the tetracycline resistance gene. Entry 
clones described above were moved into this construct via the LR reaction.   
 
Construction of Double Strains  
 A general overview of the double strain construction is shown in Figure 4.2. The 
double strains were constructed using M13 transduction.  M13 RV-1 was used to pack 
the immune lcI repressor fusions.  Cells were grown in 2XYT and ampicillin 
(200µg/mL).   The strains containing the thioredoxin fusions were grown in 2XYT 
containing tetracycline (20µg/mL).  Using a Pasteur pipette, two drops of the thioredoxin 
fusion-containing strains were put into a sterile 96-well plate.  5µL of the packed M13 
strain was put into the appropriate well (typically using a multichannel pipette).  100µL 
of LB was added to each well after incubation for 10 minutes at room temperature.  
Airpore tape was put on top of the plate and incubated at 37°C for 120 minutes.   
For selection of the double-strains, a 96 well frogger was used to stamp LB-
ampicillin- tetracycline plates.  The plates were incubated overnight at 37°C.  The next 
day, the entire grid was stamped onto fresh LB-ampicillin-tetracycline plates and 
incubated again.  This was considered streak purification or stre- frogging.  Cells were 
selected from this spot for cross-streaks.  No freezer stocks were constructed. 
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Figure 4.2. Overview of Double Strain Construction. 
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Cross-streak Assays  
 Cross-streak assays were done to assay the constructs’ ability to oligomerize. 
Strains from the streak purification were tested on plates containing tryptone or tryptone 
containing 0.2% glucose or tryptone 0.2% arabinose. Cells were first touched to the plate 
that did not contain arabinose, then to the arabinose plate. A fresh toothpick was used to 
draw the cells across the lines of phage (lKH54 and li2c). Plates were incubated at 37°C 
and the phenotype noted. For these large scale interactions, the same plates of colonies 
were used to test on three subsequent days.  
 
RESULTS 
Reconstitution of the Negative-Dominance System with Thioredoxin Fusions 
We initially constructed a small grid of lcI LTTR repressor fusions with their 
thioredoxin counterparts. Thioredoxin GCN4 and lcI GCN4 was used as a control. This 
small set of interactions is outlined in the blue box in Figure 4.3. The thioredoxin GCN4 
did not interact with any repressor fusions except lcI GCN4.  lcI GCN4 did not interact 
with any other thioredoxin fusion except GCN4.  
 All lcI LTTR proteins interacted with their respective thioredoxin fusion, as 
illustrated by the plum colored boxes in Figure 4.3.  A few heterotypic interactions were 
observed, particularly with the trx-PssR fusion agsinst lcI-YafC, lcI-CynR and lcI-
YiaU.  
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Expansion of the Grid 
 
 We next used the lcI LTTR fusions to test against 23 other trx-LTTR fusions.  
The resultant interactions are shown in Figure 4.3. Several trx-LTTR fusions had 
numerous interactions with the lcI LTTR fusions, including trx- Cbl, OxyR, PerR and 
YbeF.  Others, such as LysR, NhaR and YneJ showed only one or two interactions.  
Many showed no interactions with the lcI LTTR fusions.  
 
Results of Both Grids  
Of the 236 potential heterotypic interactions, 38 interactions were detected, 
allowing for three classes of interactions: I) those LTTRs that did not interact with other, 
II) LTTRs that formed only a few interactions and III) LTTRs that were promiscuous in 
their interactions with other LTTRs.  LTTRs in the promiscuous category are Cbl, 
OxyR, PerR, YbeF and YdaK.  Class II includes LTTRs CynR, LysR, NhaR, YneJ and 
YiaU; all other LTTRs fall into Class I.
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Figure 4.3. Interaction Grid of the LTTRs.  On the left are the immune lcI repressor fusions. Across the top are the trx-LTTR 
fusion constructs. Displayed is the result of 1 colony tested on three different days. An interaction was noted if at least two of 
cross-streaks generated a sensitive phenotype. Here, an interaction between two proteins is denoted by a colored square. Plum 
is representative of a homotypic interaction, while green is a heterotypic interaction. White implies no interaction.  
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DISCUSSION 
In this work, we present evidence that the LTTRs are specific for the formation 
of homotypic interactions, as demonstrated by the pair-wise testing of 236 potential 
heterotypic LTTR interactions. These interactions, which we have grouped into three 
classes, show that Class I is the largest class. Class II and Class III represent LTTRs that 
are able to form heterotypic interactions.  
Closer examination of the interaction patterns of Class II and Class III does not 
reveal a clear-cut interaction pattern and rules of interaction can not be generated from 
the interaction patterns in Table 4.2.  The Class III proteins do not interact with all the 
LTTRs, nor do they interact with only certain LTTRs.  The same can be said for Class II 
proteins. While they only interact with one or two other LTTRs, the interactions appear 
to be random.   
If the interactions are true, then these LTTR might represent LTTRs that are not 
expressed at the same time. Thus, the pressure to have evolved high specificity might be 
less than that of other LTTRs. However, we have not found any evidence that LTTRs are 
not expressed at the same time. In fact, we would expect all LTTRs, though at low levels 
of LTTRs, to be expressed at the same time, as most LTTRs repress themselves. Thus, 
this idea supports the notion that the LTTRs are highly-specific.  Therefore, we must 
consider that the Class II and Class III proteins could be artifacts. 
The fact that the LTTRs are specific for homotypic interactions fits well with the  
take home message in Chapter III.  The LTTRs that we have studied do not have a 
shared set of residues important for oligomerization. If each of those residues contributes 
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to the specificity of the molecule, then the results presented here only further validate 
our hot spot data. Understanding how these residues have evolved for the specificity of 
the protein will require further exploration.   
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CHAPTER V 
 
RESISTANCE TO METHOTREXATE DUE TO AcrAB-DEPENDENT EXPORT  
FROM Eschericia coli* 
 
 
OVERVIEW 
 
Many laboratory strains of Escherichia coli are resistant to methotrexate (MTX), 
a folate analogue that binds dihydrofolate reductase (DHFR). Mutations that inactivate 
either tolC or acrA confer MTX sensitivity. Further, overexpression of a fusion protein 
with DHFR activity reverses this sensitivity by titrating out intracellular MTX. These 
results suggest that MTX accumulates in cells where mutations in acrA or tolC have 
inactivated the TolC-dependent AcrAB multidrug resistance efflux pump.  
 
INTRODUCTION 
 
Methotrexate (MTX) is a folate analogue that inhibits the activity of 
dihydrofolate reductase (DHFR) (Miller 1972), which catalyzes the NADPH-dependent 
reduction of dihydrofolate to tetrahydrofolate. Reduced folates are substrates in a number 
of one-carbon transfers in purine, pyrimidine, and amino acid biosynthesis (Baccanari et 
al. 1981). 
  
_____________ 
 
*The work described in this chapter was previously published as : Kopytek, S.J., Dyer, 
J.C., Knapp, G.S., and Hu, J.C. 2000. Resistance to methotrexate due to AcrAB-
dependent export from Escherichia coli. Antimicrob Agents Chemother 44: 3210-3212. 
Reprinted with permission from American Society for Microbiology, Copyright 2000.  
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Inhibition of DHFR activity initially results in the depletion of N5,N10-methylene 
tetrahydrofolate, followed by inhibition of DNA synthesis and ultimately cell death 
(Howell et al. 1988). DHFR is thus a well-studied target of antibiotic and antineoplastic  
therapy.  
Although MTX binds both human and Escherichia coli DHFR very tightly, with 
Ki values of 3.4 and 1.0 pM, respectively (Appleman et al. 1988), all of the E. coli 
isolates we tested (genotypes of the strains used in this study are listed in Table 5.1), 
which included both common laboratory strains (MG1655, MC4100, AG1688, and 
ZK126) and clinical isolates (O157:H7, RM74A, STM1, LL, RM52B, DD, and  RM33B), 
were resistant to MTX added to solid medium at concentrations of up to 1 mM, the 
highest concentration we tested (data not shown). 
Antibiotic resistance can occur by a variety of mechanisms, including failure of 
the drug to bind its target, overexpression of the drug target, modification or degradation 
of the drug, creation of permeability barriers, or active export of the drug. It is 
increasingly recognized that active efflux plays a major role in the resistance of many 
organisms to a plethora of agents (Levy 1992; Nikaido 1994). A wide variety of 
antibiotics are exported from E. coli by one of several active efflux systems (Levy 1992; 
Lewis 1994; Nikaido 1994; 1996). At least two of these systems, the AcrAB and EmrAB 
efflux pumps, have been shown to depend on the outer membrane protein TolC  (Lewis 
1994; Nikaido 1994; Fralick 1996; Nikaido 1996; Aono et al. 1998).  
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To determine whether the MTX resistance was due to a TolC-dependent efflux 
pump, we examined the effect of a tolC ::Tn10 mutation. LBB1175, in which tolC had 
been inactivated by the Tn10 insertion, was sensitive to 1 mM MTX, while W4573, the  
isogenic TolC+ control, was resistant. Similar results were obtained using the  common 
laboratory strain MG1655, which is the reference wild-type E. coli K-12 strain used for 
the genome sequence (Blattner et al. 1997), and AG1688 (see below). Strains carrying 
Tn10 at a different chromosomal location remained resistant to MTX. These results 
suggest that MTX resistance is mediated by a TolC-containing multidrug resistance 
efflux pump (MDR).  
tolC mutants are pleiotropic (Morona et al. 1983; Wandersman and Delepelaire 
1990) and are hypersensitive to many hydrophobic agents (Nagel de Zwaig and Luria 
1967). Thus, the loss of MTX resistance in the tolC mutant might not be due to the loss 
of function of an MDR. To address this possibility, we tested the  effects of mutations that 
inactivate specific TolC-dependent MDRs. The AcrAB pump belongs to the RND (for 
resistance, nodulation,  and division) family,
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Table 5.1.  E. coli Strains Used 
Strain Genotype Reference and/or source 
MG1655 K-12 F-l- (Perkins et al. 1993); 
D. Siegele 
MC4100 F- araD139 D(argF-lac)U169 rpsL150 relA1 
deoC1 rbsR flhD5301 fruA25 l- 
(Bremer et al. 1984); 
D. Siegele 
AG1688 F'128 lacIq lacZ::Tn5/araD139 D(ara-
leu)7697 D(lac)X74 galE15 galK16 rpsL(Strr) 
hsdR2 mcrA mcrB1 
MC1061 F'128 lacIq 
lacZ::Tn5 (Hu et al. 1993) 
ZK126 W3110 D(lac)U169 tna-2 (Dougherty and Pucci 
1994); D. Siegele 
O157:H7 E. coli isolate from human (Izumiya et al. 1997); 
D. Siegele 
RM74A Group I E. coli from human female (Milkman 1973); 
D. Siegele 
STM1 Group I E. coli from human male (Whittam et al. 1983); 
D. Siegele 
LL Group II E. coli from human infant (Selander and Levin 1980); 
D. Siegele 
RM52B Group II E. coli from human female (Milkman 1973); 
D. Siegele 
DD Group III E. coli from human infant (Whittam et al. 1983); 
D. Siegele 
RM33B Group III E. coli from human female (Milkman 1973); 
D. Siegele 
W4573 K-12 F- lac ara mal xyl mtl gal rpsL (Ma et al. 1993); 
J. A. Fralick 
LBB1175 W4573 tolC::Tn10 J. A. Fralick  
N43 W4573 acrA1 (Ma et al. 1993); 
J. A. Fralick 
OLS103 AMS6 emrB::Km (Lomovskaya et al. 1995); 
J. A. Fralick 
AMS6 K-12 F- DlacU169 (Lomovskaya et al. 1995); 
J. A. Fralick 
SK627 W4573 acrA1 emrB::Km N43 × P1 vir (OLS103)  
SK636 W4573 emrB::Km W4573 × P1 vir (OLS103)  
KH803 MC4100 tolC::Tn10 R. Young  
SK642 W4573 acrA1 tolC::Tn10 N43 × P1 vir (KH803)  
SK660 W4573 acrA1 emrB::Km tolC ::Tn10 SK627 × P1 vir (KH803)  
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Table 5.1. Continued 
Strain Genotype Reference and/or source 
SK037 AG1688 tolC ::Tn10 AG1688 × P1 virKH803)  
SK029 AG1688(pSK029) pSK029, a pBR322-
derived plasmid that 
expresses a l cI-E. coli 
DHFR fusion protein from 
PlacUV5, was introduced 
by M13-mediated 
transduction (Vershon et 
al. 1986) into AG1688  
XZ020 AG1688(pXZ020) pXZ020, a pBR322-
derived plasmid that 
expresses a lcI-GCN4 
leucine zipper fusion 
protein from PlacUV5 
 
 
and its substrates include sodium dodecyl sulfate, basic dyes, novobiocin, and 
tetracycline (Nikaido 1994; 1996); the EmrAB pump belongs to the MF (major 
facilitator) family, and  its substrates include carbonyl cyanide m-chlorophenylhydrazone, 
nalidixic acid, and phenyl mercury acetate (Nikaido 1994; 1996). A strain containing the 
acrA1 mutation (N43) was sensitive to 1 mM MTX, while its isogenic parent (W4573) 
was resistant. In contrast, both the emrB mutant (OLS103) and its isogenic parent 
(AMS6) were MTX resistant. These results show that the MTX sensitivity of the tolC 
strains is at least partly due to inactivation of the  AcrAB MDR, while the EmrAB pump 
does not have a major role in MTX export.  
MICs of MTX were determined for a set of isogenic E. coli strains containing 
combinations of acrA, emrB, and tolC mutations (Table 5.2). The wild-type strain 
(W4573) was resistant to 1,024 µM MTX, the highest concentration tested. The emrB 
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mutation did not affect the MIC, either alone (compare W4573 to SK636) or in 
combination with acrA1 (compare N43 to SK627) or tolC ::Tn10 (compare SK642 to 
SK660). Inactivation of either acrA or tolC resulted in a decrease of the MTX MIC to 
256 or 64 µM, respectively. Since the acrA1 allele is an IS2 insertion in the second 
codon of acrA (Ma et al. 1993) , it is unlikely that the remaining MTX resistance in the 
acrA1 mutant is due to residual activity of the acrA gene product. The tolC gene product 
seems to have more than one role in MTX resistance. It is unclear if this is due to the loss 
of function of another, unidentified TolC-containing MDR or the highly pleiotropic  
effects of tolC mutations on outer membrane structure (Morona et al. 1983; Wandersman 
and Delepelaire 1990). Similar alterations have not been found in the outer membrane  of 
acr mutants (Nikaido and Vaara 1985; Vaara 1993; Nikaido 1996).  
The additional role of TolC is not related to the EmrAB MDR, since the acrA1 
emrB double mutation (in SK627) yielded an MIC  identical to that yielded by the acrA1 
single mutation. Similar combinations of mutations in a different background (AG1688) 
yielded identical MICs (data not shown). This further demonstrates that the observed 
effects are not strain specific.  
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Table 5.2. Sensitivities of acrA, tolC, and emrB Mutants to MTX 
Strain Relevant genotypea MICb of MTX (µM)  
W4573 Wild type >1,024  
SK636 emrB >1,024  
N43 acrA1 256  
SK627 acrA1 emrB 256  
LBB1175 tolC 64  
SK642 acrA1 tolC 64  
SK660 acrA1 tolC emrB 64 
   
a For a full listing of genotypes, see Table 5.1. 
b MICs were determined by examining the growth of 2-ml liquid cultures 
containing twofold serial dilutions of MTX (2 to 1,024 µM) in Luria-Bertani liquid 
broth. The inoculum (20 µl) contained approximately 105 cells per ml. The MIC 
was determined as the lowest concentration that prevented visible growth after 8 h 
on a roller drum at 37°C. All the tested strains grew to saturation in the absence of 
MTX. The values are the averages of three separate experiments. 
 
 
To determine whether inhibition of DHFR was sufficient to explain the MTX 
sensitivity of tolC strains, we examined whether the MTX sensitivity of AG1688 
tolC::Tn10 (SK037) could be suppressed by overexpression of DHFR activity. In the 
course of other (unpublished) studies, we had constructed a plasmid, pSK029, which 
expresses a fusion protein, cI-DHFR, in which the N-terminal DNA binding domain of 
the bacteriophage l repressor is fused to E. coli DHFR; the fusion protein is expressed 
under the control of the lacUV5 promoter. Neither pSK029 nor pXZ020, a control 
plasmid expressing cI-GCN4 (a fusion to the leucine zipper of GCN4), affected the  MTX 
resistance of wild-type AG1688 whether or not the fusion proteins  were overexpressed 
(Table 5.3, lines 3 and 5). AG1688 tolC ::Tn10 strains containing either plasmid were 
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sensitive to MTX under conditions in which the fusion proteins were uninduced (Table 
5.3 lines 4 and 6). However, in the presence of isopropyl-ß-D-thiogalactopyranoside 
(IPTG), which induces the overexpression of cI-DHFR, SK029 tolC::Tn10 was resistant 
to high concentrations of MTX  (Table 4.3, line 4). In contrast, IPTG-induced  
overexpression of the control protein cI-GCN4 had no protective effect on the tolC strain 
(Table 5.3, line 6).  
These results show that MTX sensitivity in the tolC strain is due to the inhibition 
of endogenous DHFR by the drug. When cI-DHFR is overexpressed, the DHFR activity 
provided by the DHFR domain in the fusion protein cannot be titrated out, which 
strongly suggests that the plasmid-coded DHFR acts to sequester MTX that is added to 
the medium. Increasing the level of DHFR should not relieve  sensitivity due to 
mechanisms that do not involve uptake of MTX.  
The results of this study can be summarized as follows. (i) All of the TolC + 
AcrA+ strains of E. coli we tested were resistant to at least 1 mM MTX when grown on 
solid medium containing the drug. (ii) MTX resistance is decreased by mutations that 
disrupt tolC or acrA, genes that code for integral components of the AcrAB MDR, 
suggesting that resistance is due to active export of MTX via the AcrAB MDR. (iii) 
Mutation of the emrB gene does not decrease MTX resistance, suggesting that MTX is 
not a substrate of this MDR. (iv) The difference between the MICs for tolC ::Tn10 and 
acrA::IS2 strains suggests the possibility of another mechanism for low-level TolC-
dependent MTX resistance.  
  
111
Table 5.3. Suppression of the MTX Sensitivities of TolC Mutants by cI-DHFR 
Growtha 
 IPTG  +IPTG  Line Strainb 
Fusion 
protein tolC genotype 
-MTX +MTX -MTX +MTX 
1 AG1688 None tolC+ + + + + 
2 SK037 None tolC mutant +  +  
3 SK029 cI-DHFR tolC+ + + + + 
4 SK029 tolC::Tn10 cI-DHFR tolC mutant +  + + 
5 XZ020 cI-GCN4 tolC+ + + + + 
6 XZ020 tolC ::Tn10 cI-GCN4 tolC mutant +  +  
a Cultures were grown to saturation in Luria-Bertani broth at 37°C overnight and diluted in M9 salts to 
approximately 5,000 CFU/ml. A total of 10 µl of each diluted culture was pipetted onto Luria-Bertani agar plates 
containing no IPTG ( IPTG) or 1 mM IPTG (+IPTG) and either no MTX ( MTX) or 1 mM MTX (+MTX) as 
indicated. The spots were allowed to dry and then the plates were incubated at 37°C overnight. +, growth; , no 
growth. The observations are from at least three separate experiments.  
b tolC::Tn10 was introduced into the indicated strains by P1 vir transduction using KH803 as the donor.  
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CHAPTER VI 
 
CONCLUSIONS 
 
 
 
The driving question behind this dissertation is “What is necessary for 
oligomerization in the LysR-Type Transcriptional Regulators?”  Understanding the 
nature of this oligomerization involved determination of which proteins interact and also 
characterizing a residue’s contribution to oligomerization in individual LTTRs.  
Specificity lies in the protein’s ability to discriminate between related molecules 
and to identify the appropriate target molecule. In Chapter IV, I demonstrated that the 
LTTRs from E. coli are specific for the formation of homotypic interactions and the 
consequences of not forming the proper interactions are discussed in that chapter. How, 
though, is that specificity determined? To try and address that question, we sought to 
identify the residues that were important for oligomerization in two LTTRs.  
Our approach was to determine the residues in contact at the oligomeric interface 
and use alanine-scanning mutagenesis to test the contribution of each interface residue in 
driving oligomerization through the use of lcI repressor fusions.  As described in 
Chapter II, the seven hot spots from OxyR are not especially conserved. Among the 
OxyR orthologs, S235 was the least conserved of all the hot spots, with a conservation of 
35%. In fact, 28% of the orthologs had alanine in this position, yet presumably can still 
form oligomers.  
While many of the interfaces residues are conserved, the conservation of the 
actual contacts has not been significantly addressed.  For example, OxyR has M230 
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interacting with L124.  Do any orthologs have L230 interacting with M124? This would 
be particularly interesting to find residues that are involved in hydrogen bonding or salt-
bridges.  From the output of QConAlign, one would simply begin to count the number of 
ML and LM at the given position.  Residues that are identical in all orthologs and 
involved in contacts would not need to be done, as their change is already known.  
Several studies have emphasized the importance of structurally conserved 
positions in protein binding sites. The second question posed was “Are the same  
residues important in the oligomerization of a LTTR of unknown structure?” As 
discussed in Chapter III, we found that while most of the residues buried in the CynR 
interface correspond to equivalent residues in OxyR,  there was no overlap in the 
residues important for oligomerization in OxyR and CynR., Why, then, do we not detect 
any overlap? 
One possibility may lie in the protein that we used as a template. At the 
commencement of these studies, we were limited in crystal structures available to us. 
OxyR and CysB were the only ones available and for reasons we do not understand, 
CysB is not immune as a lcI repressor fusion.  The response of OxyR to oxidative stress 
is characterized by the large rotation between the subunits. Now that we can examine the 
structure of CynR in the presence and absence of inducer, there is not a substantial 
difference between the residues in contact between the subunits, indicating that such 
rotation is not occurring in CynR.  It would be interesting to know if other LTTRs that 
bind small molecules as their effectors shared hot spots with CynR. This would support 
the described hypothesize.  The ten hot spots would be used to guide the initial 
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mutagenesis. Then, one could go after residues that are unique to the structures’ contact 
profiles (as indicated by the shaded blue boxes in Figure 3.7.)  
One advantage of alanine-scanning is that the contribution of the atoms beyond 
Cß can be evaluated. Yet, caution is warranted when evaluating the results of alanine-
scanning, as illustrated by DeLano in 2002.  As one is perturbing the interface, 
unexpected results can occur. For example, the mutation though located in the interface, 
can cause the protein to become unfolded. We suspect that this is the case in one of the 
Class I mutations in CynR, L228.  This residue is located in the interface, but, 
examination of the atoms in both crystal forms shows that the atoms are completely 
buried in the monomer. Conversely, the mutation can reveal a negative design element 
that the protein has evolved (DeLano 2002). Thus, the mutation would cause appear to 
have no effect in oligomerization. If this type of interaction in OxyR was present, it 
might have been detected through the use of the regulatory domain in the lower 
expression vector, pLM1000, as wild-type OxyR is sensitive in this vector.  
 The repressor system is shown to be beneficial for the study of protein-protein 
interactions. In addition to identifying homotypic interactions in genome-wide screens 
(Marino-Ramirez and Hu 2002; Marino-Ramirez et al. 2004), it has been used 
extensively to study the oligomerization of the GCN4 leucine zippers, an elegant model 
for protein-protein interactions (Zeng et al. 1997; Zeng and Hu 1997).  However, 
through the use of the cI repressor fusions, we were able to screen over 60 mutations and 
their contribution to oligomerization at different fusion protein concentrations.  
Evaluating this large number of mutations by traditional means would require 
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expression, purification and biochemical characterization of each individual mutation. 
This would be impractical for many LTTRs, which tend to be insoluble after over-
expression. With the lcI repressor fusion, we were able to determine a qualitative 
strength of the mutations and focus the number of mutations for further studies. This is 
important in any system of proteins that are notoriously difficult to work with in vitro.  
 
FUTURE DIRECTIONS 
 
 This project has laid the foundation for using the LTTRs as a model system for 
studying protein-protein interactions. While we have asked specific questions to address 
certain aspects of oligomerization in LTTRs, much more can still be done. 
A long term goal of the oligomerization studies with OxyR was to utilize the 
negative-dominant system to study the residue’s contribution to specificity.  We did do 
pilot studies with the thioredoxin-OxyR fusions and lcI OxyR repressor fusions.  
However, these strains were repeatedly immune to the li21c, something that was 
unexpected.  The use of the regulatory domain as an inhibitor may serve as a better 
negative-dominant fusion. However, this result may be unavoidable with the 
thioredoxin-OxyR fusion, as the thioredoxin gene is a target of OxyR. Movement of the 
OxyR genes into the original cI- vector may be necessary to continue negative dominant 
studies with the lcI repressor fusion (Zeng et al. 1997). 
We also wanted to determine if the oligomerization changed with oxidative state. 
An ahpCF deletion lacks alkylhydroperoxide reductase and these strains have elevated 
endogenous levels of hydrogen peroxide (Rosner and Storz 1994). While we attempted 
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to perform the cross-streaks in a constitutively oxidizing environment, the control cI 
GCN4 repressor did not behave as expected. Additionally, we were limited by proteins 
that were only sensitive or immune in the vectors; that is, class 1a and class 3c. 
Therefore, moving the mutations out of the repressor system may be necessary for 
further characterization of the mutants. Giesela Storz’s lab has used many different 
techniques to study OxyR in vitro and we have many of the strains and antibodies 
necessary in the lab, due to her generous gifts.  
 Parallel to studying the mutant OxyR’s response to oxidative stress, we originally 
wanted to study CynR’s response to its effector molecule, KCON. In the literature, we 
found many constructs that would allow for an in vivo negative-dominant system that 
was originally used to study CynR as a transcriptional regulator. Unfortunately, these 
constructs were lost in a freezer meltdown in the Fuch’s lab at the University of 
Minnesota. One possibility we were pursuing with CynR was the use of a promoter-gfp 
fusions.  We have obtained both the cyn promoter region fused to gfp in both directions. 
Expression of the mutants in trans should allow for assaying the mutant CynR’s ability 
to behave as a transcriptional regulator in the presence and absence of KCON.   
 Finally, a long term goal is to take the information garnered from the alanine-
scanning mutagenesis, as well as the resultant negative-dominant studies and reengineer 
the LTTRs to have alternate specificity.    For example, thioredoxin CynR fusion is 
interacting with the lcI IciA fusion. It would be interesting to know whether hot spot 
mutations in CynR, as described in Chapter III, when made into a thioredoxin fusion, 
could disrupt this interaction.  Conversely, do those mutations allow CynR to interact 
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with any other lcI LTTR repressor besides CynR and IciA?  The same argument can be 
applied to the OxyR interactions. 
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APPENDIX A 
 
PERL SCRIPTS WRITTEN FOR THIS PROJECT 
 
 
QConAlign.pl 
 
#!/usr/bin/perl 
 
 
# Qcons alignv1.pl 
# 
# This is a program to map the contact profile from a member  
# of a COG to other members of the COG for which the structure  
# is unavailable. 
# The sequence alignment is based on CLUSTALW, for now. 
 
# ppialignv2.pl has been modified such that the numbers 
generated and output  
# are based on the universal coordinate system.  Further, all of 
the translated 
# output is put into three files.   
 
# ppialinv3.pl has been modified from ppialignv2.pl to account 
for the fact that 
# chains may not be JUST A or B. In this case, it was chain P 
that was needed.  
 
#Qconalign.pl has been evolved to utilize the output from Qcons. 
It has the same  
#functionality as ppialign, just takes into account the 
different output format of Qcons.  
# gsk 07.20.04 
 
#Usage: 
#perl Qconalign.pl < [alignment file] t [protein template] res 
[Qcon residue file] 
 
# ------------------------------------------------------ 
# ---------------- Input Variables --------------------- 
# ------------------------------------------------------ 
 
# if pdb file residue numbering or register is not the same as 
in the sequence file 
# reset here 
$pdboffset = varafteroption("o", 1, "sequence offset of the pdb 
file to sequence file "); 
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# debugging 
$debug = 0; 
 
# Asks which sequence in the alignment is the template sequence. 
#printf STDERR "yo\n"; 
 
$template = varafteroption("t", "none", "template defined as "); 
if ($template eq "none") { 
    printf "Jim says he needs a template name after option 
t!\n"; 
    die; 
} 
 
# Defining names of Qcon files (for input) 
# voronoi interactions 
$byres = varafteroption("res", "CbnR.res", "The file being used 
is "); 
if (! -r $byres) { 
    printf "Cannnot read $byres!\n"; 
    die; 
} 
 
 
 
 
# -------------------------------------------------------------- 
# ----Read in Sequence alignment from STDIN -------------------- 
# -------------------------------------------------------------- 
 
# stores COG multiples sequence alignment information in 
variable seq 
# initializes hash to zero 
 
%seq = ();  
 
# takes input from  STDIN  
# removes header and white space and joins the sequences 
together. 
while (<STDIN>) { 
     
   # printf "Hi\n"; 
    next if /^CLUSTAL /; 
    chomp; 
    @tmp = split ' '; 
    next unless scalar(@tmp) == 2; 
    $seqp=sprintf ("%s%s", $seq{$tmp[0]},$tmp[1]); 
} 
 
# This is checking to see if template name is in the file 
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$isnotthere=1; 
foreach $a (keys %seq) { 
    if ($a eq $template) { 
        $isnotthere=0;  
 last; 
    } 
} 
if($isnotthere) { die "didn't have $template in the file! 
exiting ...\n"; } 
 
# Creating master index to template sequence 
# note $template depends on above 
@seqarray= split '', $seq{$template}; 
$sequenceindex=$pdboffset; @masterindex=(); 
for ($resnum=0;$resnum<@seqarray;$resnum++) { 
    $resname=$seqarray[$resnum]; 
    if ($resname ne "-") { 
        $masterindex[$sequenceindex]=$resnum; 
 $masterseq[$sequenceindex]=$resname; 
        $sequenceindex++; 
    } 
} 
 
 
# ----------------------------- 
# READ IN DATA FROM ppiContacts 
# ----------------------------- 
 
# Initializing variables 
%resnameA = (); %resnumA = (); 
%resnameB = (); %resnumB = (); 
%chainA = (); %chainO = (); 
 
 
 
 
# Commands for calling subroutines (below) 
 
 
readbyres(); 
 
 
# this is just a check 
if ($debug) { 
    foreach $a (sort ascending keys %resnameA) { 
 printf STDERR "$a      A $resnumA{$a} $resnameA{$a} to B 
$resnumB{$a} $resnameB{$a}\n"; 
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 printf STDERR "$a      A $masterseq[$resnumA{$a}] 
$masterindex[$resnumA{$a}]  to B  $masterseq[$resnumB{$a}] 
$masterindex[$resnumB{$a}]\n"; 
    } 
} 
 
# -------------------------------------------------------------- 
# going over the multiple sequence alignment & doing replacement  
# -------------------------------------------------------------- 
 
open(OO,">${template}.resvor") || die "couldn't open 
${template}.resvor\n"; 
printf OO "Protein Name, INnum, Chain, ResNum, MIN, Res to 
INnum, Chain, ResNum, MIN, Res  \n"; 
 
 
foreach $protein (keys %seq) { 
    #next if $protein eq $template; 
    $sequences=$seq{$protein}; 
    printf STDERR "$protein $sequences\n"; 
    @seqpos = split //, $sequences; 
    @seqposnum = (); $nn=0; 
     
    for ($ii=0,$nn=0;$ii<@seqpos;$ii++) { 
 $residue = $seqpos[$ii]; 
 if ($residue eq '-') { 
     $seqposnum[$ii] = $nn + 0.5; 
 } 
 else { 
     $nn++; 
     $seqposnum[$ii]= $nn; 
 } 
    } 
     
     
     
#outputting the information for the hSA 
#This will output the protein name, index number, the chain 
name, the original residue number, the masterindex number, the 
residue at that position in the protein to 
#the chain name, the original residue number, the master index 
number and the residue at that position in the protein. 
     
foreach $a (sort ascending keys %resnameA) { 
 #printf STDERR 
"$a\tA\t$masterindex[$resnumA{$a}]\t$resnameA{$a}\tto\tB\t$maste
rindex[$resnumB{$a}]\t$resnameB{$a}\n"; 
 #printf STDERR 
"$a\tA\t$masterindex[$resnumA{$a}]\t$seqpos[$masterindex[$resnum
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A{$a}]]\tto\tB\t$masterindex[$resnumB{$a}]\t$seqpos[$masterindex
[$resnumB{$a}]]\n"; 
  
 printf OO "%15s %15d  %6s %6s  %7d  %4s  to  %6s %6s %7d  
%4s\n", $protein, $a, $chainA{$a}, $resnumA{$a}, 
$masterindex[$resnumA{$a}], $seqpos[$masterindex[$resnumA{$a}]], 
$chainO{$a}, $resnumB{$a}, $masterindex[$resnumB{$a}], 
$seqpos[$masterindex[$resnumB{$a}]]; 
    } 
     
     
     
} 
close (OO); 
 
 
 
# -------- SUBROUTINES ----------- 
 
# subroutine to read in hSA 
#     0     1  2   3 4  5   6   7   8 
#     4587  10 LEU A -  347 THR B 100.00 
sub readbyres { 
    printf STDERR "byres\n"; 
    open (SA, $byres); 
    while(<SA>) { 
        chomp; 
        next if $_ =~ /^\#/; 
  #next unless $_ =~ / \- /; 
  
        my @column = split(' ', $_); 
  
  my $identnum = $column[0]; 
        my $firstchain = $column[3]; 
  
# fill data for chain A 
        if($firstchain eq 'A') { 
            $resnumA{$identnum} = $column[1]; 
            $resnameA{$identnum} = $column[2]; 
   $chainA{$identnum}= $column[3]; 
      
            $resnumB{$identnum} = $column[5]; 
            $resnameB{$identnum} = $column[6]; 
   $chainO{$identnum} = $column[7]; 
      
        } else { 
            $resnumB{$identnum} = $column[1]; 
            $resnameB{$identnum} = $column[2]; 
      $chainO{$identnum} = $column[3]; 
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            $resnumA{$identnum} = $column[5]; 
      $resnameA{$identnum} = $column[6]; 
   $chainA{$identnum} = $column[7]; 
        } 
    } 
    close(SA); 
} 
 
 
# subroutine to return variable after command line argument 
# usage: $stt = varafteroption("stt", 1.00, "start oxygen radii 
at "); 
 
sub varafteroption { 
    my $changed=0; 
    for($ii=0;$ii<@ARGV;$ii++)  { 
        if($ARGV[$ii] eq $_[0])  { 
            $var = $ARGV[$ii+1]; $changed++; 
            print STDERR "NEW $_[2]($_[0]) $var\n"; 
            last; 
        } 
    } 
     
    if(!$changed)  { 
        $var = $_[1]; 
        print STDERR "DEFAULT $_[2]($_[0]) $var\n"; 
    } 
    return $var; 
} 
 
sub ascending { $a <=> $b; } 
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QconAAtally.pl 
#!/usr/bin/perl 
 
#QconAAtally.pl 
#April 10, 2006 
 
#usage perl QconAAtally.pl < (Alignment file) 
 
#output: Column aa and #, aa and #, aa and # etc.  
 
 
open(OO,">AAcount.txt") || die "couldn't open AAcount.txt!: 
$!\n"; 
# printf OO "Hi"; 
 
# takes input from  STDIN  
# removes header and white space and joins the sequences 
together. 
# reads data into hash called $seq{} 
 
%seq = (); 
while (<STDIN>) { 
    next if /^CLUSTAL /; 
     
#skip blank lines     
    next if /^(\s)*$/;               
     
    # printf stderr "%s", $_; 
    chomp; 
    @tmp = split ' '; 
    next unless scalar(@tmp) == 2; 
    $seq{$tmp[0]}= sprintf ("%s%s", $seq{$tmp[0]},$tmp[1]); 
} 
 
#just testing to see if it's actually joining.... 
#It is actually working.... 
 
# foreach $a (keys %seq) { 
#     printf OO "%30s %s\n", $a, $seq{$a}; 
# } 
 
# $msa[$position]{$aa} for reading array 
# but from where does msa come? 
 
#The -1 is saying if this is the fist time you've seen this.  
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$msa = ();   
$seqlength = -1; 
 
foreach $ss (keys %seq) { 
#spliting the sequence into individual characters 
    @tmp = split //, $seq{$ss};     
     
    # below is a safety check for sequence length 
    if ($seqlength == -1) {  
 $seqlength = scalar(@tmp);  
    } 
     
    elsif ($seqlength != scalar(@tmp)) {  
 printf stderr "warning %s sequence %d is a different length 
than %d\n", $ss, scalar(@tmp), $seqlength; 
    } 
     
    # for ($position=0; $position<@tmp; $tmp) {   this was 
wrong, needed to increment position 
    for ($position=0;$position<scalar(@tmp);$position++) { 
 $aa=$tmp[$position];                 # getting amino acid 
type 
 $msa[$position]{$aa}++;              # incrementing that 
type 
    } 
} 
 
 
# Dereferencing 
# It used to be $position+1 so that it started at 1; however 
this made the  
# MIN be off one from QconAlign MIN.  Therefore, the positioning 
will start at 0. 
 
for ($position=0; $position<scalar(@msa); $position++) { 
    printf OO "%3d ", $position; 
    foreach $aa (keys %{@msa[$position]}) { 
 printf OO "| %s %-2d ", $aa, $msa[$position]{$aa}; 
    } 
   
    printf OO "\n"; 
} 
 
close OO; 
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APPENDIX B 
 
OxyR ORTHOLOGS 
 
 
>EOxyR 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGMLLVDQART 
VLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCVILALVKESEAFIEVPLFDEPMLLAIYEDHPWANRECVPMADLAGEKLLMLEDGHCLRDQAMGFCFE 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPPERKRDGVVYLPCIKPEPRRTIGLVYRPGSPLRS 
RYEQLAEAIRARMDGHFDKVLKQAV 
 
>gi|83569771|ref|ZP_00921220.1| COG0583: Transcriptional regulator 
[Shigella dysenteriae 1012] 
MNYRGNGGWIMNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQA 
GMLLVDQARTVLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKLEMYLHEAQTH 
QLLAQLDSGKLDCVILALVKESEAFIEVPLFDEPMLLAIYEDHPWANRECVPMADLAGEKLLMLEDGHCL 
RDQAMGFCFEAGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPPERKRDGVVYLPCIKPEPRRTIGL 
VYRPGSPLRSRYEQLAEAIRARMDGHFDKVLKQAV 
 
>gi|75176648|ref|ZP_00696776.1| COG0583: Transcriptional regulator 
[Shigella boydii BS512] 
MNYRGDGGWIMNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQA 
GMLLVDQARTVLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKLEMYLHEAQTH 
QLLAQLDSGKLDCVILALVKESEAFIEVPLFDEPMLLAIYEDHPWANRECVPMADLAGEKLLMLEDGHCL 
RDQAMGFCFEAGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPPERKRDGVVYLPCIKPEPRRTIGL 
VYRPGSPLRSRYEQLAEAIRARMDGHFDKVLKQAV 
 
>gi|26250736|ref|NP_756776.1| Hydrogen peroxide-inducible genes 
activator [Escherichia coli CFT073] 
MLPIAANYRGNGGWIMNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKV 
LFTQAGMLLVDQARTVLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKLEMYLH 
EAQTHQLLAQLDSGKLDCVILALVKESEAFIEVPLFDEPMLLAIYEDHPWANRECVPMADLAGEKLLMLE 
DGHCLRDQAMGFCFEAGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPPERKRDGVVYLPCIKPEPR 
RTIGLVYRPGSPLRSRYEQLAEAIRARMDGHFDKVLKQAV 
 
>gi|75238409|ref|ZP_00722408.1| COG0583: Transcriptional regulator 
[Escherichia coli E110019] 
MNYRGDGGWIMNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQA 
GMLLVDQARTVLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKLEMYLHEAQTH 
QLLAQLDSGKLDCVILALVKESEAFIEVPLFDEPMLLAIYEDHPWANRECVPMADLAGEKLLMLEDGHCL 
RDQAMGFCFEAGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPPERKRDGVVYLPCIKPEPRRTIGL 
VYRPGSPLRSRYEQLAEAIRERMDGHFDKVLKQAV 
 
>gi|15804557|ref|NP_290598.1| activator, hydrogen peroxide-inducible 
genes [Escherichia coli O157:H7 EDL933] 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGMLLVDQART 
VLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCVILALVKESEAFIEVPLFDEPMLLAIYEDHPWANRECVPMADLAGEKLLMLEDGHCLRDQAMGFCFE 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPPERKRDGVVYLPCIKPEPRRTIGLVYRPGSPLRS 
RYEQLAEAIRARMDGHFDKVLKQAV 
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>gi|74314463|ref|YP_312882.1| activator, hydrogen peroxide-inducible 
genes [Shigella sonnei Ss046] 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGMLLVDQART 
VLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCVILALVKESEAFIEVPLFDEPMLLAIYEDHPWANRECVPMADLAGEKLLMLEDGHCLRDQAMGFCFE 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPPERKRDGVVYLPCIKPEPRRTIGLVYRPGSPLRS 
RYEQLAEAIRARMDGYFDKVLKQAV 
 
>gi|147042|gb|AAA24257.1| oxyR protein 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGMLLVDQART 
VLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCVILALVKESERFIEVPLFDEPMLLAIYEDHPWANRECVPMADLAGEKLLMLEDGHCLRDQAMGFCFE 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPPERKRDGVVYLPCIKPEPRRTIGLVYRPGSPLRS 
RYEQLAEAIRARMDGHFDKVLKQAV 
 
>gi|146880|gb|AAA24176.1| morphology control protein (put.); putative 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGMLLVDQART 
VLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCVILALVKESEAFIEVPLFDEPMLLAIYEDHPWANRECVPMADLAGEKLLMLEDGHCLRDQAMGFCFE 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPPEAKRDGVVYLPCIKPEPRRTIGLVYRPGSPLRS 
RYEQLAEAIRARMDGHFDKVLKQAV 
 
>gi|110807820|ref|YP_691340.1| OxyR [Shigella flexneri 5 str. 8401] 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGMLLVDQART 
VLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCVILALVKESEAFIEVPLFDEPMLLAIYEDHPWANRECVLMADLAGEKLLMLEDGHCLRDQAMGFCFE 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPPERKRDGVVYLPCIKPEPRRTIGLVYRPGSPLRS 
RYEQLAEAIRARMDGHFDKVLKQAV 
 
>gi|24115255|ref|NP_709765.1| activator of hydrogen peroxide-inducible 
genes OxyR [Shigella flexneri 2a str. 301] 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGMLLVDQART 
VLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCVILALVKESEAFIEVPLFDEPMLLAIYEDHPWANRECVLMADLAGEKLLMLEDGHCLRDQAMGFCFE 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPPERKRDGVVYLPCIKPEPCRTIGLVYRPGSPLRS 
RYEQLAEAIRARMDGHFDKVLKQAV 
 
>gi|150957599|gb|ABR79629.1| activator, hydrogen peroxide-inducible 
genes [Klebsiella pneumoniae subsp. pneumoniae MGH 78578] 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVDQART 
VLREVKVLKEMASQQGETMSGPLHIGLIPTIGPYLLPHIIPMLHQTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCAILALVKESEAFIEVPLFDEPMMLAIYEDHPWANRDRVPMSDLAGEKLLMLEDGHCLRDQAMGFCFE 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPQERKRDGVVYLPCIKPEPRRTIGLVYRPGSPLRS 
RYEHLAEAIRGTMDGHFDKALKQAV 
 
>gi|16762318|ref|NP_457935.1| hydrogen peroxide-inducible regulon 
activator [Salmonella enterica subsp. enterica serovar Typhi str. CT18] 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVDQART 
VLREVKVLKEMASQQGETMSGPLHIGLIPTIGPYLLPLIIPMLHQTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCAILALVKESEAFIEVPLFDEPMMLAIYEDHPWANRDRVPMSDLAGEKLLMLEDGHCLRDQAMGFCFE 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPQERKRDGVVYLPCIKPEPRRTVGLVYRPGSPLRS 
RYEQLAEAIRGAMDGHFDKALKQAV 
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>gi|62182584|ref|YP_219001.1| regulatory protein sensor for oxidative 
stress, regulates intracellular hydrogen peroxide (LysR family) 
[Salmonella enterica subsp. enterica serovar Choleraesuis str. SC-B67] 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVDQART 
VLREVKVLKEMASQQGETMSGPLHIGLIPTIGPYLLPLIIPMLHQTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCAILALVKESEAFIEVPLFDEPMMLAIYEDHPWANRDRVPMSDLAGEKLLMLEDGHCLRDQAMGFCFE 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPQERKRDGVVYLPCIKPEPRRTVGLVYRPGSPLRS 
RYEQLAEAIRGAMDGHFDKALKQAI 
 
>gi|146313657|ref|YP_001178731.1| transcriptional regulator, LysR 
family [Enterobacter sp. 638] 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVDQART 
VLREVKVLKEMASQQGEAMSGPLHIGLIPTVGPYLLPLIIPMLHQTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCAILALVKESEAFIEVPLFDEPMMLAIYEDHPWANRDRVPMGDLAGEKLLMLEDGHCLRDQAMGFCFE 
AGAEEDTHFRATSLETLRNMVAAGSGITLLPALAVPRERRRDGVVYLPCIKPEPRRTVGLVYRPGSPLRS 
RYEQLAEAIRSSMDGHFDDALKQAV 
 
>gi|8134603|sp|P71318|OXYR_PECCC Hydrogen peroxide-inducible genes 
activator 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVEQART 
VLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPQIIPMLHRTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCAILAMVKESEAFIEVPLFDEPMKLAIYQDHPWANRERVAMSDLAGEKLLMLEDGHCLRDQAMGFCFQ 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALSVPRERERDGVCYLPCYKPEPKRTIALVYRPGSPLRG 
RYEQLADTIREHMQGYMETLSK 
 
>gi|50123163|ref|YP_052330.1| hydrogen peroxide-inducible genes 
activator [Erwinia carotovora subsp. atroseptica SCRI1043] 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVEQART 
VLREVKVLKEMASQQGESMSGPLHIGLIPTVGPYLLPQIIPMLHRTFPKLEMYLHEAQTHQLLAQLDSGK 
LDCAILAMVKESEAFIEVPLFDEPMKLAIYQDHPWANRERVAMSDLAGEKLLMLEDGHCLRDQAMGFCFQ 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALSVPRERERDGVCYLPCYKPEPKRTIALVYRPGSPLRA 
RYEQLADTIREHMQGYMENLSK 
 
>gi|118069258|ref|ZP_01537505.1| transcriptional regulator, LysR family 
[Serratia proteamaculans 568] 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVEQART 
VLREVKVLKEMASQQGEAMSGPLHIGLIPTVGPYLLPQIIPTLHKTFPKLEMYLHEAQTQQLLAQLDSGK 
LDCAILALVKETEAFIEVPLFDEPMKLAVYSDHPWSQRDRVAMPDLAGEKLLMLEDGHCLRDQAMGFCFQ 
AGADEDTHFRATSLETLRNMVAAGSGITLLPSLAVPPQRERDGVCYLDCYKPEPKRTIALVYRPGSPLRS 
RYEQLAEAIREHMQNYLGTTLKQAV 
 
>gi|85060136|ref|YP_455838.1| hydrogen peroxide-inducible regulon 
activator [Sodalis glossinidius str. 'morsitans'] 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQVRKLEDELGVMLLERTSRKVLFTQAGLLLVDQART 
VLREVKVLREMASQQGESMSGPLHIGLIPTVGPYLLSHIVPMLHQAFPKLEMYLHESQTSQLLQQLDSGR 
LDCVILALVKESEAFIEVPLFDETMQLAIYADHPWADRDRVPMSDLAGERLLMLEDGHCLRDQAMGFCFQ 
AGADEDTHFRATSLETLRNMVAAGSGITLLPSLAVPRERKRDGVCYLPCYRPEPKRTIALVYRPGSPLRA 
RYEQLADCIRSHMQAYMGTGLKQAV 
 
>gi|8134604|sp|Q9X725|OXYR_ERWCH Hydrogen peroxide-inducible genes 
activator 
MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVEQART 
VLREVKVLKEMASQQGEAMSGPLHIGLIPTVGPYLLPQIIPMLHRAFPKLEMYLHEAQTHQLLAQLDSGK 
LDCAILAMVKESEAFIEVPLFDEPMKLAIYQDHPWANRERVAMSDLSGEKLLMLEDGHCLRDQAMGFCFQ 
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AGADEDTHFRATSLETLRNMVAAGSGITLLPSLAVPQERIRDGVCYLPCYKPEPKRTIALVYRPGSPLRG 
RYEQLADSVREHMQLHMEKLSAQSA 
 
>gi|51594478|ref|YP_068669.1| oxidative stress transcriptional 
regulatory protein [Yersinia pseudotuberculosis IP 32953] 
MNIRDLEYLVALAEFRHFRRAADSCHVSQPTLSGQIRKLEDELGIMLLERTSRKVLFTQAGLLLVEQAKT 
VLREVKVLKEMASLQGESMSGPLHIGLIPTVGPYLLPQIIPMLHKTFPKLEMYLHEAQTQNLLAQLDSGK 
LDCAILALVKETEAFIEIPLFDEPMNLAIYADHPWANRERVEMHELAGEKLLMLEDGHCLRDQAMGFCFQ 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPNERQRDGVCYLECYKPVPKRTIALVYRPGSPLRG 
RYEQLAEAIRDHMQERMASSLEQAI 
 
>gi|16124047|ref|NP_407360.1| oxidative stress transcriptional 
regulatory protein [Yersinia pestis CO92] 
MNIRDLEYLVALAEFRHFRRAADSCHVSQPTLSGQIRKLEDELGIMLLERTSRKVLFTQAGLLLVEQAKT 
VLREVKVLKEMASLQGESMSGPLHIGLIPTVGPYLLPQIIPMLHKTFPKLEMYLHEAQTQNLLAQLDSGK 
LDCAILALVKETEAFIEIPLFDEPMNLAIYADHPWANRERVEMHELAGEKLLMLEDGHCLRDQAMGFCFQ 
AGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPNERQRDGVCYLECYKPVPKRTIALVYRPGSPLRG 
RYEQLAEAIRDHMQERMAPSLEQAI 
 
>gi|123440532|ref|YP_001004526.1| oxidative stress transcriptional 
regulatory protein [Yersinia enterocolitica subsp. enterocolitica 8081] 
MNIRDLEYLVALAEFRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVEQART 
VLREVKVLKEMASLQGESMSGPLHIGLIPTVGPYLLPQIIPMLHQTFPKLEMYLHEAQTQNLLAQLDSGK 
LDCAILALVKETEAFIEVPLFDEPMQLAIYADHPWADRDKVQMHELAGEKLLMLEDGHCLRDQAMGFCFQ 
AGADEDTHFRATSLETLRNMVAAGSGITLLPSLAVPNERKRDGVCYLECYKPVPKRTIALVYRPGSPLRG 
RYEQLAEAIREHMQPRMNSDVINQKLEQAV 
 
>gi|77961065|ref|ZP_00824913.1| COG0583: Transcriptional regulator 
[Yersinia mollaretii ATCC 43969] 
MNIRDLEYLVALAEFRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVEQART 
VLREVKVLKEMASLQGESMSGPLHIGLIPTVGPYLLPQIIPTLHQAFPKLEMYLHEAQTQNLLAQLDSGK 
LDCAILALVKETEAFIEVPLFDEPMQLAIYADHPWADRDRVQMHELAGEKLLMLEDGHCLRDQAMGFCFQ 
AGAEEDTHFRATSLETLRNMVAAGSGITLLPSLAVPNERKRDGVCYLECYKPVPKRTIALVYRPGSPLRG 
RYEQLAEAIREHMQPRMSEELKQAV 
 
>gi|77973001|ref|ZP_00828555.1| COG0583: Transcriptional regulator 
[Yersinia frederiksenii ATCC 33641] 
MNIRDLEYLVALAEFRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVEQART 
VLREVKVLKEMASLQGESMSGPLHIGLIPTVGPYLLPQIIPMLHQTFPKLEMYLHEAQTQNLLAQLDSGK 
LDCAILALVKETEAFIEVPLFDEPMQLAIYSDHPWASREKVQMHELAGEKLLMLEDGHCLRDQAMGFCFQ 
AGAEEDTHFRATSLETLRNMVAAGSGITLLPSLAVPNERTRDGVCYLECYKPVPKRTIALVYRPGSPLRG 
RYEQLAEAIREHMQPRMSPEVINEKSEQAV 
 
>gi|77976810|ref|ZP_00832280.1| COG0583: Transcriptional regulator 
[Yersinia intermedia ATCC 29909] 
MNIRDLEYLVALAEFRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVEQART 
VLREVKVLKEMASLQGESMSGPLHIGLIPTVGPYLLPQIIPMLHKTFPKLEMYLHEAQTQNLLAQLDSGK 
LDCAILALVKETEAFIEVPLFDEPMNLAIYADHPWADRDRVQMHELAGEKLLMLEDGHCLRDQAMGFCFQ 
AGAEEDTHFRATSLETLRNMVAAGSGITLLPSLAVPNERKRDGVCYLECYKPVPKRTVALVYRPGSPLRG 
RYEQLAEAIREHMQPRMSSEVTNEKLEQAV 
 
>gi|77957411|ref|ZP_00821468.1| COG0583: Transcriptional regulator 
[Yersinia bercovieri ATCC 43970] 
MNIRDLEYLVALAEFRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGLLLVEQART 
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VLREVKVLKEMASLQGESMSGPLHIGLIPTVGPYLLPQIIPTLHQTFPKLEMYLHEAQTQNLLAQLDSGK 
LDCAILALVKESEAFIEVPLFDEPMQLAIYADHPWAGRDRVQMHELAGEKLLMLEDGHCLRDQAMGFCFQ 
AGAEEDTHFRATSLETLRNMVAAGSGITLLPSLAVPNERERDGVCYLECYKPIPKRTIALVYRPGSPLRG 
RYEQLAEAIREHMQPRMSQDVISEKLEQAV 
 
>gi|37528557|ref|NP_931902.1| hydrogen peroxide-inducible genes 
activator [Photorhabdus luminescens subsp. laumondii TTO1] 
MNIRDLEYLVALAEHRHFRHAADSCHVSQPTLSGQIRKLEDNLGVMLLERTSRKVLFTQQGMLLVEQART 
VLREVRILQEMASLQGENMSGPLHIGLIPTVGPYLLPHIIPRLHSLFPKLEMYLYEAQTQSLLAQLDSGK 
LDCAILAMVKETRDFIEVPLFEEPMKLAIYDDHPWAERKKIAMDELAGEKLLMLEDGHCLRDQAMGFCFQ 
AGAKEDTHFRATSLETLRNMVAAGSGITLLPDLAVPQEKKRDGVCYLECNSPEPKRSVVLIYRPGSPLRG 
RYEQLAEAIRAKMGTYYGQSK 
 
>gi|53733092|ref|ZP_00349646.1| COG0583: Transcriptional regulator 
[Haemophilus influenzae R2846] 
MNIRDLEYLVALSEYKHFRRAADSCNVSQPTLSGQIRKLEDELGIILLERTSRKVLFTQSGMLLVDQART 
VLREVKLLKEMASNQGKEMTGPLHIGLIPTVGPYLLPYIVPMLKAAFPDLEVFLYEAQTHQLLEQLETGR 
LDCAIVATVPETEAFIEVPIFNEKMLLAVSEHHPWAQESKLPMNQLNGQEMLMLDDGHCLRNQALDYCFT 
AGAKENSHFQATSLETLRNMVAANAGITFMPELAVLNEGTRKGVKYIPCYSPEPSRTIALVYRPGSPLRN 
RYERVASAVSDEVKSILGGLK 
 
>gi|16272514|ref|NP_438728.1| hydrogen peroxide-inducible genes 
activator [Haemophilus influenzae Rd KW20] 
MNIRDLEYLVALSEYKHFRRAADSCNVSQPTLSGQIRKLEDELGIILLERTSRKVLFTQSGMLLVDQART 
VLREVKLLKEMASNQGKEMTGPLHIGLIPTVGPYLLPYIVPMLKAAFPDLEVFLYEAQTHQLLEQLETGR 
LDCAIVATVPETEAFIEVPIFNEKMLLAVSEHHPWAQESKLPMNQLNGQEMLMLDDGHCLRNQALDYCFT 
AGAKENSHFQATSLETLRNMVAANAGITFMPELAVLNEGTRKGVKYIPCYSPEPSRTIALVYRPGSPLRN 
RYERVASAVSDEVKSILDGLK 
 
>gi|145631749|ref|ZP_01787510.1| DNA-binding transcriptional regulator 
OxyR [Haemophilus influenzae 22.4-21] 
MNIRDLEYLVALSEYKHFRRAADSCNVSQPTLSGQIRKLEDELGIILLERTSRKVLFTQSGMLLVDQART 
VLREVKLLKEMASNQGKEMTGPLHIGLIPTVGPYLLPYIVPMLKAAFPDLEVFLYEAQTHQLLEQLETGR 
LDCAIVATVPETEAFIEVPIFNEKMLLAVSEHHPWAQESKLPMNQLNGQEMLMLDDGHCLRNQTLDYCFT 
AGAKENSHFQATSLETLRNMVAANAGITFMPELAVLNEGTRKGVKYIPCYSPEPSRTIALVYRPGSPLRN 
RYERVASAVSDEVKSILGGLK 
 
>gi|145637931|ref|ZP_01793573.1| hydrogen peroxide-inducible genes 
activator [Haemophilus influenzae PittHH] 
MNIRDLEYLVALSEYKHFRRAADSCNVSQPTLSGQIRKLEDELGIILLERTSRKVLFTQSGMLLVDQART 
VLREVKLLKEMASNQGKEMTGPLHIGLIPTVGPYLLPYIVPMLKAAFPDLEVFLYEAQTHQLLEQLETGR 
LDCAIVATVPETEAFIEVPIFNEKMLLAVSEHHPWAQESKLPMNQLNGQEMLMLDDGHCLRNQALDYCFT 
AGAKENSHFQATSLETLRNMVAANAGITFMPELAVLNEGTRRGVKYIPCYSPEPSRTIALVYRPGSPLRN 
RYERVASAVSDEVKSILDGLK 
 
>gi|145635342|ref|ZP_01791044.1| DNA-binding transcriptional regulator 
OxyR [Haemophilus influenzae PittAA] 
MNIRDLEYLVALSEYKHFRRAADSCNVSQPTLSGQIRKLEDELGIILLERTSRKVLFTQSGMLLVDQART 
VLREVKLLKEMASNQGKEMTGPLHIGLIPTIGPYLLPYIVPTLKAAFPDLEVFLYEAQTHQLLEQLETGR 
LDCAIVATVPETEAFIEVPIFNEKMLLAVSEHHPWAQESKLPMNQLDGQEMLMLDDGHCLRNQALDYCFT 
AGAKENSHFQATSLETLRNMVAANAGITFMPELAVLNEGTRKGVKYIPCYSPEPSRTIALVYRPGSPLRN 
RYERVASAVSDEVKSILGGLK 
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>gi|145640547|ref|ZP_01796131.1| hydrogen peroxide-inducible genes 
activator [Haemophilus influenzae R3021] 
MNIRDLEYLVALSEYKHFRRAADSCNVSQPTLSGQIRKLEDELGIILLERTSRKVLFTQSGMLLVDQART 
VLREVKLLKEMASNQGKEMTGPLHIGLIPTVGPYLLPYIVPMLKAAFPDLEVFLYEAQTHQLLEQLETGR 
LDCAIVATVPETEAFIEVPIFNEKMLLAVSEHHPWAQESKLLMNQLNGQEMLMLDDGHCLRNQTLDYCFT 
AGAKENSHFQATSLETLRNMVAANAGITFMPELAVLNEGTRKGVKYIPCYSPEPSRTIALVYRPGSPLRN 
RYERVASAVSDEVKSILDGLK 
 
>gi|38488592|dbj|BAD02310.1| oxyR like protein [Actinobacillus 
actinomycetemcomitans] 
MNIRDLEYLVALAEHKHFRRAADSCHVSQPTLSGQIRKLEDELGIILLERTSRKVLFTQSGLLLVDQAKT 
VLREVKLLKEMASNQGKDMTGPLHIGIIPTVGPYLMPHIVPTLQQNFPDLELFLYEAQTYRLLEQLETGR 
LDCAIVASVPETEAFIEVQLFNEKMLLAVAEQHPWANENSVSMSLLKDCEILMLDDGHCLRNQALGYCFT 
AGARENAHFQATSLETLRNMVAANTGVTLMPQLAVLSEGNRSGVKYLPCDEPEPSRDITLVYRPGSPLRA 
RYERVANTVSQSVKSILSS 
 
>gi|15603211|ref|NP_246285.1| OxyR [Pasteurella multocida subsp. 
multocida str. Pm70] 
MNIRDLEYLVALAEHKHFRRAADACHVSQPTLSGQIRKLEDELGIILLERTSRKVLFTQSGLLLVDQAKN 
VLKEVKLLKEMASNQGKDMTGPIHIGVIPTVGPYLLPYIMPVLKETFPDLELFLYEAQTNQLLEQLETGH 
LDCAIVASVRETEAFIEVPIFHEAMLLAVSENHPWANERTIAMNRLNGCEMLMLDDGHCLRDQTIGYCFS 
AGAKENAHFQATSLETLRNMVASNTGITLMPKLAVINEGNRTGVKYIPCHSPAPSRAITLVYRPGSPLRN 
RYEKIAQTISHSVQDVLD 
 
>gi|90413601|ref|ZP_01221591.1| putative Hydrogen peroxide-inducible 
genes activator [Photobacterium profundum 3TCK] 
MNIRDLEYLIALSEHKHFRKAAESCFVSQPTLSGQIRKLEDELGVSLLERTSRRVLFTDAGLSLVAQAQK 
VLLEVKVLTELASQQGESMSGPLHIGFIPTVGPYLLPLIIPMFRESFPDLELFLHEAQTSQLTHLLEEGK 
LDCILLAAVKETESFIELPLYDEPMVVAVPDTHPWAEKDEMDMASLHGETLLMLGDGHCLRDQAMGFCFA 
AGANEDGRFKATSLETLRNMVAAGSGITLLPQLATPKERSRDGVCYIKVHDPIPTRLITLCYRPGSPLRT 
RYEKIATEIKDRMVTYFEQ 
 
>gi|75437399|ref|ZP_00733420.1| transcriptional regulator 
[Actinobacillus succinogenes 130Z] 
MNIRDLEYLVSLAEFKHFRRAADACNVSQPTLSGQIRKLEDELGITLLERTSRKVLFTQSGLLLVAQAKQ 
VLREVKLLKEMASNQGKDMTGPLHVGVIPTVGPYLLPYIMPVLKESFPELELFLYEAQTNQLVDQLETGR 
LDCAIVAMVVETEPFIQVPLFNEKMLIAVSEAHPWAKEKNIPLDYLKGTEVLMLDDGHCLREQALGYCFA 
AGASENSHFQATSLEMLRNMIAANAGVTLMPELAVLNEGQRRGVKYIPCINPEPQRTIALIYRPGSPLRA 
RYERVANAVKKAVRPILEGD 
 
>gi|52424209|ref|YP_087346.1| LysR protein [Mannheimia 
succiniciproducens MBEL55E] 
MNIRDLEYLAALAEYKHFRRAADACHVSQPTLSGQIRKLEDELGITLLERTSRKVLFTQSGLILVEQAKK 
VLREVKLLKEMASNQGKEMTGPLHLGVIPTVGPYLLPYIMPALKEAFPDLELYLYEAQTSHLLDQLESGR 
LDCAILATVPETEPFIEVPIFNERMLLAVSEQHPWAKEKSIKMHALQGHEVLMLDDGHCLRDQALGYCFT 
AGARENSHFQATSLETLRNMIAANAGMTLMPELAMLNEGTRAGVKYIPCTDPEPKRTIALVYRPGSPLRS 
RYERVANAVGDAVKAILHTEGD 
 
>gi|54307494|ref|YP_128514.1| putative Hydrogen peroxide-inducible 
genes activator [Photobacterium profundum SS9] 
MNIRDLEYLIALSEHKHFRKAAESCFVSQPTLSGQIKKLENELGVSLLERTSRRVLFTDAGLTLVAQAQK 
VLLEVKVLTELASQQGESMSGPLHIGFIPTVGPYLLPLIIPMFRESFPDLELFLHEAQTSQLTHLLEEGK 
LDCILLAAVKETESFIELPLYDEPMVVAVPDTHPWAEKDEMDMASLHGETLLMLGDGHCLRDQAMGFCFA 
AGAKEDGRFKATSLETLRNMVAAGSGITLLPQLATPKERSRDGVCYIKVHDPIPTRLITLCYRPGSPLRT 
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RYEKIAAEIKDRMVTYFEQ 
 
>gi|90580866|ref|ZP_01236668.1| putative Hydrogen peroxide-inducible 
genes activator [Vibrio angustum S14] 
MNIRDLEYLVALSEHKHFRKAAEACYVSQPTLSGQIRKLEDELGVSLLERTSRRVLFTDAGLSLVAQAQK 
VLLEVKILTELASVQGESMSGPLHIGFIPTVGPYLLPQIIPSLKEAFPELELFLHEAQTHQLVQQLEEGK 
LDCIILAAVKESEPFIELPLYDEPMMLAVPETHKWASEKDIDMSLLHGESLLMLEDGHCLRNQALGFCFA 
AGARDDGRFKATSLETLRNMVAAGSGITLLPQLASPKEHCRDGVCYIAAKHPQPTRLITLAYRPGSPLKA 
RYEKLAEVIKEKMPEVFAKHTQP 
 
>gi|46156415|ref|ZP_00132876.2| COG0583: Transcriptional regulator 
[Haemophilus somnus 2336] 
MNIRDLEYLVSLAEHKHFRRAADACYVSQPTLSGQIRKLEDELGIVLLERTSRKVLFTQSGLLLVKQAKT 
VLREIKLLKEMASNQGKEMNGPLHMGVIPTIGPYLLPYIVPALKNTFPDLELFLYEAQTQKLLEQLETGH 
LDCVILASVDEAEAFIEVPMFNERMLLAVSDEHPLSKEDSIKMDKLKGYEMLMLDDGHCLRNQALDYCFA 
AGAKENQNFRATSLETLRNMVSANTGITLIPELALLNEGSRKGIKYLPCFSPEPSRGISLVYRPGSPLRG 
RYERIANKVSEIIKPLLNNRKNGN 
 
>gi|89075201|ref|ZP_01161632.1| putative Hydrogen peroxide-inducible 
genes activator [Photobacterium sp. SKA34] 
MNIRDLEYLVALSEHKHFRKAAEACYVSQPTLSGQIRKLEDELGVSLLERTSRRVLFTDAGLSLVAQAQK 
VLLEVKILTELASVQGESMSGPLHIGFIPTVGPYLLPQIIPSLKEAFPELELFLHEAQTHQLVQQLEEGK 
LDCMILAAVKESEPFIELPLYDEPMMLAVPETHKWASEKDIDMSLLQGESLLMLEDGHCLRNQALGFCFA 
AGARDDGRFKATSLETLRNMVAAGSGITLLPQLASPNEHCRDGVCYIAAKHPQPTRLITLAYRPGSPLKA 
RYEKLAEVIKEKMPEVFAKHTQP 
 
>gi|59712906|ref|YP_205682.1| hydrogen peroxide-inducible genes 
activator [Vibrio fischeri ES114] 
MNIRDFEYLVALAEHKHFRKAAESCFVSQPTLSGQIKKLEDEVGLALLERTSRKVLFTEAGLQLVEQAKK 
ILLEVKRFSELANQQGKEMTGPLHLGFIPTVGPYVLPWIVPTLKAQFPDLNLYLHEAQTHQLVKMLEEGK 
IDCMILASVEETNMFIEVPVYDEPMVLAVPKDHKWAKEVSIDMSRLSGESVLMLGDGHCLRDQALGFCFA 
AGAKDDDHFKATSLETLRNMVAAGGGITLMPYLSVPKEKERDGVCYLPAQDPVPHRQIVLAYRPGSPLRA 
RYESLAKEIENKMSNVIRS 
 
>gi|86147322|ref|ZP_01065636.1| transcriptional regulator, LysR family 
protein [Vibrio sp. MED222] 
MNIRDFEYLVALAEHKHFRKAAEACFVSQPTLSGQIRKLEDEIGLQLTERSPRKVIFTESGLQLVEQAKR 
ILNEVKTFKDMASGHGEAMTGPMHIGFIPTVGPYILPKIIPHLKDSFPDLELYLHEAQTHQLVSQLEDGK 
LDCLVLAAVDETAAFKEIDVYNEPLSVAVPCDHEWAKQDTVDMLQLNGQTVLALGDGHCLRDQALGFCFA 
AGAKDDERFKATSLETLRNMVAAGAGITLLPQLSVPKEKQKDGVCYVPAVNPTPSRRIVVAYRPGSPLKG 
RFEQLAEAIRTQLDKAV 
 
>gi|84390825|ref|ZP_00991517.1| transcriptional regulator, LysR family 
[Vibrio splendidus 12B01] 
MNIRDFEYLVALAEHKHFRKAAEACFVSQPTLSGQIRKLEDEIGLQLTERSPRKVIFTESGLQLVEQAKR 
ILNEVKTFKDMASGHGEAMTGPMHIGFIPTVGPYILPKIIPHLKENFPDLELYLHEAQTHQLVSQLEDGK 
LDCLVLAAVDETAAFKEIDVYDEPLSVAVPCDHEWAQQDAVDMLQLNGQTVLALGDGHCLRDQALGFCFA 
AGAKDDERFKATSLETLRNMVAAGAGITLLPQLSVPKEKQKDGVCYVPAVNPTPSRRIVVAYRPGSPLKG 
RFEQLAEAIRTQLEKTA 
 
>gi|148979177|ref|ZP_01815356.1| DNA-binding transcriptional regulator 
OxyR [Vibrionales bacterium SWAT-3] 
MNIRDFEYLVALAEHKHFRKAAEACFVSQPTLSGQIRKLEDEIGLQLTERSPRKVIFTESGLQLVEQAKR 
ILNEVKTFKDMASGHGEAMTGPMHIGFIPTVGPYILPKIVPHLKESFPELELYLHEAQTHQLVSQLEDGK 
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LDCLVLAAVDETAVFKEIDVYDEPLSVAVPCDHEWAQQDTVDMLQLNGQTVLALGDGHCLRDQALGFCFA 
AGAKDDERFKATSLETLRNMVAAGAGITLLPQLSVPKEKQKDGVCYVPAVNPTPSRRIVVAYRPGSPLKG 
RFEQLAETIRTQLEKVV 
 
>gi|149189164|ref|ZP_01867451.1| DNA-binding transcriptional regulator 
OxyR [Vibrio shilonii AK1] 
MNIRDFEYLVALAEHKHFRKAAEACFVSQPTLSGQIRKLEDEIGTSLLERSSRRVLFTDAGLQLVEQAKR 
VLKEVKTFREMAAGQSGEMTGPMHIGFIPTVGPYLLPKIIPKLKDAFPELELYLHEAQTHQLVRQLEEGK 
LDCLVLASVPETAPFKEIEVYNEPMSVAVPCDHEWANKDQIEMAELNGQTVLSLGDGHCLRDQALGFCFA 
AGARDDERFKATSLETLRNMVAAGAGITLLPELSLPTEKVKDGVCYVTAINPTPSRSIVLAYRPGSPLRA 
RFEKLAKAITEYLS 
 
>gi|148868418|gb|EDL67529.1| hydrogen peroxide-inducible genes 
activator [Vibrio harveyi HY01] 
MNIRDFEYLVALAEHKHFRKAAEACFVSQPTLSGQIRKLEDELGTALLERSSRRVLFTDSGLQLVEQAKR 
ILSEVKTFKDMASGQSGAMTGPMHIGFIPTVGPYLLPKIVPRLKEEFPELELFLHEAQTHQLVRQLEEGK 
LDCLVLASVDETAPFKEIEVYNEPLSVAVPCDHEWAGLDHIDMLDLNGRTVLALGDGHCLRDQALGFCFA 
AGAKDDERFKATSLETLRNMVAAGAGITLLPELSVPHEKKKDGVCYVPAVNPTPSRSIVLVYRPGSPLRA 
RFEALASTIKSILEAKQNSIAA 
 
>gi|116183621|ref|ZP_01473601.1| hypothetical protein VEx2w_02003825 
[Vibrio sp. Ex25] 
MNIRDFEYLVALAEHKHFRKAAEACFVSQPTLSGQIRKLEDELGTTLLERSSRRVLFTDSGLQLVEQAKR 
ILSEVKTFKDMASGQSGAMTGPMHIGFIPTVGPYLLPKILPQIKEAFPELELFLHEAQTHQLVRQLEEGK 
LDCLVLASVDETAPFKEIEVYNEPLSVAVPCDHEWASLDHVDMLELNGKTVLALGDGHCLRDQALGFCFA 
AGAKDDERFKATSLETLRNMVAAGAGITLLPQLSIPNEKQKDGVCYVPAVNPTPSRNIVLVYRPGSPLRA 
RFEALAAKIKEVLASYPSLNAAA 
 
>gi|150424013|gb|EDN15952.1| transcriptional regulator, LysR family 
[Vibrio cholerae AM-19226] 
MNIRDFEYLVALADHKHFRKAAEACFVSQPTLSGQIRKLEDEIGTTLLERSSRRVLFTEAGLQLVDQAKK 
ILSEVKTFKDMANQQTGAMTGPLHIGFIPTLGPYLLPKIIPTLKERFPELELYLHEAQTNQLVRQLEEGK 
LDCLVLASVEETAPFKEIELYNEVLSIAVPCDHAWAARDEVDMLELKGKTVLALGDGHCLRDQALGFCFA 
AGAKDDERFKATSLETLRNMVAAGAGITLLPELALPEDKTKDGVCYLRAINPIPSRRLVLAYRPGSPLRQ 
RFEQLAEVIKHRLQQSE 
 
>gi|15642631|ref|NP_232264.1| transcriptional regulator, LysR family 
[Vibrio cholerae O1 biovar eltor str. N16961] 
MNIRDFEYLVALADHKHFRKAAEACFVSQPTLSGQIRKLEDEIGTTLLERSSRRVLFTEAGLQLVDQAKK 
ILSEVKTFKDMANQQTGAMTGPLHIGFIPTLGPYLLPKIIPTLKERFPELELYLHEAQTNQLVRQLEEGK 
LDCLVLASVEETAPFKEIELYNEVLSIAVPCDHAWAARDEVDMLELKGKTVLALGDGHCLRDQALGFCFA 
AGAKDDERFKATSLETLRNMVAAGAGITLLPELALPEDKTKDGVCYLRAVNPIPSRRLVLAYRPGSPLRQ 
RFEQLAEVIKHRLQQSE 
 
>gi|28899526|ref|NP_799131.1| transcriptional regulator, LysR family 
[Vibrio parahaemolyticus RIMD 2210633] 
MNIRDFEYLVALAEHKHFRKAAEACFVSQPTLSGQIRKLEDELGTALLERSSRRVLFTDSGLQLVDQAKR 
ILSEVKTFKDMASGQSGAMTGPMHIGFIPTVGPYLLPKILPQLKEEFPELELFLHEAQTHQLVRQLEEGK 
LDCLVLASVAETAPFKEIEVYNEPLSVAVPCGHEWAQLDQVDMLELNGKTVLALGDGHCLRDQALGFCFA 
AGAKDDERFKATSLETLRNMVAAGAGITLLPQLSIPAEKQKDGVCYIPAVNPTPSRSIVLAYRPGSPLRA 
RFEALAAKIKAILESQPSSMAA 
 
>gi|91227290|ref|ZP_01261715.1| transcriptional regulator, LysR family 
protein [Vibrio alginolyticus 12G01] 
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MNIRDFEYLVALAEHKHFRKAAEACFVSQPTLSGQIRKLEDELGTTLLERSSRRVLFTDSGLQLVEQAKR 
ILSEVKTFRDMASGQSGAMTGPMHIGFIPTVGPYLLPKILPQIKEAFPELELFLHEAQTHQLVRQLEEGK 
LDCLVLASVDETAPFKEIEVYQEPLSVAVPCDHEWASLDHVDMLELNGKTVLALGDGHCLRDQALGFCFA 
AGAKDDERFKATSLETLRNMVAAGAGITLLPQLSIPNEKQKDGVCYVPAVNPTPSRNIVLVYRPGSPLRA 
RFEALAAKIKEVLASYPSLNAAA 
 
>gi|46143704|ref|ZP_00204557.1| COG0583: Transcriptional regulator 
[Actinobacillus pleuropneumoniae serovar 1 str. 4074] 
MNIRDLEYLIALADYKHFRRAADACNVSQPTLSGQIRKLEDELGTVLLERTSRKVLFTQAGLTLVEQAKA 
VLREVKVLKEMASNQGKEMSGPLHVGIIPTLGPYLLPLVLPALKSTFPELELYIYELQTTQLVDQLESGQ 
LDCGILAFVKESEPFIEVPIFNEQMLLAVSDKHEWSHKSKMDISYLKDKELLFLDDGHCLRTQTLDYCLS 
VGAKESTHFKATNLETLRNMVAANVGMSLIPELAAKPCEGLNYLTFDEPKPYRTVGLIYRPGSPLRIRYE 
RLAKEVSKIMKQEKIHE 
 
>gi|27364769|ref|NP_760297.1| Transcriptional regulator [Vibrio 
vulnificus CMCP6] 
MNIRDFEYLVALAEHKHFRKAAEACFVSQPTLSGQIRKLEEEIGTTLLERSSRRVLFTDAGLQLVEQAKN 
ILKEVKTFKEMASGQSGAMTGPMHIGFIPTLGPYLLPKIVPQLKERFPELELFLHEAQTQQLVRQLEDGK 
LDCLVLASVAETEPFKEIEVYNEPLSVAVPCHHEWAALEQLDMLELNGKTVLALGDGHCLRDQALGFCFA 
AGARDDERFKATSLETLRNMVAAGAGITLLPELSVPKEKQKDGVCYIKAVNPVPSRTIVVVYRPGSPLRA 
RFEQLAATIKELLVSGSEQ 
 
>gi|37681180|ref|NP_935789.1| transcriptional regulator [Vibrio 
vulnificus YJ016] 
MGMNIRDFEYLVALAEHKHFRKAAEACFVSQPTLSGQIRKLEEEIGTTLLERSSRRVLFTDAGLQLVEQA 
KNILKEVKTFKEMASGQSGAMTGPMHIGFIPTLGPYLLPKIVPQLKERFPELELFLHEAQTQQLVRQLED 
GKLDCLVLASVAETEPFKEIEVYNEPLSVAVPCHHEWAALEQLDMLELNGKTVLALGDGHCLRDQALGFC 
FAAGARDDERFKATSLETLRNMVAAGAGITLLPELSVPKEKQKDGVCYIKAVNPVPSRTIVVVYRPGSPL 
RARFEQLAVTIKELLVSGSEQ 
 
>gi|33151874|ref|NP_873227.1| hydrogen peroxide-inducible genes 
activator [Haemophilus ducreyi 35000HP] 
MNIRDLEYLIALADYKHFRRAADACNVSQPTLSGQIRKLENELGTILLERTSRKVLFTQAGLTLVEQAKA 
VLREVKILKEMASNQGKEMSGPLHVGIIPTLGPYLLPFALPALKSAFPELDLYIYELQTSQLIDQLEAGQ 
LDCGILALVKESEPFIEIPIFNEEMLLAVPKQHEWAKQSSLTINALKDKELLFLDDGHCLRTQTLDYCLS 
VGAKESTHFKATNLETLRNMVATNAGMSLVPELAAKQNANIHYLTFENPQPYRAIGLIYRPGSPLRIRYE 
RLAKEVAYIMTKEGKNE 
 
>gi|117620885|ref|YP_857687.1| hydrogen peroxide-inducible genes 
activator [Aeromonas hydrophila subsp. hydrophila ATCC 7966] 
MRARILDPGPPCFIGLSTFPLAPSLVRSAVLGHANGPIGWQDSGCMNLRDLEYLVALEEEKHFRKAAERC 
FVSQPTLSGQLRKLEDELGVILIERTSRKVLFTPAGDAMAQQARKVLKEVRELKSIGQHFAEPMSGEIHI 
GFIPTVGPYLLPHIIQDLREHFPKLEFYLYEEQTQVLLKRLEEGELDCLILAELEGMDGFGSIPLYQEPM 
WLAVPQQHPEAKAKAVPLSNLKGKKLLMLADGHCLRDQAMGFCFAAGIGEDQRFKGTSLETLRNMVAAGS 
GMTLVPRLAVPANAEEGGVSYRPVIDPVPGRTIALLYRHYSVRRPCFNELAARISRLMQSLLG 
 
>gi|145298146|ref|YP_001140987.1| hydrogen peroxide-inducible genes 
activator [Aeromonas salmonicida subsp. salmonicida A449] 
MSLRDLEYLVALEEEKHFRKAAERCFVSQPTLSGQLRKLEDELGVILIERTSRKVLFTPAGDAMAHQARK 
VLKEVRELKNIGQHFAEPMSGEIHIGFIPTVGPYLLPHIIQDLREHFPKLEFYLYEEQTQLLLKRLEEGE 
LDCLILAELDGMEGFGSIPLYQEPMWLAVPQHHPEAKARAVPLSNLKGKKLLMLADGHCLRDQAMGFCFA 
AGIGEDQRFKGTSLETLRNMVAAGSGMTLVPRLAVPANAEEGGVSYRPVVDPVPGRTISLLYRHYSVRRP 
CFNELASRISTLMKSLLG 
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>gi|149909427|ref|ZP_01898082.1| regulatory protein sensor for 
oxidative stress, regulatesintracellular hydrogen peroxide (LysR 
family) [Moritella sp. PE36] 
MNLRDLEYLVALQELKHFRKAAEKCFVSQPTLSGQIRKLEDELDVILIERTSRKVLFTPAGDQIADQART 
VLLESKAIKEIAKSYASPTAGAIHIGLIPTVAPYLLPLIVPSMKKKFPDLDMFLHENQTHELLKQLDEGE 
LDCLLLAYLPGMEKYGHIELYKEPLELIIPSSHRFKGRDRVDLSELRGEKVLMLEDGHCLRDQAMDYCFT 
AGAEEDQSFKATSLETLRHMIAAEAGVTLLPHLAIPRSRFTEGVEYIKFVEPEPIRKIVLLYRKGSVRRP 
CFNDIAEVISKQVAATIV 
 
>gi|90407841|ref|ZP_01216017.1| putative Hydrogen peroxide-inducible 
genes activator [Psychromonas sp. CNPT3] 
MNFRDLEYLIALEELKHFRKAAEKCFVSQPTLSGQIRKLEEELNVQLMERSSRKVIFTQAGLDIVAKAKN 
ILVEAKSLREIAKSHNQPMHGQLHIGLIPTVAPYLLPLIIPSIRKEFPDLEVFLHENQTKVLLKQLESGE 
LDCLMLALLPDMQAFHNYPLYVEPLELALSETHQWANEHQIDIKKLSGERVLMLADGHCLRDQALGFCFA 
AGAIEDNSFKATSLETLRHMIGADNGLTLLPQLAIPLNRHQAGIKYIPFMAPIPTRSIVLLCRKNSVRTQ 
CFEQLSTLITSKVNKQLKMY 
 
>gi|119947099|ref|YP_944779.1| transcriptional regulator, substrate-
binding, LysR family protein [Psychromonas ingrahamii 37] 
MNFRDLEYLIALEELKHFRKAAEKCFVSQPTLSGQIRKLEDELGIQLMERSPRKVLFTPAGLDIVAKAKT 
ILLEVKSLKEIAKSYNEPMQGTLHIGLIPTVAPYLLPLIVAVIKANFPDLSLYLYEKQTNLLLKQLEEGE 
LDCLILALLPGMESFTQYHLYQEPLELAITDVHPWAKQPEIELNGLRGEHVLMLEDGHCLRDQTKGFCFA 
AGALEDGSFQATSLETLRHMISAENGMTLLPQLAIPVNRHEGGIQYIPFKNPKPTREISLLCRKNSVRKI 
CFEQLAKLISTTVQAKLKEYG 
 
>gi|116216130|ref|ZP_01482018.1| hypothetical protein VchoR_02002081 
[Vibrio cholerae RC385] 
MNIRDFEYLVALADHKHFRKAAEACFVSQPTLSGQIRKLEDEIGTTLLERSSRRVLFTEAGLQLVDQAKK 
ILSEVKTFKDMANQQTGAMTGPLHIGFIPTLGPYLLPKIIPTLKERFPELELYLHEAQTNQLVRQLEEGK 
LDCLVLASVEETAPFKEIELYNEVLSIAVPCDHAWAARDEVDMLELKGKTVLALGDGHCLRDQALGFC 
 
>gi|71278569|ref|YP_271362.1| hydrogen peroxide-inducible genes 
activator [Colwellia psychrerythraea 34H] 
MIKLRDLEYLTAIDKHKHFGKAAQSCFVSQPTLSGQLMKLEEQLGLQLVERHRRNVMLTPAGEQLVKEAR 
KVLQAAGQFESCAKALLDPFAGDLHLGLIPTLAPYLLPHIMADLNKALPNINFFLHENQTKVLLQELDEG 
KLDVLILPYLDEMDKFESYQLFDEPLMLATPKNHRLANKKDLSLSDLHDEKILTLADGHCLKDQAMGYCF 
SAGAKEDNSFQATSLETLRHMVASGMGITLLPALAAQGNLASDTIHYGQFQAPVPVRGISLVIRPNYSRM 
QCVRSIVASVRKSLNGIIT 
 
>gi|21230306|ref|NP_636223.1| oxidative stress transcriptional 
regulator [Xanthomonas campestris pv. campestris str. ATCC 33913] 
MNLRDLKYLVALADHKHFGRAATACFVSQPTLSTQIKKLEDELGVPLVERAPRKVMLTPAGREAAMRARS 
IVAEVEQMKEAARRSQDPEAGTVRLGIFPTLAPYLLPHVVPRIRERFPRLELLLIEEKSDQLIHQLREGR 
MDAALLALPLQDEQLHAEFLFEEPFVLAVPEGHPLSRHDSMTLDDLSEQRLLLLEDGHCLREQALDVCHL 
AGALEKSEFQATSLETLRQMVAANVGVTLLPMLAVKPPVARSENIRLIRFREDKQPNRRIAMAWRRSSAM 
TAFLEQLSQIFKELPDSLFTLDQPASGPKAVAA 
 
>gi|119877904|ref|ZP_01644878.1| transcriptional regulator, LysR family 
[Stenotrophomonas maltophilia R551-3] 
MNLRDLKYLVALADHKHFGRAAASCFVSQPTLSTQIRKLEEELGLPLVERAPRKVMLTPAGQEAAARARV 
IVSEVEQLKEAARRSRDPEAGTVRLGIFPTLGPYLLPHVIPRIRERFPELELLLVEEKSDVLLDRLREGK 
LDAALLALPVIDDQLHAEFLFEEPFLLAVSGRHPLARREHLDVQELATQKLLLLEDGHCLRDQALEVCRL 
FGANEKSEFRATSLETLRQMVAADVGITLLPSLSVQPPVPRSSNIRLLDFTGEGRPSRRIAMIWRRSSAM 
NDFLTELADQFKRLPEALFTLEAVNAGGDASTLPGPVLNG 
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>gi|2098748|gb|AAC45427.1| oxidative stress transcriptional regulator; 
OxyR [Xanthomonas campestris] 
MNLRDLKYLVALADHKHFGRAASACFVSQPTLSTQIKKLEDELGVSLVERAPRKVMLTPAGREAAVRARS 
IVAEVEQMKEAARRSQDPEAGTVRLGIFPTLAPYLLPHVVPRIRQRFPRLELLLIEEKSDQLMHQLREGR 
LDAALLALPLQDDQLHAEFLFEEPFVLAVPEGHPLSRHDSMTLDDLSEQRLLLLEDGHCLRDQALDVCHL 
AGALEKSEFQATSLETLRQMVAANVGVTLLPLLAVKPPVARSENIRLIRFREDKQPSRRIAMAWRRSSAM 
TAFLEQLSQLFKELPESLFTLDQPATGPKAVAA 
 
>gi|78046497|ref|YP_362672.1| transcriptional regulator, LysR family 
[Xanthomonas campestris pv. vesicatoria str. 85-10] 
MNLRDLKYLVALADHKHFGRAASACFVSQPTLSTQIKKLEDELGVSLVERAPRKVMLTPAGREAAVRARS 
IVAEVEQMKEAARRSQDPEAGTVRLGIFPTLAPYLLPHVVPRIRERFPRLELLLIEEKSDQLMHQLREGR 
LDAALLALPLQDDQLHAEFLFEEPFVLAVPEGHPLSRHDSMTLDDLSEQRLLLLEDGHCLRDQALDVCHL 
AGAMEKSEFQATSLETLRQMVAANVGVTLLPLLAVKPPVARSENIRLIRFREDKQPSRRIAMAWRRSSAM 
TAFLEQLSQLFKELPESLFTLDQPATGPKAVAA 
 
>gi|21241675|ref|NP_641257.1| oxidative stress transcriptional 
regulator [Xanthomonas axonopodis pv. citri str. 306] 
MNLRDLKYLVALADHKHFGRAASACFVSQPTLSTQIKKLEDELGVSLVERAPRKVMLTPAGREAAVRARS 
IVAEVEQMKEAARRSQDPEAGTVRLGIFPTLAPYLLPHVVPRIRERFPRLELLLIEEKSDQLMHQLREGR 
LDAALLALPLQDDQLHAEFLFEEPFVLAVPESHPLSRHDSMTLDDLSEQRLLLLEDGHCLRDQALDVCHL 
AGALEKSEFQATSLETLRQMVAANVGVTLLPLLAVKPPVARSENIRLIRFREDKQPSRRIAMAWRRSSAM 
TAFLEQLSQLFKELPESLFTLDQPAPGPKAVAA 
 
>gi|54294702|ref|YP_127117.1| Hydrogen peroxide-inducible genes 
activator [Legionella pneumophila str. Lens] 
MNLRDLHYFVILADVKHFGEAAKRCFVSQPTLSMQIKKLEEELGVVLFERTNKQVLLTDQGSKLLDRTRK 
ILILIDEMKELARQSEDPFTGELRLGVIPTVSPYMLPLVMPELKNEYPRLKVWLIEDQTHRLITKLEQGE 
LDVAIMALPIDKRFSCQILYEEKFYFACANTHPLAQAKSVNINDLKNQPIMLLEEGHCLREQAMAVCQSA 
KADDIADFTATSLETLRLMVQAGMGVTLLPALSTLTASTNHLKCIPFSEPAPSRIVGLFWRAGTPRQICF 
NAIAELITKNVQSKLA 
 
>gi|119469939|ref|ZP_01612744.1| hypothetical protein ATW7_04854 
[Alteromonadales bacterium TW-7] 
MNLKDFEYVKAIAQHKHFRKAADACFVSQPTLSGQVKKLEQTLGVTLFDRSTKQVTLTAKGVRLLAQIEV 
ILEQTQILKELASASNEPLQGKITIGIIPTIAPYLLPTLLTSMKEAFVDSQFAFIEMQTATILDALNNGE 
LDFAILADVAELNHYHTIPLYKEDFLVAVSKDNALAKHKKVALSDLQGCSLLMLSDGHCFKDQAQKFCFS 
AGVDVSNQYKGNSLETLLALVAMDDGVTFVPKLACTQRTGIDYMPIFPNQQRNVVFACRKHYPHLAGVEQ 
LGEWLSAHPNLKTQLAKAL 
 
>gi|52842042|ref|YP_095841.1| hydrogen peroxide-inducible genes 
activator OxyR [Legionella pneumophila subsp. pneumophila str. 
Philadelphia 1] 
MNLRDLHYFVILADVKHFGEAAKRCFVSQPTLSMQIKKLEEELGVVLFERTNKQVLLTDQGSKLLDRTRK 
ILILIDEMKELARQSEDLFTGELRLGVIPTVSPYMLPLVMPELKNEYPRLKVWLIEDQTHRLITKLEQGE 
LDVAIMALPIDKRFSCQTLYEEKFYFACANTHPLAQAKSVNINDLKNQPIMLLEEGHCLREQAMAVCQSA 
KADDIADFTATSLETLRLMVQAGMGVTLLPALSTLTASTNHLKCIPFSEPAPSRILGLFWRAGTPRQVCF 
NAIAELITKNVQSKLA 
 
>gi|15838133|ref|NP_298821.1| oxidative stress transcriptional 
regulator [Xylella fastidiosa 9a5c] 
MWNYIPSLAARFGFMNLRDLKYLIALADYKHFGRAATACFVSQPTLSTQIKKLEGELGVSLVERAPRKVM 
MTPAGREAAIRARSIVAEVEEMKEAARRSRDPEAGAVRLGIFPTLGPYLLPHVVPSIRYRFPQLELLLVE 
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EKSDELLAQLREGKLDAALLALPLHDEQLHTEFLFEEPFVLAVPEGHPLATRREMTMEELADERLLLLQD 
GHCLREQALDVCHMTGASEKSEFQATSLETLRQMVVANVGITLLPLLSVKPPVVCSESIRLINFPLDKQP 
SRRIAMVWRRSSAMTTFLERFSGMFKELPKELFDLPQTVVLYKGR 
 
>gi|71274705|ref|ZP_00650993.1| regulatory protein, LysR:LysR, 
substrate-binding [Xylella fastidiosa Dixon] 
MNLRDLKYLIALADYKHFGRAATACFVSQPTLSTQIKKLEGELGVSLVERAPRKVMMTPAGREAAIRARS 
IVAEVEEMKEAARRSRDPEAGAVRLGIFPTLGPYLLPHVVPSIRYRFPQLELLLVEEKSDELLAQLREGK 
LDAALLALPLHDEQLHTEFLFEEPFVLAVPEGHPLATRREMTMEELADERLLLLQDGHCLREQALDVCHM 
TGASEKSEFQATSLETLRQMVVANVGITLLPLLSVKPPVVCSESIRLINFPLDKQPSRRIAMVWRRSSAM 
TTFLERFSSMFKELPKELFDLPQTVVLYKGR 
 
>gi|28198653|ref|NP_778967.1| oxidative stress transcriptional 
regulator [Xylella fastidiosa Temecula1] 
MNLRDLKYLIALADYKHFGRAATACFVSQPTLSTQIKKLEGELGVSLVERAPRKVMMTPAGREAAIRARS 
IVAEVEEMKEAARRSRDPEAGAVRLGIFPTLGPYLLPHVVPSIRYRFPQLELLLVEEKSDELLAQLREGK 
LDAALLALPLHDEQLHTEFLFEEPFVLAVPEGHPLATRREMTMEELADERLLLLQDGHCLREQALDVCHM 
TGASEKSEFQATSLETLRQMVVANVGITLLPLLSVKPPVVCSESIRLINFPLDKQPSRRIAMVWRRSSAM 
TTFLERFSSMFKELPKELFDLPQTAVLYKGR 
 
>gi|58583270|ref|YP_202286.1| oxidative stress transcriptional 
regulator [Xanthomonas oryzae pv. oryzae KACC10331] 
MNLRDLKYLVALADHKHFGRAATACFVSQPTLSTQIKKLEDELGVSLVERAPRKVMLTPAGREAALRARS 
IVAEVEQMKEAARRSQDPEAGTVRLGIFPTLAPYLLPHVVPRIRERFPRLELLLIEEKSDQLMHQLREGR 
LDAALLALPLQDDQLHAEFLFEEPFVLAVPEGHPLSRHDNMTLDALSEQRLLLLGDGHCLREQALDVCHL 
AGALEKSEFQATSLETLRQMVAANVGVTLLPLLAVKPPVARSDNIRLIRFRDDKQPSRRIGMAWRRSSAM 
TAFLDQLSQLFKELPDSLFTLDQPAAGPKAVAA 
 
>gi|54297727|ref|YP_124096.1| Hydrogen peroxide-inducible genes 
activator [Legionella pneumophila str. Paris] 
MNLRDLHYFVILADVKHFGEAAKRCFVSQPTLSMQIKKLEEELGVVLFERTNKQVLLTDQGSKLLDRTRK 
ILILIDEMKELARQSEDPFTGELRLGVIPTVSPYMLPLVMPELKNEYPRLKVWLIEDKTHRLITKLEQGE 
LDVAIMALPIDKRFSCQILYEEKFYFACANTHPLAQAKSVNINDLKNQPIMLLEEGHCLREQAMAVCQLA 
KADDIADFTATSLETLRLMVQAGMGVTLLPALSTLTASTNHLKCIPFSEPAPSRILGLFWRAGTPRQVCF 
NAVAELITKNVQSKLA 
 
>gi|84625106|ref|YP_452478.1| oxidative stress transcriptional 
regulator [Xanthomonas oryzae pv. oryzae MAFF 311018] 
MNLRDLKYLVALADHKHFGRAATACFVSQPTLSTQIKKLEDELGVSLVERAPRKVMLTPAGREAALRARS 
IVAEVEQMKEAARRSQDPEAGTVRLGIFPTLAPYLLPHVVPRIRKRFPRLELLLIEEKSDQLMHQLREGR 
LDAALLALPLQDDQLHAEFLFEEPFVLAVPEGHPLSRHDNMTLDALSEQRLLLLGDGHCLREQALDVCHL 
AGALEKSEFQATSLETLRQMVAANVGVTLLPLLAVKPPVARSDNIRLIRFRDDKQPSRRIGMAWRRSSAM 
TAFLDQLSQLFKELPDSLFTLDQPAAGPKAVAA 
 
>gi|71900667|ref|ZP_00682791.1| regulatory protein, LysR:LysR, 
substrate-binding [Xylella fastidiosa Ann-1] 
MNLRDLKYLIALADYKHFGRAATACFVSQPTLSTQIKKLEGELGVSLVERAPRKVMMTPAGREAAIRARS 
IVAEVEEMKEAARRSRDPEAGAVRLGIFPTLGPYLLPHVVPSIRYRFPQLELLLVEEKSDELLAQLREGK 
LDAALLALPLHDEQLHTEFLFEEPFVLAVPEWHPLATRREMTMEELADERLLLLQDGHCLREQALDVCHM 
TGASEKSEFQATSLETLRQMVVANVGITLLPLLSVKPPVVCSESIRLINFPLDKQPSRRIAMVWRRSSAM 
TTFLERFSSMFKELPKELFDLPQTVLMYKGR 
 
>gi|94490867|ref|ZP_01298093.1| hypothetical protein CburD_01002045 
[Coxiella burnetii Dugway 7E9-12] 
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MNIRDLKYLLAVADSAHFGKAAEKCFVSQPTLSAQLKKLEEELGVRLFERNNKRVLITPIGQIIAAQVRV 
ILQEVEKLKVLAQNAQDPFAGVFHLGIIPTLGPYLLPIILEIFKKRLPKLNLVVYENKTENILHELQQGR 
LDAVILALPVSAPNLVVQELFCEPFYVALPKHHPLAKKKSVTLADLEKETLLLLEEGHCLREQALEACSM 
TAAKTETGFKATSLETLRHLVAAGAGITLLPALSVNAEKSELAIKSFNATIPSRSIGMLWRDFSARKECC 
ETMAKLISAEVKKHPKLKTRAPLKVMERKLE 
 
>gi|29654767|ref|NP_820459.1| hydrogen peroxide-inducible genes 
activator OxyR [Coxiella burnetii RSA 493] 
MNIRDLKYLLAVADSAHFGKAAEKCFVSQPTLSAQLKKLEEELGVRLFERNNKRVLITPIGQIIAAQVRV 
ILQEVEKLKVLAQNAQDPFAGVFHLGIIPTLGPYLLPIIFEIFKKRLPKLNLVVYENKTENILHELQQGR 
LDAVILALPVSAPNLVVQELFCEPFYVALPKHHPLAKKKSVTLADLEKETLLLLEEGHCLREQALEACSM 
TAAKTETGFKATSLETLRHLVAAGAGITLLPALSVNAEKSELAIKSFNATIPSRSIGMLWRDFSARKECC 
ETMAKLISAEVKKHPKLKTRAPLKVMERKLE 
 
>gi|89357996|ref|ZP_01195818.1| oxidative stress transcriptional 
regulator [Xanthobacter autotrophicus Py2] 
MTLRELQYLVALADHRNFRRAAEACLVSQPTLSTQLRKLEEELGVPLVERAPRRVMLTPAGREAVERARR 
ILDEVEQLKEGARRSCAAEAGALKLGVFPTLGPYLLPHVVPLIRARFPELELLLFEEKSAALISRLNYGT 
LDAAFLALPVHDSHFHAEFLFEEPFLLAVPGTHALASRDNLSITELSRYNLMLLEDGHCLRDQALDVCQM 
AGAREKSEFRATSLETLRQMVAAGVGMTLLPMLATRTPSQPAENIHLLEFSDSKPSRQIAMLWRKTSAMG 
RLLADVAQVCRTLPQELLAPRH 
 
>gi|77359710|ref|YP_339285.1| hydrogen peroxide-inducible genes 
activator similar to OxyR (but also to other LysR like activators) 
[Pseudoalteromonas haloplanktis TAC125] 
MNMNLKDLEYVKAIAHFKHFRKAADACFVSQPTLSGQVKKLEQELGVTLFDRSTKQVTLTAKGERLLTQI 
NVILEQTQILKELAATSNEPLQGKLTIGIIPTIAPYLLPVLLTSMKEAFINSRFSFIEMQTATILEALDN 
GELDFAILADVPELKKYHSVNLYKEDFLVAVSHDNSLAQQKKVALRELQGCSLLMLSDGHCFKDQAQQFC 
FSAGVNVSSQYQGNSLETLLALVAMDDGVTFVPKLACTERVGVNYLAIYPNQQRNIVFACRKHYPHLSGV 
EQLGEWLSAHPNLKAKLTKSLN 
 
>gi|88811285|ref|ZP_01126541.1| oxidative stress transcriptional 
regulator [Nitrococcus mobilis Nb-231] 
MVQINLRDLRYLVAVANHRHFGRAAAACYVSQPTLSTQLKKLEQQLGVQLIERNSKQVMLTQAGKMIAER 
AHRVLNEVADIVDAARAAGDPMAGDLRLGLIPTVGPYLLPHLIPVLRDVCPRLKPLLYEEQTRALVTRLH 
RGELDAALMAVPVNDPRLHFTSLFHEPFYLALPAEHWLARGQHIELGDLEGEHILLLEEGHCLRDQALDV 
CDLAGASDIAEFHATSLETLRQMVALGAGVTLLPALAAAANAAVPNHAAIELRPFQQPVPQREMALYWRK 
GAAREPALHALADLIRNLSVVRALREPKQANHSAA 
 
>gi|120575115|gb|EAX31739.1| hydrogen peroxide-inducible genes 
activator [Coxiella burnetii 'MSU Goat Q177'] 
MNIRDLKYLLAVADSAHFGKAAEKCFVSQPTLSAQLKKLEEELGVRLFERNNKRVLITPIGQIIAAQVRV 
ILQEVEKLKVLAQNAQDPFAGVFHLGIIPTLGPYLLPIILEIFKKRLPKLNLVVYENKTENILHELQQGR 
LDAVILALPVSAPNLVVQELFCEPFYVALPKHHPLAKKKSVTLADLEKETLLLLEEGHCLREQALEACSM 
TAAKTETGFKAKATSLETLRHLVAAGAGITLLPALSVNAEKSELAIKSFNATIPSRSIGMLWRDFSARKE 
CCETMAKLISAEVKKHPKLKTRAPLKVMERKLE 
 
>gi|94494050|ref|ZP_01301253.1| hypothetical protein Rgryl_01000580 
[Rickettsiella grylli] 
MNFRDLSYLLALAEYRHFGKAAKACSVSQPTLSIQLKKLEQTLGMKLFERGQKKVLMTTSGLRMVEKAKH 
IVQAVDEFKRFAKLEKDPFLAELRLGVISSLCPYLLPYILPSIMQELPKITLYLYEDKTENLLIQLKEGK 
LDAVVLALPIPHKGLYLRPLFKEPFFLIMPRSHALYDAKKLDLNDLGHYNLLLLEEGHCFRDQALDVCHK 
RSNLKEKTNYRATSLETLRHMVGTGAGITLLPLLALETHPFIKNVPLASPVPERKIGMLWRKGSALERCC 
KKIATLIENNIPNVITHLEKKLQSKHRMHR 
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>gi|74318341|ref|YP_316081.1| oxidative stress transcriptional 
regulator [Thiobacillus denitrificans ATCC 25259] 
MTLQELRYLVALADHGHFGRAAEACFITQSTLSTQIKKLEDFLGVTLFDRSLKRVTPTPIGREILQAART 
IVDEAERIRTLAKHAQDPMTRTVHLGVIPTLGPYYLPHALTLVHRKHPGLRLLLREEMTPQILEHLADGK 
LDAGLLALPVTDEGLRVEPLFHEPFYAALPADHALAAREALSVADIMAEKLLLLDEGHCLREQALDVCGA 
RSSGREEVRATSLETLRQMVGMGLGLTLLPALAVDAAPRQTRKLVEIRPFRSPPPGRTIGLVWRRRAPFP 
ETFERLAATLKASLPAGVEAV 
 
>gi|121999203|ref|YP_001003990.1| transcriptional regulator, LysR 
family [Halorhodospira halophila SL1] 
MNLRDLRYLVAVAEHRHFGRAARACYVSQPTLSTQLKKLEEYLEVQLVERNRRRVLLTPLGERLAERARS 
ILSAVDDMVEVARAQAEPMTGDVRLGVIPTAGPYLLPHVIPDLAQSYPRLRLHLREDLTQRLLDQLRAGS 
LDGAILASPIAGDDLVSEPLCHEPFYLAVPRGHDLDRPEPVDAKDLQQTELMLLEEGHCLREQALELCRR 
NDVGEAAAFRATSLETLRQMVAAGVGVTLLPALAAAASRLGPDHAAISLRPFAEPAPSRDLALYWRVGTA 
REPTFRELVERMRSAAVLQDPTQTLPAA 
 
>gi|115422998|emb|CAJ49528.1| hydrogen peroxide-inducible genes 
activator [Bordetella avium 197N] 
MTLTELKYIVAVARERHFGRAAEACFVSQPTLSVAIRKLEDELGVTLFERGGSEVGVTPIGQRIVAQAQK 
VLEESASIKEIARQGHDPLAGPLRVGVIHTIGPYLLPRLVPLQIERTPQMPLLLQENFTVRLVELLRQGE 
IDCAIMALPLPEAGLVTQPLYDEPFLVAVPNDHEWAQRQSIDAQDLKQQTMLLLGSGHCFRDQVLEVCPE 
LSRFAATSDGIQRTFEGSSLETIRHMVAAGIGVTVLPVTAVPEQATSKSLITYVPFEGAAPTRRVVLAWR 
RSFPRMAAVEALAQAVYACGLPGVTMLDDEAAQSQGESLLA 
 
>gi|149928262|ref|ZP_01916505.1| oxidative stress-inducible genes 
activator [Limnobacter sp. MED105] 
MTLTELKYIVALAREKHFGRAADACFVSQPTLSVAIKKLEEELSVSLFERGSNEVSLTPVGERIVVQAQR 
VLEEASAIKSIAQQGMDPLAGPLRVGVIYTIGPYLLPGLVSSMIERVPSMPLVLQENFTVRLLELLKQGE 
IDVAVLALPINESGFVIQPLYDEPFMVALPKSHRWAHEKTINSDDLRSENMLLLGTGHCFRDQVLGVCPE 
LSRFSQSSEGIQRTFEGSSLETIRHMVASGVGITVLPSSSVPNPVPKESLLTYIPLADDDTRRTVALVWR 
KSFGRREALEALRDAIMECDLNGVEFLDAPQMVR 
 
>gi|33592699|ref|NP_880343.1| probable LysR-family transcriptional 
regulator [Bordetella pertussis Tohama I] 
MTLTELKYIVAVARERHFGRAAEACFVSQPTLSVAIRKLEDELGVTLFERGGTEVGVTPIGQRIVAQAQK 
VLEESASIKEIARQGHDPLAGPLRVGVIHTIGPYLLPRLVPEQIARTPQMPLLLQENFTVRLVELLRQGE 
IDCAIMALPLPEAGLVMQPLYDEPFVVAVPHDHEWAQRKAIDAQDLKQQTMLLLGSGHCFRDQVLEVCPE 
LSRFSASSDGIQRTFEGSSLETIRHMVAAGIGVTVLPFTAVPNPPQPKSLLRYLPFDGETPERRVVLAWR 
RSFPRLAAIEALAQAVYACGLPGVRMLDEEAASAQVD 
 
>gi|104784350|ref|YP_610848.1| transcriptional regulator, LysR family 
[Pseudomonas entomophila L48] 
MTLTELRYIVTLAQEQHFGHAAERCHVSQPTLSVGVKKLEDELGVLIFERSKSAVRLTPVGESIVAQAQK 
VLEQAQGIRELAQAGKNQLTAPLKVGAIYTVGPYLFPHLIPQLHRVAPQMPLYIEENFTHVLREKLRNGE 
LDAVIIALPFNEADVLTLPLYDEPFCALMPADHPWTQKDTIDTAMLNDKSLLLLGEGHCFRDQVLEACPT 
LNKGGEGSKHTTVESSSLETIRHMVASGLGVSILPLSAVHSHHYAPGVIEVRPLTAPAPFRTVAIAWRAS 
FPRPKAIEILADSIRLCSVAKAPVEQPA 
 
>gi|66043472|ref|YP_233313.1| regulatory protein, LysR:LysR, substrate-
binding [Pseudomonas syringae pv. syringae B728a] 
MTLTELRYIVTLAQEQHFGHAAERCHVSQPTLSVGVKKLEDELGVLIFERSKSAVRLTPVGEGIVAQAQK 
VLEQAQGIRELAQAGKNQLTAPLKVGAIYTVGPYLFPHLIPQLHRVAPQMPLYIEENFTHVLRDKLRNGE 
LDAVIIALPFNEADVLTLPLYDEPFSVLMPADHPWTQKETIDASALNDKSLLLLGEGHCFRDQVLEACPT 
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LGKGNEGAKHTTVESSSLETIRHMVASGLGISILPLSAVDSHHYAPGVIEVRPLTPPVPFRTVAIAWRAS 
FPRPKAIEILADSARLCSVARPKTVAS 
 
>gi|126356271|ref|ZP_01713276.1| transcriptional regulator, LysR family 
[Pseudomonas putida GB-1] 
MTLTELRYIVTLAQEQHFGHAAERCHVSQPTLSVGVKKLEDELGVLIFERSKSAVRLTPVGESIVAQAQK 
VLEQAQGIRELAQAGKNQLTAPLKVGAIYTVGPYLFPHLIPQLHRVAPQMPLYIEENFTHVLREKLRNGE 
LDAVIIALPFNEADVLTLPLYDEPFCALMPADHPWTAKKTIDTAMLNDKSLLLLGEGHCFRDQVLEACPT 
LNKGGEGSRHTTVESSSLETIRHMVASGLGVSILPLSAVHSHHYAPGVIEVRPLTAPAPFRTVAIAWRAS 
FPRPKAIEILADSIRLCSVAKNPAEQPA 
 
>gi|146280532|ref|YP_001170685.1| probable transcriptional regulator 
[Pseudomonas stutzeri A1501] 
MLTMTLTELRYIVTLAQEQHFGRAAERCHVSQPTLSVGVKKLEDELGVLIFERTKSAVRLTPVGEGIVTQ 
AQKVLEQAQSIRELAQVGKNQLAAPLKVGAIYTVGPYMFPHLIPQLHRVAPDMPLYIEENFTHVLRDKLR 
TGELDAIIIALPFQEADVLTKPLYDEPFYVLMPADHPWTAKETIDAEMLNDKSLLLLGEGHCFRDQVLEA 
CPTVRKGEAASHTTVESSSLETIRHMVASGLGVSILPLSAVESHHYSPGVLEIRPLTPPVPFRTVAIAWR 
ASFPRPKAIEILADSIRLCSVGKPPSAKA 
 
>gi|26991985|ref|NP_747410.1| transcriptional regulator, LysR family 
[Pseudomonas putida KT2440] 
MTLTELRYIVTLAQEQHFGHAAERCHVSQPTLSVGVKKLEDELGVLIFERSKSAVRLTPVGENIVAQAQK 
VLEQAQGIRELAQAGKNQLTAPLKVGAIYTVGPYLFPHLIPQLHRVAPQMPLYIEENFTHVLREKLRNGE 
LDAVIIALPFNEADVLTLPLYDEPFCALMPADHPWTAKKTIDTAMLNDKSLLLLGEGHCFRDQVLEACPT 
LNKGGEGSRHTTVESSSLETIRHMVASGLGVSILPLSAVHSHHYAPGVIEVRPLTAPAPFRTVAIAWRAS 
FPRPKAIEILADSIRLCSVAKNPAEQPA 
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